date generated: 2020-09-10
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## A1BG -0.3065476
## A1BG-AS1 0.2667380
## A1CF -0.1889397
## A2M -0.4487032
## A2M-AS1 -0.9062206
## A2ML1 1.1221162
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 2400 |
| num_genes_in_profile | 21631 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 8419 |
| num_profile_genes_not_in_sets | 13212 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used: GMT file of genesets: ReactomePathways.gmt
| Gene sets metrics | |
|---|---|
| num_genesets | 2400 |
| num_genesets_excluded | 1039 |
| num_genesets_included | 1361 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Top N= 100 gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| IRAK4 deficiency (TLR2/4) | 10 | 2.19e-06 | 0.864 | 3.11e-05 |
| MyD88 deficiency (TLR2/4) | 10 | 2.19e-06 | 0.864 | 3.11e-05 |
| Peptide chain elongation | 88 | 5.06e-36 | -0.771 | 6.88e-34 |
| Eukaryotic Translation Elongation | 93 | 1.44e-37 | -0.767 | 2.18e-35 |
| Selenocysteine synthesis | 92 | 1.36e-35 | -0.750 | 1.68e-33 |
| Viral mRNA Translation | 88 | 6.76e-34 | -0.747 | 6.14e-32 |
| Formation of a pool of free 40S subunits | 100 | 4.05e-38 | -0.746 | 6.88e-36 |
| Eukaryotic Translation Termination | 92 | 3.30e-34 | -0.734 | 3.21e-32 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 1.52e-05 | 0.721 | 1.79e-04 |
| alpha-linolenic acid (ALA) metabolism | 12 | 1.52e-05 | 0.721 | 1.79e-04 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 94 | 1.58e-32 | -0.708 | 1.20e-30 |
| Translocation of ZAP-70 to Immunological synapse | 24 | 1.98e-09 | -0.707 | 5.09e-08 |
| L13a-mediated translational silencing of Ceruloplasmin expression | 110 | 7.55e-35 | -0.678 | 8.56e-33 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | 111 | 1.11e-34 | -0.674 | 1.16e-32 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | 100 | 3.17e-31 | -0.672 | 2.27e-29 |
| Formation of the ternary complex, and subsequently, the 43S complex | 51 | 1.92e-16 | -0.665 | 8.41e-15 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 11 | 1.55e-04 | 0.659 | 1.33e-03 |
| Regulation of TLR by endogenous ligand | 11 | 2.34e-04 | 0.641 | 1.88e-03 |
| Major pathway of rRNA processing in the nucleolus and cytosol | 180 | 6.06e-50 | -0.641 | 2.06e-47 |
| Cap-dependent Translation Initiation | 118 | 2.65e-33 | -0.640 | 2.12e-31 |
| Eukaryotic Translation Initiation | 118 | 2.65e-33 | -0.640 | 2.12e-31 |
| rRNA processing in the nucleus and cytosol | 190 | 7.19e-52 | -0.636 | 4.89e-49 |
| Selenoamino acid metabolism | 114 | 2.44e-30 | -0.620 | 1.58e-28 |
| RHO GTPases Activate ROCKs | 18 | 6.30e-06 | 0.615 | 8.41e-05 |
| Uptake and function of anthrax toxins | 10 | 8.17e-04 | 0.611 | 4.92e-03 |
| Activation of the pre-replicative complex | 32 | 2.71e-09 | -0.607 | 6.59e-08 |
| MET activates RAP1 and RAC1 | 10 | 1.02e-03 | 0.600 | 5.89e-03 |
| rRNA processing | 217 | 2.08e-51 | -0.593 | 9.44e-49 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 114 | 1.63e-27 | -0.588 | 9.23e-26 |
| Nonsense-Mediated Decay (NMD) | 114 | 1.63e-27 | -0.588 | 9.23e-26 |
| rRNA modification in the nucleus and cytosol | 59 | 5.93e-15 | -0.587 | 2.45e-13 |
| SRP-dependent cotranslational protein targeting to membrane | 111 | 1.23e-26 | -0.586 | 6.19e-25 |
| Translation initiation complex formation | 58 | 1.23e-14 | -0.585 | 4.80e-13 |
| Nucleobase biosynthesis | 13 | 2.88e-04 | -0.581 | 2.22e-03 |
| Influenza Viral RNA Transcription and Replication | 135 | 5.44e-31 | -0.576 | 3.70e-29 |
| Ribosomal scanning and start codon recognition | 58 | 3.26e-14 | -0.576 | 1.20e-12 |
| Hyaluronan uptake and degradation | 12 | 5.72e-04 | 0.574 | 3.74e-03 |
| Unwinding of DNA | 12 | 5.97e-04 | -0.572 | 3.87e-03 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 59 | 2.93e-14 | -0.572 | 1.11e-12 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | 10 | 1.74e-03 | 0.572 | 8.87e-03 |
| VLDLR internalisation and degradation | 12 | 6.42e-04 | 0.569 | 4.06e-03 |
| PD-1 signaling | 28 | 2.24e-07 | -0.565 | 4.12e-06 |
| Platelet sensitization by LDL | 16 | 1.04e-04 | 0.560 | 9.47e-04 |
| DNA strand elongation | 32 | 4.60e-08 | -0.558 | 1.01e-06 |
| Processive synthesis on the lagging strand | 15 | 2.00e-04 | -0.555 | 1.67e-03 |
| Lagging Strand Synthesis | 20 | 2.12e-05 | -0.549 | 2.41e-04 |
| Gap junction trafficking | 13 | 6.40e-04 | 0.547 | 4.06e-03 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 1.79e-03 | 0.544 | 9.07e-03 |
| RHO GTPases Activate WASPs and WAVEs | 35 | 3.78e-08 | 0.537 | 8.44e-07 |
| Advanced glycosylation endproduct receptor signaling | 12 | 1.28e-03 | 0.537 | 7.01e-03 |
| PCNA-Dependent Long Patch Base Excision Repair | 21 | 2.52e-05 | -0.531 | 2.77e-04 |
| PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 9.51e-04 | 0.529 | 5.58e-03 |
| Removal of the Flap Intermediate | 14 | 6.35e-04 | -0.527 | 4.06e-03 |
| Erythrocytes take up carbon dioxide and release oxygen | 12 | 1.58e-03 | 0.527 | 8.15e-03 |
| O2/CO2 exchange in erythrocytes | 12 | 1.58e-03 | 0.527 | 8.15e-03 |
| SLBP independent Processing of Histone Pre-mRNAs | 10 | 4.33e-03 | -0.521 | 1.78e-02 |
| WNT5A-dependent internalization of FZD4 | 13 | 1.18e-03 | 0.519 | 6.60e-03 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 1.17e-05 | -0.517 | 1.47e-04 |
| Retrograde neurotrophin signalling | 12 | 2.17e-03 | 0.511 | 1.06e-02 |
| Prolonged ERK activation events | 13 | 1.51e-03 | 0.508 | 7.99e-03 |
| Purine ribonucleoside monophosphate biosynthesis | 10 | 5.45e-03 | -0.507 | 2.19e-02 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 11 | 3.87e-03 | -0.503 | 1.64e-02 |
| Influenza Infection | 154 | 4.36e-27 | -0.503 | 2.28e-25 |
| Signal transduction by L1 | 20 | 1.05e-04 | 0.501 | 9.53e-04 |
| Erythropoietin activates RAS | 13 | 1.81e-03 | 0.500 | 9.12e-03 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | 15 | 8.51e-04 | 0.497 | 5.08e-03 |
| Activation of ATR in response to replication stress | 37 | 2.01e-07 | -0.494 | 3.75e-06 |
| Telomere C-strand (Lagging Strand) Synthesis | 34 | 6.34e-07 | -0.493 | 1.04e-05 |
| Phosphorylation of CD3 and TCR zeta chains | 27 | 1.07e-05 | -0.489 | 1.38e-04 |
| RHO GTPases activate CIT | 18 | 3.25e-04 | 0.489 | 2.45e-03 |
| Generation of second messenger molecules | 38 | 2.64e-07 | -0.482 | 4.67e-06 |
| Pre-NOTCH Processing in Golgi | 18 | 4.08e-04 | 0.481 | 2.89e-03 |
| Heme degradation | 10 | 8.89e-03 | 0.478 | 3.20e-02 |
| BBSome-mediated cargo-targeting to cilium | 22 | 1.14e-04 | -0.475 | 1.02e-03 |
| Golgi Cisternae Pericentriolar Stack Reorganization | 14 | 2.08e-03 | 0.475 | 1.03e-02 |
| Diseases associated with the TLR signaling cascade | 23 | 7.99e-05 | 0.475 | 7.55e-04 |
| Diseases of Immune System | 23 | 7.99e-05 | 0.475 | 7.55e-04 |
| RHO GTPases activate IQGAPs | 11 | 6.80e-03 | 0.471 | 2.58e-02 |
| EPHB-mediated forward signaling | 32 | 4.14e-06 | 0.470 | 5.69e-05 |
| RHO GTPases Activate NADPH Oxidases | 21 | 2.04e-04 | 0.468 | 1.68e-03 |
| Telomere C-strand synthesis initiation | 13 | 3.50e-03 | -0.468 | 1.51e-02 |
| Sema4D in semaphorin signaling | 22 | 1.52e-04 | 0.466 | 1.32e-03 |
| COPI-independent Golgi-to-ER retrograde traffic | 33 | 5.41e-06 | 0.457 | 7.29e-05 |
| Cargo concentration in the ER | 30 | 1.48e-05 | 0.457 | 1.79e-04 |
| Sema4D induced cell migration and growth-cone collapse | 19 | 5.82e-04 | 0.456 | 3.79e-03 |
| Leading Strand Synthesis | 14 | 3.29e-03 | -0.454 | 1.45e-02 |
| Polymerase switching | 14 | 3.29e-03 | -0.454 | 1.45e-02 |
| Signaling by Erythropoietin | 24 | 1.26e-04 | 0.452 | 1.13e-03 |
| GPVI-mediated activation cascade | 31 | 1.49e-05 | 0.449 | 1.79e-04 |
| Neutrophil degranulation | 458 | 3.16e-61 | 0.449 | 4.30e-58 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 1.02e-02 | 0.447 | 3.63e-02 |
| RHO GTPases activate PAKs | 20 | 5.38e-04 | 0.447 | 3.59e-03 |
| Hyaluronan metabolism | 15 | 2.74e-03 | 0.447 | 1.24e-02 |
| Translation | 295 | 9.42e-40 | -0.446 | 2.14e-37 |
| Frs2-mediated activation | 11 | 1.05e-02 | 0.445 | 3.69e-02 |
| Regulated proteolysis of p75NTR | 11 | 1.09e-02 | 0.443 | 3.78e-02 |
| Translesion synthesis by REV1 | 16 | 2.21e-03 | -0.442 | 1.07e-02 |
| Trafficking of GluR2-containing AMPA receptors | 12 | 8.28e-03 | 0.440 | 3.01e-02 |
| AKT phosphorylates targets in the cytosol | 14 | 4.65e-03 | 0.437 | 1.89e-02 |
| Mucopolysaccharidoses | 11 | 1.22e-02 | 0.437 | 4.12e-02 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| IRAK4 deficiency (TLR2/4) | 10 | 2.19e-06 | 0.864000 | 3.11e-05 |
| MyD88 deficiency (TLR2/4) | 10 | 2.19e-06 | 0.864000 | 3.11e-05 |
| Peptide chain elongation | 88 | 5.06e-36 | -0.771000 | 6.88e-34 |
| Eukaryotic Translation Elongation | 93 | 1.44e-37 | -0.767000 | 2.18e-35 |
| Selenocysteine synthesis | 92 | 1.36e-35 | -0.750000 | 1.68e-33 |
| Viral mRNA Translation | 88 | 6.76e-34 | -0.747000 | 6.14e-32 |
| Formation of a pool of free 40S subunits | 100 | 4.05e-38 | -0.746000 | 6.88e-36 |
| Eukaryotic Translation Termination | 92 | 3.30e-34 | -0.734000 | 3.21e-32 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 1.52e-05 | 0.721000 | 1.79e-04 |
| alpha-linolenic acid (ALA) metabolism | 12 | 1.52e-05 | 0.721000 | 1.79e-04 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 94 | 1.58e-32 | -0.708000 | 1.20e-30 |
| Translocation of ZAP-70 to Immunological synapse | 24 | 1.98e-09 | -0.707000 | 5.09e-08 |
| L13a-mediated translational silencing of Ceruloplasmin expression | 110 | 7.55e-35 | -0.678000 | 8.56e-33 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | 111 | 1.11e-34 | -0.674000 | 1.16e-32 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | 100 | 3.17e-31 | -0.672000 | 2.27e-29 |
| Formation of the ternary complex, and subsequently, the 43S complex | 51 | 1.92e-16 | -0.665000 | 8.41e-15 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 11 | 1.55e-04 | 0.659000 | 1.33e-03 |
| Regulation of TLR by endogenous ligand | 11 | 2.34e-04 | 0.641000 | 1.88e-03 |
| Major pathway of rRNA processing in the nucleolus and cytosol | 180 | 6.06e-50 | -0.641000 | 2.06e-47 |
| Cap-dependent Translation Initiation | 118 | 2.65e-33 | -0.640000 | 2.12e-31 |
| Eukaryotic Translation Initiation | 118 | 2.65e-33 | -0.640000 | 2.12e-31 |
| rRNA processing in the nucleus and cytosol | 190 | 7.19e-52 | -0.636000 | 4.89e-49 |
| Selenoamino acid metabolism | 114 | 2.44e-30 | -0.620000 | 1.58e-28 |
| RHO GTPases Activate ROCKs | 18 | 6.30e-06 | 0.615000 | 8.41e-05 |
| Uptake and function of anthrax toxins | 10 | 8.17e-04 | 0.611000 | 4.92e-03 |
| Activation of the pre-replicative complex | 32 | 2.71e-09 | -0.607000 | 6.59e-08 |
| MET activates RAP1 and RAC1 | 10 | 1.02e-03 | 0.600000 | 5.89e-03 |
| rRNA processing | 217 | 2.08e-51 | -0.593000 | 9.44e-49 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 114 | 1.63e-27 | -0.588000 | 9.23e-26 |
| Nonsense-Mediated Decay (NMD) | 114 | 1.63e-27 | -0.588000 | 9.23e-26 |
| rRNA modification in the nucleus and cytosol | 59 | 5.93e-15 | -0.587000 | 2.45e-13 |
| SRP-dependent cotranslational protein targeting to membrane | 111 | 1.23e-26 | -0.586000 | 6.19e-25 |
| Translation initiation complex formation | 58 | 1.23e-14 | -0.585000 | 4.80e-13 |
| Nucleobase biosynthesis | 13 | 2.88e-04 | -0.581000 | 2.22e-03 |
| Influenza Viral RNA Transcription and Replication | 135 | 5.44e-31 | -0.576000 | 3.70e-29 |
| Ribosomal scanning and start codon recognition | 58 | 3.26e-14 | -0.576000 | 1.20e-12 |
| Hyaluronan uptake and degradation | 12 | 5.72e-04 | 0.574000 | 3.74e-03 |
| Unwinding of DNA | 12 | 5.97e-04 | -0.572000 | 3.87e-03 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 59 | 2.93e-14 | -0.572000 | 1.11e-12 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | 10 | 1.74e-03 | 0.572000 | 8.87e-03 |
| VLDLR internalisation and degradation | 12 | 6.42e-04 | 0.569000 | 4.06e-03 |
| PD-1 signaling | 28 | 2.24e-07 | -0.565000 | 4.12e-06 |
| Platelet sensitization by LDL | 16 | 1.04e-04 | 0.560000 | 9.47e-04 |
| DNA strand elongation | 32 | 4.60e-08 | -0.558000 | 1.01e-06 |
| Processive synthesis on the lagging strand | 15 | 2.00e-04 | -0.555000 | 1.67e-03 |
| Lagging Strand Synthesis | 20 | 2.12e-05 | -0.549000 | 2.41e-04 |
| Gap junction trafficking | 13 | 6.40e-04 | 0.547000 | 4.06e-03 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 1.79e-03 | 0.544000 | 9.07e-03 |
| RHO GTPases Activate WASPs and WAVEs | 35 | 3.78e-08 | 0.537000 | 8.44e-07 |
| Advanced glycosylation endproduct receptor signaling | 12 | 1.28e-03 | 0.537000 | 7.01e-03 |
| PCNA-Dependent Long Patch Base Excision Repair | 21 | 2.52e-05 | -0.531000 | 2.77e-04 |
| PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 9.51e-04 | 0.529000 | 5.58e-03 |
| Removal of the Flap Intermediate | 14 | 6.35e-04 | -0.527000 | 4.06e-03 |
| Erythrocytes take up carbon dioxide and release oxygen | 12 | 1.58e-03 | 0.527000 | 8.15e-03 |
| O2/CO2 exchange in erythrocytes | 12 | 1.58e-03 | 0.527000 | 8.15e-03 |
| SLBP independent Processing of Histone Pre-mRNAs | 10 | 4.33e-03 | -0.521000 | 1.78e-02 |
| WNT5A-dependent internalization of FZD4 | 13 | 1.18e-03 | 0.519000 | 6.60e-03 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 1.17e-05 | -0.517000 | 1.47e-04 |
| Retrograde neurotrophin signalling | 12 | 2.17e-03 | 0.511000 | 1.06e-02 |
| Prolonged ERK activation events | 13 | 1.51e-03 | 0.508000 | 7.99e-03 |
| Purine ribonucleoside monophosphate biosynthesis | 10 | 5.45e-03 | -0.507000 | 2.19e-02 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 11 | 3.87e-03 | -0.503000 | 1.64e-02 |
| Influenza Infection | 154 | 4.36e-27 | -0.503000 | 2.28e-25 |
| Signal transduction by L1 | 20 | 1.05e-04 | 0.501000 | 9.53e-04 |
| Erythropoietin activates RAS | 13 | 1.81e-03 | 0.500000 | 9.12e-03 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | 15 | 8.51e-04 | 0.497000 | 5.08e-03 |
| Activation of ATR in response to replication stress | 37 | 2.01e-07 | -0.494000 | 3.75e-06 |
| Telomere C-strand (Lagging Strand) Synthesis | 34 | 6.34e-07 | -0.493000 | 1.04e-05 |
| Phosphorylation of CD3 and TCR zeta chains | 27 | 1.07e-05 | -0.489000 | 1.38e-04 |
| RHO GTPases activate CIT | 18 | 3.25e-04 | 0.489000 | 2.45e-03 |
| Generation of second messenger molecules | 38 | 2.64e-07 | -0.482000 | 4.67e-06 |
| Pre-NOTCH Processing in Golgi | 18 | 4.08e-04 | 0.481000 | 2.89e-03 |
| Heme degradation | 10 | 8.89e-03 | 0.478000 | 3.20e-02 |
| BBSome-mediated cargo-targeting to cilium | 22 | 1.14e-04 | -0.475000 | 1.02e-03 |
| Golgi Cisternae Pericentriolar Stack Reorganization | 14 | 2.08e-03 | 0.475000 | 1.03e-02 |
| Diseases associated with the TLR signaling cascade | 23 | 7.99e-05 | 0.475000 | 7.55e-04 |
| Diseases of Immune System | 23 | 7.99e-05 | 0.475000 | 7.55e-04 |
| RHO GTPases activate IQGAPs | 11 | 6.80e-03 | 0.471000 | 2.58e-02 |
| EPHB-mediated forward signaling | 32 | 4.14e-06 | 0.470000 | 5.69e-05 |
| RHO GTPases Activate NADPH Oxidases | 21 | 2.04e-04 | 0.468000 | 1.68e-03 |
| Telomere C-strand synthesis initiation | 13 | 3.50e-03 | -0.468000 | 1.51e-02 |
| Sema4D in semaphorin signaling | 22 | 1.52e-04 | 0.466000 | 1.32e-03 |
| COPI-independent Golgi-to-ER retrograde traffic | 33 | 5.41e-06 | 0.457000 | 7.29e-05 |
| Cargo concentration in the ER | 30 | 1.48e-05 | 0.457000 | 1.79e-04 |
| Sema4D induced cell migration and growth-cone collapse | 19 | 5.82e-04 | 0.456000 | 3.79e-03 |
| Leading Strand Synthesis | 14 | 3.29e-03 | -0.454000 | 1.45e-02 |
| Polymerase switching | 14 | 3.29e-03 | -0.454000 | 1.45e-02 |
| Signaling by Erythropoietin | 24 | 1.26e-04 | 0.452000 | 1.13e-03 |
| GPVI-mediated activation cascade | 31 | 1.49e-05 | 0.449000 | 1.79e-04 |
| Neutrophil degranulation | 458 | 3.16e-61 | 0.449000 | 4.30e-58 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 1.02e-02 | 0.447000 | 3.63e-02 |
| RHO GTPases activate PAKs | 20 | 5.38e-04 | 0.447000 | 3.59e-03 |
| Hyaluronan metabolism | 15 | 2.74e-03 | 0.447000 | 1.24e-02 |
| Translation | 295 | 9.42e-40 | -0.446000 | 2.14e-37 |
| Frs2-mediated activation | 11 | 1.05e-02 | 0.445000 | 3.69e-02 |
| Regulated proteolysis of p75NTR | 11 | 1.09e-02 | 0.443000 | 3.78e-02 |
| Translesion synthesis by REV1 | 16 | 2.21e-03 | -0.442000 | 1.07e-02 |
| Trafficking of GluR2-containing AMPA receptors | 12 | 8.28e-03 | 0.440000 | 3.01e-02 |
| AKT phosphorylates targets in the cytosol | 14 | 4.65e-03 | 0.437000 | 1.89e-02 |
| Mucopolysaccharidoses | 11 | 1.22e-02 | 0.437000 | 4.12e-02 |
| Detoxification of Reactive Oxygen Species | 32 | 2.51e-05 | 0.430000 | 2.77e-04 |
| Metabolism of non-coding RNA | 53 | 6.30e-08 | -0.429000 | 1.30e-06 |
| snRNP Assembly | 53 | 6.30e-08 | -0.429000 | 1.30e-06 |
| RHO GTPases activate PKNs | 48 | 3.53e-07 | 0.425000 | 6.00e-06 |
| Gap junction trafficking and regulation | 15 | 4.41e-03 | 0.425000 | 1.81e-02 |
| Regulation of IFNG signaling | 14 | 6.27e-03 | 0.422000 | 2.43e-02 |
| Recycling pathway of L1 | 26 | 2.57e-04 | 0.414000 | 2.03e-03 |
| Translesion synthesis by POLI | 17 | 3.35e-03 | -0.411000 | 1.47e-02 |
| Negative regulation of MET activity | 18 | 2.58e-03 | 0.410000 | 1.18e-02 |
| Polymerase switching on the C-strand of the telomere | 26 | 2.94e-04 | -0.410000 | 2.25e-03 |
| RNA Polymerase I Promoter Opening | 19 | 2.22e-03 | 0.405000 | 1.07e-02 |
| Dissolution of Fibrin Clot | 12 | 1.51e-02 | 0.405000 | 4.93e-02 |
| ERKs are inactivated | 13 | 1.17e-02 | 0.404000 | 4.00e-02 |
| Regulation of signaling by CBL | 18 | 3.09e-03 | 0.403000 | 1.38e-02 |
| tRNA modification in the nucleus and cytosol | 43 | 5.03e-06 | -0.402000 | 6.85e-05 |
| Insulin receptor recycling | 21 | 1.49e-03 | 0.400000 | 7.93e-03 |
| MAP2K and MAPK activation | 34 | 5.66e-05 | 0.399000 | 5.54e-04 |
| Extension of Telomeres | 51 | 9.09e-07 | -0.397000 | 1.44e-05 |
| IRAK1 recruits IKK complex | 10 | 3.02e-02 | 0.396000 | 8.52e-02 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 10 | 3.02e-02 | 0.396000 | 8.52e-02 |
| Integrin signaling | 22 | 1.34e-03 | 0.395000 | 7.29e-03 |
| RORA activates gene expression | 18 | 3.76e-03 | 0.394000 | 1.61e-02 |
| Interactions of Vpr with host cellular proteins | 37 | 3.43e-05 | -0.394000 | 3.70e-04 |
| Resolution of Abasic Sites (AP sites) | 37 | 4.22e-05 | -0.389000 | 4.35e-04 |
| Translesion synthesis by POLK | 17 | 5.73e-03 | -0.387000 | 2.26e-02 |
| VxPx cargo-targeting to cilium | 19 | 3.50e-03 | 0.387000 | 1.51e-02 |
| Signaling by high-kinase activity BRAF mutants | 31 | 2.02e-04 | 0.386000 | 1.68e-03 |
| Rev-mediated nuclear export of HIV RNA | 35 | 7.89e-05 | -0.386000 | 7.55e-04 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 14 | 1.27e-02 | -0.385000 | 4.25e-02 |
| mRNA decay by 3' to 5' exoribonuclease | 16 | 7.70e-03 | -0.385000 | 2.86e-02 |
| Regulation of expression of SLITs and ROBOs | 159 | 6.82e-17 | -0.383000 | 3.09e-15 |
| Signaling by Leptin | 10 | 3.66e-02 | 0.382000 | 9.82e-02 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | 21 | 2.48e-03 | 0.381000 | 1.15e-02 |
| Neurodegenerative Diseases | 21 | 2.48e-03 | 0.381000 | 1.15e-02 |
| Chondroitin sulfate biosynthesis | 12 | 2.22e-02 | 0.381000 | 6.68e-02 |
| G-protein beta:gamma signalling | 29 | 3.86e-04 | 0.381000 | 2.79e-03 |
| Processive synthesis on the C-strand of the telomere | 19 | 4.06e-03 | -0.381000 | 1.70e-02 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | 25 | 9.91e-04 | -0.380000 | 5.79e-03 |
| Interactions of Rev with host cellular proteins | 37 | 6.52e-05 | -0.379000 | 6.34e-04 |
| Collagen degradation | 29 | 4.12e-04 | 0.379000 | 2.90e-03 |
| tRNA Aminoacylation | 42 | 2.27e-05 | -0.378000 | 2.56e-04 |
| Postmitotic nuclear pore complex (NPC) reformation | 27 | 6.85e-04 | -0.377000 | 4.22e-03 |
| Mitochondrial tRNA aminoacylation | 21 | 2.83e-03 | -0.376000 | 1.27e-02 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | 25 | 1.13e-03 | 0.376000 | 6.37e-03 |
| p130Cas linkage to MAPK signaling for integrins | 11 | 3.09e-02 | 0.376000 | 8.65e-02 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | 29 | 4.77e-04 | 0.375000 | 3.25e-03 |
| Vpr-mediated nuclear import of PICs | 34 | 1.62e-04 | -0.374000 | 1.38e-03 |
| Glycogen breakdown (glycogenolysis) | 13 | 1.99e-02 | 0.373000 | 6.13e-02 |
| Mitochondrial translation elongation | 91 | 8.68e-10 | -0.372000 | 2.32e-08 |
| Pentose phosphate pathway | 13 | 2.07e-02 | 0.370000 | 6.30e-02 |
| tRNA processing in the nucleus | 59 | 9.95e-07 | -0.368000 | 1.56e-05 |
| Budding and maturation of HIV virion | 26 | 1.18e-03 | 0.367000 | 6.60e-03 |
| ROS and RNS production in phagocytes | 31 | 4.06e-04 | 0.367000 | 2.89e-03 |
| Spry regulation of FGF signaling | 16 | 1.13e-02 | 0.366000 | 3.90e-02 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 22 | 2.99e-03 | 0.366000 | 1.34e-02 |
| Transferrin endocytosis and recycling | 26 | 1.25e-03 | 0.365000 | 6.94e-03 |
| HDMs demethylate histones | 22 | 3.02e-03 | 0.365000 | 1.35e-02 |
| EPH-Ephrin signaling | 79 | 2.09e-08 | 0.365000 | 4.82e-07 |
| COPI-mediated anterograde transport | 78 | 2.88e-08 | 0.363000 | 6.53e-07 |
| Beta-catenin phosphorylation cascade | 17 | 9.56e-03 | 0.363000 | 3.43e-02 |
| Smooth Muscle Contraction | 31 | 4.74e-04 | 0.363000 | 3.25e-03 |
| Early Phase of HIV Life Cycle | 14 | 1.88e-02 | -0.363000 | 5.84e-02 |
| Signaling by RAF1 mutants | 34 | 2.62e-04 | 0.362000 | 2.05e-03 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | 40 | 8.08e-05 | 0.360000 | 7.58e-04 |
| Diseases of DNA repair | 10 | 4.87e-02 | -0.360000 | 1.21e-01 |
| Folding of actin by CCT/TriC | 10 | 4.90e-02 | -0.360000 | 1.22e-01 |
| Cytosolic tRNA aminoacylation | 24 | 2.30e-03 | -0.359000 | 1.09e-02 |
| Mitochondrial translation termination | 91 | 3.55e-09 | -0.358000 | 8.47e-08 |
| Recognition of DNA damage by PCNA-containing replication complex | 30 | 6.95e-04 | -0.358000 | 4.24e-03 |
| Mitochondrial translation initiation | 91 | 3.68e-09 | -0.358000 | 8.63e-08 |
| NEP/NS2 Interacts with the Cellular Export Machinery | 32 | 4.77e-04 | -0.357000 | 3.25e-03 |
| Metabolism of amine-derived hormones | 10 | 5.10e-02 | -0.356000 | 1.26e-01 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 14 | 2.13e-02 | -0.355000 | 6.43e-02 |
| Growth hormone receptor signaling | 20 | 5.93e-03 | 0.355000 | 2.32e-02 |
| InlB-mediated entry of Listeria monocytogenes into host cell | 12 | 3.35e-02 | 0.354000 | 9.15e-02 |
| Mismatch Repair | 15 | 1.78e-02 | -0.353000 | 5.60e-02 |
| Intraflagellar transport | 39 | 1.35e-04 | -0.353000 | 1.19e-03 |
| Nuclear import of Rev protein | 34 | 3.66e-04 | -0.353000 | 2.72e-03 |
| FOXO-mediated transcription of cell death genes | 16 | 1.50e-02 | 0.351000 | 4.91e-02 |
| COPII-mediated vesicle transport | 65 | 1.07e-06 | 0.350000 | 1.66e-05 |
| Mitochondrial translation | 97 | 2.66e-09 | -0.350000 | 6.59e-08 |
| BMAL1:CLOCK,NPAS2 activates circadian gene expression | 25 | 2.61e-03 | 0.348000 | 1.19e-02 |
| RNA Polymerase I Transcription Initiation | 47 | 3.98e-05 | -0.346000 | 4.14e-04 |
| Interleukin-6 signaling | 10 | 5.85e-02 | 0.346000 | 1.38e-01 |
| ER to Golgi Anterograde Transport | 129 | 1.91e-11 | 0.342000 | 6.05e-10 |
| Post-translational protein phosphorylation | 70 | 7.43e-07 | 0.342000 | 1.19e-05 |
| Regulation of IFNA signaling | 12 | 4.03e-02 | 0.342000 | 1.07e-01 |
| tRNA processing | 134 | 8.34e-12 | -0.342000 | 2.83e-10 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | 55 | 1.17e-05 | 0.342000 | 1.47e-04 |
| RNA Polymerase I Transcription Termination | 30 | 1.23e-03 | -0.341000 | 6.81e-03 |
| Notch-HLH transcription pathway | 28 | 1.79e-03 | 0.341000 | 9.07e-03 |
| Platelet Aggregation (Plug Formation) | 28 | 1.83e-03 | 0.340000 | 9.18e-03 |
| activated TAK1 mediates p38 MAPK activation | 19 | 1.03e-02 | 0.340000 | 3.65e-02 |
| Signal regulatory protein family interactions | 12 | 4.17e-02 | 0.340000 | 1.10e-01 |
| Beta-oxidation of very long chain fatty acids | 10 | 6.34e-02 | 0.339000 | 1.46e-01 |
| Removal of the Flap Intermediate from the C-strand | 17 | 1.56e-02 | -0.339000 | 5.03e-02 |
| LDL clearance | 18 | 1.31e-02 | 0.338000 | 4.36e-02 |
| Termination of translesion DNA synthesis | 32 | 1.09e-03 | -0.334000 | 6.22e-03 |
| Adenylate cyclase inhibitory pathway | 11 | 5.99e-02 | 0.328000 | 1.41e-01 |
| EPHA-mediated growth cone collapse | 13 | 4.09e-02 | 0.327000 | 1.08e-01 |
| HDR through MMEJ (alt-NHEJ) | 10 | 7.32e-02 | -0.327000 | 1.63e-01 |
| ADP signalling through P2Y purinoceptor 1 | 21 | 9.78e-03 | 0.326000 | 3.49e-02 |
| G beta:gamma signalling through PI3Kgamma | 22 | 8.21e-03 | 0.326000 | 3.00e-02 |
| Pyrimidine salvage | 10 | 7.49e-02 | 0.325000 | 1.66e-01 |
| trans-Golgi Network Vesicle Budding | 69 | 3.01e-06 | 0.325000 | 4.22e-05 |
| Activation of gene expression by SREBF (SREBP) | 42 | 2.86e-04 | 0.323000 | 2.21e-03 |
| Export of Viral Ribonucleoproteins from Nucleus | 33 | 1.39e-03 | -0.322000 | 7.46e-03 |
| RNA Polymerase III Chain Elongation | 18 | 1.82e-02 | -0.322000 | 5.69e-02 |
| TBC/RABGAPs | 45 | 1.90e-04 | 0.322000 | 1.59e-03 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | 12 | 5.56e-02 | 0.319000 | 1.33e-01 |
| Energy dependent regulation of mTOR by LKB1-AMPK | 27 | 4.14e-03 | 0.319000 | 1.72e-02 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | 38 | 6.83e-04 | 0.318000 | 4.22e-03 |
| Signaling by RAS mutants | 38 | 6.83e-04 | 0.318000 | 4.22e-03 |
| Signaling by moderate kinase activity BRAF mutants | 38 | 6.83e-04 | 0.318000 | 4.22e-03 |
| Signaling downstream of RAS mutants | 38 | 6.83e-04 | 0.318000 | 4.22e-03 |
| DNA methylation | 20 | 1.37e-02 | 0.318000 | 4.53e-02 |
| RAF activation | 32 | 1.97e-03 | 0.316000 | 9.83e-03 |
| RAB GEFs exchange GTP for GDP on RABs | 88 | 3.07e-07 | 0.316000 | 5.28e-06 |
| Pre-NOTCH Expression and Processing | 65 | 1.10e-05 | 0.315000 | 1.41e-04 |
| Clathrin-mediated endocytosis | 127 | 8.71e-10 | 0.315000 | 2.32e-08 |
| Transport of the SLBP Dependant Mature mRNA | 36 | 1.09e-03 | -0.315000 | 6.22e-03 |
| Transport of the SLBP independent Mature mRNA | 35 | 1.28e-03 | -0.314000 | 7.01e-03 |
| Signal amplification | 28 | 4.16e-03 | 0.313000 | 1.72e-02 |
| Gastrin-CREB signalling pathway via PKC and MAPK | 14 | 4.34e-02 | 0.312000 | 1.13e-01 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 12 | 6.18e-02 | 0.311000 | 1.43e-01 |
| Diseases of hemostasis | 12 | 6.18e-02 | 0.311000 | 1.43e-01 |
| Transport of Ribonucleoproteins into the Host Nucleus | 32 | 2.36e-03 | -0.311000 | 1.11e-02 |
| Lysosome Vesicle Biogenesis | 32 | 2.44e-03 | 0.310000 | 1.14e-02 |
| Synthesis of PC | 24 | 8.72e-03 | 0.309000 | 3.15e-02 |
| Pre-NOTCH Transcription and Translation | 49 | 1.82e-04 | 0.309000 | 1.55e-03 |
| PPARA activates gene expression | 104 | 5.50e-08 | 0.308000 | 1.17e-06 |
| Signalling to ERKs | 32 | 2.54e-03 | 0.308000 | 1.17e-02 |
| Thrombin signalling through proteinase activated receptors (PARs) | 27 | 5.61e-03 | 0.308000 | 2.23e-02 |
| PKA activation in glucagon signalling | 14 | 4.67e-02 | 0.307000 | 1.18e-01 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | 28 | 4.96e-03 | -0.307000 | 2.00e-02 |
| Diseases of programmed cell death | 23 | 1.09e-02 | 0.307000 | 3.78e-02 |
| RHO GTPases activate KTN1 | 11 | 7.89e-02 | 0.306000 | 1.72e-01 |
| RAB geranylgeranylation | 60 | 4.39e-05 | 0.305000 | 4.46e-04 |
| Dual Incision in GG-NER | 41 | 8.66e-04 | -0.301000 | 5.14e-03 |
| Mitochondrial protein import | 64 | 3.50e-05 | -0.299000 | 3.75e-04 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 81 | 3.26e-06 | 0.299000 | 4.53e-05 |
| CD22 mediated BCR regulation | 59 | 7.14e-05 | -0.299000 | 6.89e-04 |
| Common Pathway of Fibrin Clot Formation | 14 | 5.37e-02 | 0.298000 | 1.30e-01 |
| Regulation of lipid metabolism by PPARalpha | 106 | 1.33e-07 | 0.296000 | 2.56e-06 |
| GAB1 signalosome | 15 | 4.79e-02 | 0.295000 | 1.19e-01 |
| Metabolism of RNA | 685 | 1.65e-39 | -0.294000 | 3.21e-37 |
| Fanconi Anemia Pathway | 36 | 2.26e-03 | -0.294000 | 1.08e-02 |
| MET activates RAS signaling | 10 | 1.08e-01 | 0.294000 | 2.15e-01 |
| G beta:gamma signalling through CDC42 | 17 | 3.62e-02 | 0.293000 | 9.75e-02 |
| GABA receptor activation | 35 | 2.73e-03 | 0.293000 | 1.24e-02 |
| Golgi Associated Vesicle Biogenesis | 55 | 1.83e-04 | 0.292000 | 1.55e-03 |
| Transport to the Golgi and subsequent modification | 155 | 3.74e-10 | 0.291000 | 1.16e-08 |
| Glycosphingolipid metabolism | 36 | 2.50e-03 | 0.291000 | 1.15e-02 |
| NS1 Mediated Effects on Host Pathways | 40 | 1.45e-03 | -0.291000 | 7.73e-03 |
| Translesion Synthesis by POLH | 18 | 3.30e-02 | -0.290000 | 9.06e-02 |
| Semaphorin interactions | 57 | 1.53e-04 | 0.290000 | 1.32e-03 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 92 | 1.56e-06 | 0.290000 | 2.28e-05 |
| Toll Like Receptor 2 (TLR2) Cascade | 92 | 1.56e-06 | 0.290000 | 2.28e-05 |
| Toll Like Receptor TLR1:TLR2 Cascade | 92 | 1.56e-06 | 0.290000 | 2.28e-05 |
| Toll Like Receptor TLR6:TLR2 Cascade | 92 | 1.56e-06 | 0.290000 | 2.28e-05 |
| Homologous DNA Pairing and Strand Exchange | 42 | 1.16e-03 | -0.290000 | 6.52e-03 |
| Cargo recognition for clathrin-mediated endocytosis | 90 | 2.04e-06 | 0.290000 | 2.95e-05 |
| Suppression of phagosomal maturation | 12 | 8.26e-02 | 0.289000 | 1.79e-01 |
| Misspliced GSK3beta mutants stabilize beta-catenin | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
| S33 mutants of beta-catenin aren't phosphorylated | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
| S37 mutants of beta-catenin aren't phosphorylated | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
| S45 mutants of beta-catenin aren't phosphorylated | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
| T41 mutants of beta-catenin aren't phosphorylated | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
| phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 15 | 5.30e-02 | 0.289000 | 1.28e-01 |
| Caspase activation via extrinsic apoptotic signalling pathway | 25 | 1.26e-02 | 0.288000 | 4.24e-02 |
| Platelet activation, signaling and aggregation | 221 | 1.64e-13 | 0.288000 | 5.86e-12 |
| Activation of GABAB receptors | 30 | 6.39e-03 | 0.288000 | 2.46e-02 |
| GABA B receptor activation | 30 | 6.39e-03 | 0.288000 | 2.46e-02 |
| Signaling by MET | 61 | 1.02e-04 | 0.288000 | 9.39e-04 |
| ATF6 (ATF6-alpha) activates chaperone genes | 10 | 1.15e-01 | 0.288000 | 2.24e-01 |
| EGFR downregulation | 27 | 9.76e-03 | 0.287000 | 3.49e-02 |
| Rab regulation of trafficking | 121 | 4.86e-08 | 0.287000 | 1.05e-06 |
| Dectin-2 family | 19 | 3.03e-02 | 0.287000 | 8.53e-02 |
| Biotin transport and metabolism | 11 | 1.02e-01 | -0.285000 | 2.09e-01 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | 27 | 1.04e-02 | -0.285000 | 3.68e-02 |
| Post-chaperonin tubulin folding pathway | 19 | 3.18e-02 | 0.285000 | 8.79e-02 |
| Apoptosis induced DNA fragmentation | 10 | 1.20e-01 | 0.284000 | 2.31e-01 |
| Plasma lipoprotein assembly | 10 | 1.21e-01 | 0.283000 | 2.31e-01 |
| Golgi-to-ER retrograde transport | 111 | 2.50e-07 | 0.283000 | 4.54e-06 |
| Response to elevated platelet cytosolic Ca2+ | 110 | 2.85e-07 | 0.283000 | 4.96e-06 |
| Plasma lipoprotein remodeling | 18 | 3.77e-02 | 0.283000 | 1.01e-01 |
| SUMOylation of immune response proteins | 11 | 1.05e-01 | 0.283000 | 2.13e-01 |
| Presynaptic phase of homologous DNA pairing and strand exchange | 39 | 2.28e-03 | -0.282000 | 1.08e-02 |
| Scavenging by Class A Receptors | 11 | 1.05e-01 | 0.282000 | 2.13e-01 |
| Response of Mtb to phagocytosis | 22 | 2.24e-02 | 0.281000 | 6.72e-02 |
| SUMOylation of SUMOylation proteins | 35 | 4.04e-03 | -0.281000 | 1.70e-02 |
| Signaling by ROBO receptors | 199 | 8.54e-12 | -0.281000 | 2.83e-10 |
| Late endosomal microautophagy | 30 | 7.81e-03 | 0.281000 | 2.87e-02 |
| Transcriptional Regulation by E2F6 | 34 | 4.63e-03 | -0.281000 | 1.89e-02 |
| RUNX3 regulates NOTCH signaling | 14 | 6.92e-02 | 0.281000 | 1.57e-01 |
| ATF6 (ATF6-alpha) activates chaperones | 12 | 9.25e-02 | 0.281000 | 1.95e-01 |
| rRNA processing in the mitochondrion | 27 | 1.17e-02 | -0.280000 | 4.00e-02 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 32 | 6.07e-03 | -0.280000 | 2.37e-02 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | 32 | 6.07e-03 | -0.280000 | 2.37e-02 |
| TNFs bind their physiological receptors | 25 | 1.53e-02 | -0.280000 | 4.98e-02 |
| DARPP-32 events | 22 | 2.31e-02 | 0.280000 | 6.88e-02 |
| Rap1 signalling | 13 | 8.18e-02 | 0.279000 | 1.78e-01 |
| Platelet degranulation | 106 | 7.37e-07 | 0.278000 | 1.19e-05 |
| NOTCH3 Intracellular Domain Regulates Transcription | 20 | 3.15e-02 | 0.278000 | 8.75e-02 |
| ADP signalling through P2Y purinoceptor 12 | 18 | 4.24e-02 | 0.276000 | 1.11e-01 |
| G beta:gamma signalling through BTK | 15 | 6.41e-02 | 0.276000 | 1.47e-01 |
| L1CAM interactions | 85 | 1.25e-05 | 0.274000 | 1.56e-04 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 12 | 1.01e-01 | 0.273000 | 2.09e-01 |
| Membrane Trafficking | 558 | 2.21e-28 | 0.273000 | 1.37e-26 |
| Degradation of the extracellular matrix | 78 | 3.14e-05 | 0.273000 | 3.42e-04 |
| Toll Like Receptor 4 (TLR4) Cascade | 121 | 2.61e-07 | 0.271000 | 4.67e-06 |
| Glutamate and glutamine metabolism | 12 | 1.04e-01 | -0.271000 | 2.13e-01 |
| G1/S-Specific Transcription | 29 | 1.20e-02 | -0.269000 | 4.07e-02 |
| Regulation of FZD by ubiquitination | 15 | 7.17e-02 | -0.269000 | 1.60e-01 |
| Assembly of active LPL and LIPC lipase complexes | 10 | 1.43e-01 | 0.267000 | 2.64e-01 |
| Signaling by BRAF and RAF fusions | 57 | 4.86e-04 | 0.267000 | 3.29e-03 |
| XBP1(S) activates chaperone genes | 47 | 1.53e-03 | 0.267000 | 8.06e-03 |
| Transcriptional regulation of granulopoiesis | 46 | 1.73e-03 | 0.267000 | 8.87e-03 |
| The NLRP3 inflammasome | 15 | 7.36e-02 | 0.267000 | 1.64e-01 |
| SUMOylation of RNA binding proteins | 47 | 1.56e-03 | -0.267000 | 8.14e-03 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 14 | 8.42e-02 | 0.267000 | 1.81e-01 |
| Presynaptic function of Kainate receptors | 18 | 5.03e-02 | 0.266000 | 1.25e-01 |
| Transcriptional regulation of white adipocyte differentiation | 77 | 5.40e-05 | 0.266000 | 5.33e-04 |
| Amyloid fiber formation | 51 | 1.02e-03 | 0.266000 | 5.89e-03 |
| SHC1 events in EGFR signaling | 12 | 1.11e-01 | 0.265000 | 2.19e-01 |
| Innate Immune System | 967 | 2.26e-44 | 0.265000 | 6.16e-42 |
| Glucagon signaling in metabolic regulation | 27 | 1.72e-02 | 0.265000 | 5.46e-02 |
| Antigen processing-Cross presentation | 97 | 6.61e-06 | 0.265000 | 8.74e-05 |
| EPH-ephrin mediated repulsion of cells | 40 | 3.78e-03 | 0.265000 | 1.61e-02 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | 48 | 1.54e-03 | 0.264000 | 8.06e-03 |
| Activation of G protein gated Potassium channels | 19 | 4.62e-02 | 0.264000 | 1.17e-01 |
| G protein gated Potassium channels | 19 | 4.62e-02 | 0.264000 | 1.17e-01 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 19 | 4.62e-02 | 0.264000 | 1.17e-01 |
| Plasma lipoprotein assembly, remodeling, and clearance | 53 | 8.83e-04 | 0.264000 | 5.21e-03 |
| NOTCH2 intracellular domain regulates transcription | 11 | 1.33e-01 | 0.262000 | 2.48e-01 |
| Signaling by NTRKs | 116 | 1.18e-06 | 0.261000 | 1.81e-05 |
| ERK/MAPK targets | 22 | 3.40e-02 | 0.261000 | 9.29e-02 |
| Membrane binding and targetting of GAG proteins | 13 | 1.05e-01 | 0.260000 | 2.13e-01 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | 13 | 1.05e-01 | 0.260000 | 2.13e-01 |
| Metabolism of steroid hormones | 20 | 4.50e-02 | 0.259000 | 1.16e-01 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 15 | 8.29e-02 | 0.259000 | 1.79e-01 |
| Activated NOTCH1 Transmits Signal to the Nucleus | 27 | 2.00e-02 | 0.259000 | 6.14e-02 |
| Signaling by NTRK1 (TRKA) | 101 | 7.13e-06 | 0.258000 | 9.33e-05 |
| MET promotes cell motility | 26 | 2.28e-02 | 0.258000 | 6.82e-02 |
| Toll-like Receptor Cascades | 143 | 1.03e-07 | 0.258000 | 2.05e-06 |
| IRE1alpha activates chaperones | 49 | 1.82e-03 | 0.257000 | 9.13e-03 |
| Integration of energy metabolism | 86 | 3.88e-05 | 0.257000 | 4.10e-04 |
| NOTCH4 Intracellular Domain Regulates Transcription | 17 | 6.77e-02 | 0.256000 | 1.54e-01 |
| G beta:gamma signalling through PLC beta | 17 | 6.83e-02 | 0.255000 | 1.55e-01 |
| PINK1-PRKN Mediated Mitophagy | 21 | 4.29e-02 | -0.255000 | 1.12e-01 |
| Glycogen metabolism | 23 | 3.46e-02 | 0.255000 | 9.36e-02 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | 43 | 3.88e-03 | -0.255000 | 1.64e-02 |
| Infection with Mycobacterium tuberculosis | 26 | 2.48e-02 | 0.254000 | 7.25e-02 |
| VEGFA-VEGFR2 Pathway | 92 | 2.49e-05 | 0.254000 | 2.77e-04 |
| Intra-Golgi traffic | 43 | 4.02e-03 | 0.253000 | 1.70e-02 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 33 | 1.17e-02 | 0.253000 | 4.00e-02 |
| Transport of Mature mRNA Derived from an Intronless Transcript | 42 | 4.56e-03 | -0.253000 | 1.87e-02 |
| MyD88 dependent cascade initiated on endosome | 89 | 3.92e-05 | 0.252000 | 4.10e-04 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | 89 | 3.92e-05 | 0.252000 | 4.10e-04 |
| Defects in vitamin and cofactor metabolism | 21 | 4.55e-02 | -0.252000 | 1.16e-01 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 88 | 4.58e-05 | 0.251000 | 4.62e-04 |
| Long-term potentiation | 14 | 1.04e-01 | -0.251000 | 2.13e-01 |
| Endogenous sterols | 17 | 7.45e-02 | 0.250000 | 1.65e-01 |
| AMER1 mutants destabilize the destruction complex | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
| APC truncation mutants have impaired AXIN binding | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
| AXIN missense mutants destabilize the destruction complex | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
| AXIN mutants destabilize the destruction complex, activating WNT signaling | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
| Truncations of AMER1 destabilize the destruction complex | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
| truncated APC mutants destabilize the destruction complex | 14 | 1.06e-01 | 0.250000 | 2.13e-01 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 2.57e-04 | -0.249000 | 2.03e-03 |
| Triglyceride catabolism | 16 | 8.46e-02 | 0.249000 | 1.82e-01 |
| Plasma lipoprotein clearance | 29 | 2.04e-02 | 0.249000 | 6.21e-02 |
| Carboxyterminal post-translational modifications of tubulin | 26 | 2.87e-02 | 0.248000 | 8.15e-02 |
| Classical antibody-mediated complement activation | 69 | 3.73e-04 | -0.248000 | 2.74e-03 |
| Oncogenic MAPK signaling | 73 | 2.75e-04 | 0.246000 | 2.14e-03 |
| Transcription of E2F targets under negative control by DREAM complex | 19 | 6.32e-02 | -0.246000 | 1.46e-01 |
| Interleukin-27 signaling | 11 | 1.58e-01 | 0.246000 | 2.79e-01 |
| Signaling by SCF-KIT | 40 | 7.14e-03 | 0.246000 | 2.68e-02 |
| HuR (ELAVL1) binds and stabilizes mRNA | 10 | 1.78e-01 | 0.246000 | 3.08e-01 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 16 | 9.01e-02 | 0.245000 | 1.91e-01 |
| Assembly Of The HIV Virion | 15 | 1.01e-01 | 0.244000 | 2.09e-01 |
| RNA Polymerase III Transcription Termination | 23 | 4.30e-02 | -0.244000 | 1.12e-01 |
| Interleukin-15 signaling | 14 | 1.15e-01 | 0.243000 | 2.24e-01 |
| Activation of Matrix Metalloproteinases | 23 | 4.37e-02 | 0.243000 | 1.13e-01 |
| Calnexin/calreticulin cycle | 26 | 3.21e-02 | 0.243000 | 8.84e-02 |
| Nuclear Pore Complex (NPC) Disassembly | 36 | 1.18e-02 | -0.242000 | 4.02e-02 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 1.47e-01 | 0.242000 | 2.69e-01 |
| RUNX3 regulates p14-ARF | 10 | 1.86e-01 | 0.241000 | 3.17e-01 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 32 | 1.81e-02 | 0.241000 | 5.68e-02 |
| Thromboxane signalling through TP receptor | 20 | 6.17e-02 | 0.241000 | 1.43e-01 |
| Butyrophilin (BTN) family interactions | 10 | 1.86e-01 | -0.241000 | 3.17e-01 |
| Myogenesis | 21 | 5.60e-02 | 0.241000 | 1.33e-01 |
| G-protein activation | 23 | 4.60e-02 | 0.240000 | 1.17e-01 |
| Interleukin-1 signaling | 97 | 4.38e-05 | 0.240000 | 4.46e-04 |
| HDR through Single Strand Annealing (SSA) | 37 | 1.16e-02 | -0.240000 | 3.97e-02 |
| Amino acids regulate mTORC1 | 50 | 3.38e-03 | 0.240000 | 1.47e-02 |
| Metabolism of porphyrins | 22 | 5.21e-02 | 0.239000 | 1.28e-01 |
| Formation of the cornified envelope | 21 | 5.84e-02 | 0.239000 | 1.38e-01 |
| Platelet homeostasis | 69 | 6.38e-04 | 0.238000 | 4.06e-03 |
| Diseases of carbohydrate metabolism | 29 | 2.70e-02 | 0.237000 | 7.77e-02 |
| Scavenging of heme from plasma | 71 | 5.61e-04 | -0.237000 | 3.69e-03 |
| Creation of C4 and C2 activators | 71 | 5.62e-04 | -0.237000 | 3.69e-03 |
| SUMOylation of chromatin organization proteins | 57 | 2.03e-03 | -0.236000 | 1.01e-02 |
| Toll Like Receptor 9 (TLR9) Cascade | 93 | 8.40e-05 | 0.236000 | 7.83e-04 |
| Interleukin receptor SHC signaling | 23 | 5.11e-02 | 0.235000 | 1.26e-01 |
| Surfactant metabolism | 21 | 6.35e-02 | 0.234000 | 1.46e-01 |
| Packaging Of Telomere Ends | 20 | 7.06e-02 | 0.234000 | 1.58e-01 |
| Interleukin-10 signaling | 34 | 1.86e-02 | 0.233000 | 5.80e-02 |
| FCGR activation | 76 | 4.56e-04 | -0.233000 | 3.17e-03 |
| HDR through Homologous Recombination (HRR) | 66 | 1.12e-03 | -0.232000 | 6.36e-03 |
| IKK complex recruitment mediated by RIP1 | 23 | 5.52e-02 | 0.231000 | 1.33e-01 |
| MTOR signalling | 38 | 1.39e-02 | 0.231000 | 4.58e-02 |
| RIP-mediated NFkB activation via ZBP1 | 17 | 9.98e-02 | 0.231000 | 2.08e-01 |
| Metabolism of steroids | 119 | 1.42e-05 | 0.230000 | 1.76e-04 |
| RET signaling | 32 | 2.46e-02 | 0.230000 | 7.23e-02 |
| Cellular response to hypoxia | 71 | 8.35e-04 | 0.229000 | 5.01e-03 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | 29 | 3.27e-02 | 0.229000 | 8.98e-02 |
| Glycogen synthesis | 13 | 1.54e-01 | 0.228000 | 2.77e-01 |
| Bile acid and bile salt metabolism | 29 | 3.33e-02 | 0.228000 | 9.12e-02 |
| HDACs deacetylate histones | 47 | 6.77e-03 | 0.228000 | 2.57e-02 |
| Chromosome Maintenance | 105 | 5.30e-05 | -0.228000 | 5.26e-04 |
| Signaling by NOTCH3 | 42 | 1.05e-02 | 0.228000 | 3.69e-02 |
| Formation of apoptosome | 11 | 1.90e-01 | 0.228000 | 3.20e-01 |
| Regulation of the apoptosome activity | 11 | 1.90e-01 | 0.228000 | 3.20e-01 |
| Aquaporin-mediated transport | 37 | 1.64e-02 | 0.228000 | 5.25e-02 |
| Signaling by VEGF | 100 | 8.60e-05 | 0.227000 | 7.96e-04 |
| Opioid Signalling | 75 | 6.72e-04 | 0.227000 | 4.22e-03 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | 179 | 1.62e-07 | 0.227000 | 3.06e-06 |
| MyD88 cascade initiated on plasma membrane | 82 | 3.87e-04 | 0.227000 | 2.79e-03 |
| Toll Like Receptor 10 (TLR10) Cascade | 82 | 3.87e-04 | 0.227000 | 2.79e-03 |
| Toll Like Receptor 5 (TLR5) Cascade | 82 | 3.87e-04 | 0.227000 | 2.79e-03 |
| Defects in cobalamin (B12) metabolism | 13 | 1.57e-01 | -0.227000 | 2.79e-01 |
| Cytochrome c-mediated apoptotic response | 13 | 1.58e-01 | 0.226000 | 2.79e-01 |
| Negative regulation of FGFR1 signaling | 24 | 5.51e-02 | 0.226000 | 1.33e-01 |
| DNA Damage Bypass | 47 | 7.76e-03 | -0.224000 | 2.86e-02 |
| NR1H2 and NR1H3-mediated signaling | 39 | 1.54e-02 | 0.224000 | 5.00e-02 |
| Signaling by cytosolic FGFR1 fusion mutants | 18 | 1.01e-01 | 0.224000 | 2.09e-01 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) | 36 | 2.04e-02 | 0.223000 | 6.22e-02 |
| Interleukin-1 family signaling | 124 | 1.75e-05 | 0.223000 | 2.02e-04 |
| Chemokine receptors bind chemokines | 37 | 1.89e-02 | -0.223000 | 5.86e-02 |
| Retinoid metabolism and transport | 24 | 5.91e-02 | 0.223000 | 1.39e-01 |
| Sphingolipid metabolism | 77 | 7.38e-04 | 0.222000 | 4.49e-03 |
| Nucleotide salvage | 21 | 7.88e-02 | 0.222000 | 1.72e-01 |
| Constitutive Signaling by AKT1 E17K in Cancer | 25 | 5.55e-02 | 0.221000 | 1.33e-01 |
| Gluconeogenesis | 28 | 4.27e-02 | 0.221000 | 1.11e-01 |
| ER-Phagosome pathway | 82 | 5.52e-04 | 0.221000 | 3.66e-03 |
| Asparagine N-linked glycosylation | 269 | 4.67e-10 | 0.221000 | 1.38e-08 |
| ZBP1(DAI) mediated induction of type I IFNs | 20 | 8.78e-02 | 0.220000 | 1.87e-01 |
| Josephin domain DUBs | 10 | 2.27e-01 | 0.220000 | 3.65e-01 |
| Metabolism of amino acids and derivatives | 324 | 9.44e-12 | -0.220000 | 3.06e-10 |
| Oncogene Induced Senescence | 33 | 2.87e-02 | 0.220000 | 8.15e-02 |
| Transport of Mature Transcript to Cytoplasm | 81 | 6.35e-04 | -0.220000 | 4.06e-03 |
| Vasopressin regulates renal water homeostasis via Aquaporins | 34 | 2.68e-02 | 0.219000 | 7.74e-02 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 38 | 1.93e-02 | -0.219000 | 5.96e-02 |
| MyD88-independent TLR4 cascade | 96 | 2.10e-04 | 0.219000 | 1.72e-03 |
| TRIF(TICAM1)-mediated TLR4 signaling | 96 | 2.10e-04 | 0.219000 | 1.72e-03 |
| Nuclear Events (kinase and transcription factor activation) | 53 | 5.86e-03 | 0.219000 | 2.31e-02 |
| Diseases associated with glycosylation precursor biosynthesis | 18 | 1.09e-01 | 0.218000 | 2.16e-01 |
| TRAF6 mediated NF-kB activation | 23 | 7.03e-02 | 0.218000 | 1.58e-01 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | 23 | 7.05e-02 | 0.218000 | 1.58e-01 |
| Viral Messenger RNA Synthesis | 44 | 1.26e-02 | -0.217000 | 4.25e-02 |
| E2F mediated regulation of DNA replication | 22 | 7.79e-02 | -0.217000 | 1.71e-01 |
| Adherens junctions interactions | 18 | 1.11e-01 | 0.217000 | 2.19e-01 |
| Acyl chain remodelling of PC | 19 | 1.02e-01 | 0.217000 | 2.09e-01 |
| Signaling by Hippo | 18 | 1.12e-01 | 0.216000 | 2.19e-01 |
| SUMOylation of DNA damage response and repair proteins | 77 | 1.05e-03 | -0.216000 | 6.05e-03 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | 21 | 8.68e-02 | -0.216000 | 1.86e-01 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 21 | 8.68e-02 | -0.216000 | 1.86e-01 |
| Regulation of insulin secretion | 60 | 3.85e-03 | 0.216000 | 1.64e-02 |
| Transport of bile salts and organic acids, metal ions and amine compounds | 55 | 5.70e-03 | 0.215000 | 2.25e-02 |
| GRB2 events in EGFR signaling | 11 | 2.17e-01 | 0.215000 | 3.53e-01 |
| Signaling by NOTCH | 182 | 6.06e-07 | 0.214000 | 1.01e-05 |
| RNA Polymerase III Transcription Initiation | 36 | 2.61e-02 | -0.214000 | 7.58e-02 |
| Apoptotic execution phase | 45 | 1.29e-02 | 0.214000 | 4.33e-02 |
| TRAF6 mediated IRF7 activation | 15 | 1.52e-01 | 0.213000 | 2.75e-01 |
| Potential therapeutics for SARS | 36 | 2.67e-02 | 0.213000 | 7.72e-02 |
| Vesicle-mediated transport | 648 | 2.00e-20 | 0.213000 | 9.72e-19 |
| Listeria monocytogenes entry into host cells | 17 | 1.29e-01 | 0.213000 | 2.43e-01 |
| Synthesis of PIPs at the plasma membrane | 52 | 7.99e-03 | 0.213000 | 2.93e-02 |
| Assembly and cell surface presentation of NMDA receptors | 18 | 1.19e-01 | -0.212000 | 2.30e-01 |
| Deadenylation-dependent mRNA decay | 53 | 7.56e-03 | -0.212000 | 2.81e-02 |
| Activation of BAD and translocation to mitochondria | 15 | 1.56e-01 | 0.212000 | 2.78e-01 |
| Biosynthesis of specialized proresolving mediators (SPMs) | 16 | 1.43e-01 | 0.211000 | 2.64e-01 |
| Interconversion of nucleotide di- and triphosphates | 27 | 5.78e-02 | -0.211000 | 1.37e-01 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | 28 | 5.36e-02 | -0.211000 | 1.30e-01 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 13 | 1.89e-01 | 0.210000 | 3.18e-01 |
| PLC beta mediated events | 43 | 1.76e-02 | 0.209000 | 5.55e-02 |
| Uptake and actions of bacterial toxins | 27 | 6.02e-02 | 0.209000 | 1.41e-01 |
| Cytosolic iron-sulfur cluster assembly | 13 | 1.92e-01 | -0.209000 | 3.22e-01 |
| COPI-dependent Golgi-to-ER retrograde traffic | 78 | 1.44e-03 | 0.209000 | 7.73e-03 |
| Interleukin-37 signaling | 19 | 1.16e-01 | 0.208000 | 2.26e-01 |
| G alpha (z) signalling events | 36 | 3.07e-02 | 0.208000 | 8.60e-02 |
| DAP12 interactions | 39 | 2.47e-02 | 0.208000 | 7.23e-02 |
| MAP kinase activation | 63 | 4.44e-03 | 0.207000 | 1.82e-02 |
| Costimulation by the CD28 family | 74 | 2.14e-03 | -0.206000 | 1.05e-02 |
| mRNA Splicing - Minor Pathway | 52 | 1.05e-02 | -0.205000 | 3.69e-02 |
| Signaling by EGFR | 46 | 1.61e-02 | 0.205000 | 5.18e-02 |
| G-protein mediated events | 44 | 1.86e-02 | 0.205000 | 5.80e-02 |
| Signaling by Receptor Tyrosine Kinases | 414 | 8.43e-13 | 0.205000 | 2.94e-11 |
| Platelet Adhesion to exposed collagen | 13 | 2.01e-01 | 0.205000 | 3.33e-01 |
| ER Quality Control Compartment (ERQC) | 21 | 1.06e-01 | 0.204000 | 2.13e-01 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | 20 | 1.15e-01 | 0.203000 | 2.24e-01 |
| Trafficking of AMPA receptors | 20 | 1.15e-01 | 0.203000 | 2.24e-01 |
| Signaling by Insulin receptor | 59 | 6.91e-03 | 0.203000 | 2.61e-02 |
| Inflammasomes | 20 | 1.17e-01 | 0.203000 | 2.26e-01 |
| Processing of SMDT1 | 15 | 1.75e-01 | -0.202000 | 3.03e-01 |
| Signaling by NOTCH4 | 78 | 2.27e-03 | 0.200000 | 1.08e-02 |
| SARS-CoV Infections | 83 | 1.69e-03 | 0.199000 | 8.68e-03 |
| Initiation of Nuclear Envelope (NE) Reformation | 19 | 1.33e-01 | 0.199000 | 2.47e-01 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 17 | 1.55e-01 | -0.199000 | 2.78e-01 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 1.68e-01 | -0.199000 | 2.95e-01 |
| Processing of Capped Intron-Containing Pre-mRNA | 238 | 1.29e-07 | -0.199000 | 2.51e-06 |
| SUMOylation of ubiquitinylation proteins | 39 | 3.19e-02 | -0.199000 | 8.80e-02 |
| Initial triggering of complement | 78 | 2.43e-03 | -0.199000 | 1.14e-02 |
| Negative regulation of FGFR3 signaling | 20 | 1.25e-01 | 0.198000 | 2.37e-01 |
| Caspase activation via Death Receptors in the presence of ligand | 16 | 1.70e-01 | 0.198000 | 2.97e-01 |
| O-linked glycosylation of mucins | 47 | 1.90e-02 | 0.198000 | 5.86e-02 |
| TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 27 | 7.52e-02 | 0.198000 | 1.66e-01 |
| RUNX2 regulates bone development | 23 | 1.01e-01 | 0.198000 | 2.09e-01 |
| PKA activation | 15 | 1.86e-01 | 0.197000 | 3.17e-01 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | 64 | 6.34e-03 | -0.197000 | 2.45e-02 |
| RHO GTPase Effectors | 250 | 7.74e-08 | 0.197000 | 1.57e-06 |
| Tight junction interactions | 18 | 1.48e-01 | -0.197000 | 2.70e-01 |
| Role of LAT2/NTAL/LAB on calcium mobilization | 74 | 3.66e-03 | -0.195000 | 1.57e-02 |
| CD28 dependent PI3K/Akt signaling | 22 | 1.13e-01 | -0.195000 | 2.21e-01 |
| Regulation of PTEN stability and activity | 66 | 6.11e-03 | 0.195000 | 2.38e-02 |
| Carnitine metabolism | 10 | 2.86e-01 | 0.195000 | 4.31e-01 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 17 | 1.65e-01 | -0.194000 | 2.90e-01 |
| KSRP (KHSRP) binds and destabilizes mRNA | 17 | 1.66e-01 | -0.194000 | 2.91e-01 |
| FCERI mediated Ca+2 mobilization | 89 | 1.57e-03 | -0.194000 | 8.15e-03 |
| Signaling by NOTCH1 | 66 | 6.51e-03 | 0.194000 | 2.50e-02 |
| FGFR1 mutant receptor activation | 24 | 1.01e-01 | 0.194000 | 2.09e-01 |
| Glycogen storage diseases | 13 | 2.27e-01 | 0.194000 | 3.65e-01 |
| Metalloprotease DUBs | 21 | 1.25e-01 | 0.193000 | 2.37e-01 |
| PIWI-interacting RNA (piRNA) biogenesis | 23 | 1.09e-01 | -0.193000 | 2.16e-01 |
| Regulation of localization of FOXO transcription factors | 11 | 2.69e-01 | 0.192000 | 4.12e-01 |
| Signaling by PDGFRA extracellular domain mutants | 12 | 2.49e-01 | 0.192000 | 3.89e-01 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 12 | 2.49e-01 | 0.192000 | 3.89e-01 |
| Ca-dependent events | 29 | 7.34e-02 | 0.192000 | 1.63e-01 |
| Cross-presentation of soluble exogenous antigens (endosomes) | 47 | 2.30e-02 | 0.192000 | 6.85e-02 |
| APC-Cdc20 mediated degradation of Nek2A | 26 | 9.07e-02 | -0.192000 | 1.92e-01 |
| Sialic acid metabolism | 28 | 7.95e-02 | 0.191000 | 1.73e-01 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 64 | 8.16e-03 | 0.191000 | 2.99e-02 |
| Dual incision in TC-NER | 65 | 7.74e-03 | -0.191000 | 2.86e-02 |
| Trafficking and processing of endosomal TLR | 13 | 2.33e-01 | 0.191000 | 3.72e-01 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | 16 | 1.86e-01 | 0.191000 | 3.17e-01 |
| Activation of the AP-1 family of transcription factors | 10 | 2.97e-01 | 0.191000 | 4.42e-01 |
| Interleukin-17 signaling | 68 | 6.57e-03 | 0.191000 | 2.51e-02 |
| Prostacyclin signalling through prostacyclin receptor | 16 | 1.89e-01 | 0.190000 | 3.18e-01 |
| Apoptotic cleavage of cellular proteins | 34 | 5.54e-02 | 0.190000 | 1.33e-01 |
| SUMOylation of DNA replication proteins | 46 | 2.61e-02 | -0.190000 | 7.58e-02 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 35 | 5.23e-02 | 0.190000 | 1.28e-01 |
| RNA Polymerase II Transcription Termination | 65 | 8.32e-03 | -0.189000 | 3.02e-02 |
| MAPK targets/ Nuclear events mediated by MAP kinases | 31 | 6.84e-02 | 0.189000 | 1.55e-01 |
| Cell-extracellular matrix interactions | 14 | 2.21e-01 | 0.189000 | 3.58e-01 |
| Telomere Maintenance | 80 | 3.48e-03 | -0.189000 | 1.51e-02 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 53 | 1.74e-02 | 0.189000 | 5.51e-02 |
| Processing of Capped Intronless Pre-mRNA | 28 | 8.38e-02 | -0.189000 | 1.81e-01 |
| SARS-CoV-1 Infection | 47 | 2.58e-02 | 0.188000 | 7.52e-02 |
| Interleukin-2 family signaling | 38 | 4.53e-02 | 0.188000 | 1.16e-01 |
| A tetrasaccharide linker sequence is required for GAG synthesis | 17 | 1.81e-01 | -0.188000 | 3.09e-01 |
| Role of phospholipids in phagocytosis | 88 | 2.40e-03 | -0.187000 | 1.13e-02 |
| Telomere Extension By Telomerase | 23 | 1.20e-01 | -0.187000 | 2.31e-01 |
| Signaling by FGFR1 | 38 | 4.70e-02 | 0.186000 | 1.19e-01 |
| Iron uptake and transport | 52 | 2.03e-02 | 0.186000 | 6.20e-02 |
| Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 17 | 1.85e-01 | 0.186000 | 3.16e-01 |
| mRNA Splicing - Major Pathway | 179 | 2.01e-05 | -0.185000 | 2.30e-04 |
| Phospholipid metabolism | 186 | 1.46e-05 | 0.184000 | 1.79e-04 |
| MHC class II antigen presentation | 101 | 1.39e-03 | 0.184000 | 7.46e-03 |
| Toll Like Receptor 3 (TLR3) Cascade | 92 | 2.29e-03 | 0.184000 | 1.08e-02 |
| Regulation of HSF1-mediated heat shock response | 79 | 4.76e-03 | -0.184000 | 1.93e-02 |
| RNA Polymerase III Abortive And Retractive Initiation | 41 | 4.19e-02 | -0.184000 | 1.10e-01 |
| RNA Polymerase III Transcription | 41 | 4.19e-02 | -0.184000 | 1.10e-01 |
| PCP/CE pathway | 86 | 3.24e-03 | 0.184000 | 1.44e-02 |
| G0 and Early G1 | 27 | 9.91e-02 | -0.183000 | 2.07e-01 |
| Metabolism of lipids | 625 | 5.63e-15 | 0.183000 | 2.40e-13 |
| mRNA Splicing | 187 | 1.64e-05 | -0.183000 | 1.90e-04 |
| Rho GTPase cycle | 126 | 4.00e-04 | 0.183000 | 2.87e-03 |
| Signaling by Interleukins | 385 | 7.78e-10 | 0.183000 | 2.16e-08 |
| SUMOylation of intracellular receptors | 25 | 1.14e-01 | 0.182000 | 2.24e-01 |
| Platelet calcium homeostasis | 21 | 1.48e-01 | 0.182000 | 2.69e-01 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 20 | 1.59e-01 | -0.182000 | 2.80e-01 |
| Hedgehog ligand biogenesis | 58 | 1.65e-02 | 0.182000 | 5.27e-02 |
| mTORC1-mediated signalling | 23 | 1.31e-01 | 0.182000 | 2.45e-01 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 78 | 5.57e-03 | -0.182000 | 2.22e-02 |
| Signaling by Rho GTPases | 367 | 2.45e-09 | 0.181000 | 6.19e-08 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 84 | 4.09e-03 | -0.181000 | 1.71e-02 |
| PI-3K cascade:FGFR2 | 12 | 2.78e-01 | -0.181000 | 4.22e-01 |
| Glycerophospholipid biosynthesis | 107 | 1.29e-03 | 0.180000 | 7.01e-03 |
| Glycosaminoglycan metabolism | 94 | 2.57e-03 | 0.180000 | 1.18e-02 |
| Synthesis of DNA | 118 | 7.45e-04 | -0.180000 | 4.51e-03 |
| Mitochondrial calcium ion transport | 22 | 1.45e-01 | -0.179000 | 2.67e-01 |
| PI Metabolism | 80 | 5.58e-03 | 0.179000 | 2.22e-02 |
| Striated Muscle Contraction | 23 | 1.37e-01 | 0.179000 | 2.55e-01 |
| Cholesterol biosynthesis | 24 | 1.30e-01 | 0.179000 | 2.44e-01 |
| FGFR2 mutant receptor activation | 22 | 1.47e-01 | -0.178000 | 2.69e-01 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 25 | 1.23e-01 | 0.178000 | 2.35e-01 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 51 | 2.79e-02 | 0.178000 | 7.98e-02 |
| NCAM1 interactions | 23 | 1.40e-01 | -0.178000 | 2.59e-01 |
| Formation of Fibrin Clot (Clotting Cascade) | 26 | 1.18e-01 | 0.177000 | 2.28e-01 |
| Synthesis of PIPs at the late endosome membrane | 11 | 3.09e-01 | 0.177000 | 4.54e-01 |
| Global Genome Nucleotide Excision Repair (GG-NER) | 84 | 5.21e-03 | -0.176000 | 2.10e-02 |
| Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | 53 | 2.66e-02 | 0.176000 | 7.70e-02 |
| Arachidonic acid metabolism | 43 | 4.58e-02 | 0.176000 | 1.17e-01 |
| Collagen formation | 66 | 1.36e-02 | 0.176000 | 4.50e-02 |
| SUMOylation of DNA methylation proteins | 16 | 2.24e-01 | -0.176000 | 3.62e-01 |
| Acyl chain remodelling of PI | 10 | 3.38e-01 | 0.175000 | 4.85e-01 |
| Ion channel transport | 133 | 5.22e-04 | 0.174000 | 3.50e-03 |
| Synthesis of PIPs at the Golgi membrane | 16 | 2.28e-01 | 0.174000 | 3.66e-01 |
| Defective CFTR causes cystic fibrosis | 59 | 2.11e-02 | 0.174000 | 6.41e-02 |
| mRNA decay by 5' to 3' exoribonuclease | 15 | 2.45e-01 | -0.174000 | 3.85e-01 |
| Elastic fibre formation | 32 | 9.00e-02 | 0.173000 | 1.91e-01 |
| Synthesis of IP2, IP, and Ins in the cytosol | 13 | 2.80e-01 | 0.173000 | 4.25e-01 |
| Triglyceride metabolism | 25 | 1.35e-01 | 0.173000 | 2.50e-01 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | 82 | 6.97e-03 | 0.172000 | 2.62e-02 |
| Inwardly rectifying K+ channels | 23 | 1.53e-01 | 0.172000 | 2.75e-01 |
| Transcriptional regulation of pluripotent stem cells | 19 | 1.94e-01 | 0.172000 | 3.24e-01 |
| Effects of PIP2 hydrolysis | 24 | 1.45e-01 | -0.172000 | 2.67e-01 |
| Base Excision Repair | 58 | 2.39e-02 | -0.171000 | 7.07e-02 |
| Downstream signal transduction | 27 | 1.23e-01 | 0.171000 | 2.35e-01 |
| Senescence-Associated Secretory Phenotype (SASP) | 66 | 1.64e-02 | 0.171000 | 5.25e-02 |
| Tie2 Signaling | 16 | 2.38e-01 | 0.171000 | 3.77e-01 |
| Insulin processing | 21 | 1.76e-01 | 0.170000 | 3.05e-01 |
| Signaling by FGFR3 | 31 | 1.01e-01 | 0.170000 | 2.09e-01 |
| G alpha (12/13) signalling events | 69 | 1.46e-02 | 0.170000 | 4.79e-02 |
| Muscle contraction | 141 | 4.92e-04 | 0.170000 | 3.31e-03 |
| Metabolism of fat-soluble vitamins | 28 | 1.20e-01 | 0.170000 | 2.31e-01 |
| Synthesis of bile acids and bile salts | 24 | 1.50e-01 | 0.170000 | 2.72e-01 |
| Signaling by WNT in cancer | 30 | 1.08e-01 | 0.169000 | 2.15e-01 |
| IRF3-mediated induction of type I IFN | 12 | 3.11e-01 | -0.169000 | 4.55e-01 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | 22 | 1.70e-01 | 0.169000 | 2.97e-01 |
| S Phase | 160 | 2.31e-04 | -0.169000 | 1.88e-03 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | 16 | 2.46e-01 | 0.168000 | 3.87e-01 |
| Regulation of ornithine decarboxylase (ODC) | 49 | 4.24e-02 | 0.168000 | 1.11e-01 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | 16 | 2.46e-01 | -0.167000 | 3.87e-01 |
| Oxidative Stress Induced Senescence | 79 | 1.01e-02 | 0.167000 | 3.59e-02 |
| Phase 4 - resting membrane potential | 10 | 3.60e-01 | 0.167000 | 5.05e-01 |
| Cleavage of the damaged purine | 24 | 1.57e-01 | 0.167000 | 2.79e-01 |
| Depurination | 24 | 1.57e-01 | 0.167000 | 2.79e-01 |
| Recognition and association of DNA glycosylase with site containing an affected purine | 24 | 1.57e-01 | 0.167000 | 2.79e-01 |
| Condensation of Prophase Chromosomes | 29 | 1.20e-01 | 0.167000 | 2.31e-01 |
| Cellular response to heat stress | 93 | 5.53e-03 | -0.166000 | 2.22e-02 |
| Mitophagy | 28 | 1.28e-01 | -0.166000 | 2.42e-01 |
| Negative regulation of FGFR4 signaling | 21 | 1.88e-01 | 0.166000 | 3.18e-01 |
| Interleukin-6 family signaling | 18 | 2.24e-01 | 0.166000 | 3.62e-01 |
| Constitutive Signaling by Overexpressed ERBB2 | 11 | 3.43e-01 | 0.165000 | 4.87e-01 |
| Regulation of beta-cell development | 19 | 2.13e-01 | 0.165000 | 3.48e-01 |
| Disorders of developmental biology | 12 | 3.23e-01 | 0.165000 | 4.67e-01 |
| Loss of function of MECP2 in Rett syndrome | 12 | 3.23e-01 | 0.165000 | 4.67e-01 |
| Pervasive developmental disorders | 12 | 3.23e-01 | 0.165000 | 4.67e-01 |
| DNA Replication | 125 | 1.50e-03 | -0.164000 | 7.95e-03 |
| Regulation of TP53 Activity through Methylation | 19 | 2.16e-01 | -0.164000 | 3.51e-01 |
| NOD1/2 Signaling Pathway | 32 | 1.10e-01 | 0.163000 | 2.17e-01 |
| Regulation of TP53 Activity through Association with Co-factors | 11 | 3.49e-01 | -0.163000 | 4.93e-01 |
| Signaling by Activin | 10 | 3.72e-01 | -0.163000 | 5.14e-01 |
| Hh mutants abrogate ligand secretion | 54 | 3.84e-02 | 0.163000 | 1.02e-01 |
| Sphingolipid de novo biosynthesis | 41 | 7.38e-02 | 0.161000 | 1.64e-01 |
| Programmed Cell Death | 169 | 3.05e-04 | 0.161000 | 2.32e-03 |
| TRAF3-dependent IRF activation pathway | 13 | 3.15e-01 | 0.161000 | 4.60e-01 |
| Neurotransmitter receptors and postsynaptic signal transmission | 123 | 2.10e-03 | 0.161000 | 1.03e-02 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 17 | 2.52e-01 | -0.161000 | 3.92e-01 |
| Autophagy | 124 | 2.10e-03 | 0.160000 | 1.03e-02 |
| tRNA processing in the mitochondrion | 30 | 1.31e-01 | -0.159000 | 2.45e-01 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 20 | 2.17e-01 | -0.159000 | 3.53e-01 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 22 | 1.96e-01 | 0.159000 | 3.26e-01 |
| Apoptosis | 166 | 4.19e-04 | 0.159000 | 2.94e-03 |
| Intrinsic Pathway of Fibrin Clot Formation | 16 | 2.73e-01 | 0.158000 | 4.17e-01 |
| Regulation of FOXO transcriptional activity by acetylation | 10 | 3.87e-01 | 0.158000 | 5.28e-01 |
| Diseases of signal transduction by growth factor receptors and second messengers | 340 | 5.72e-07 | 0.158000 | 9.60e-06 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 53 | 4.74e-02 | 0.157000 | 1.19e-01 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | 53 | 4.74e-02 | 0.157000 | 1.19e-01 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 53 | 4.74e-02 | 0.157000 | 1.19e-01 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | 53 | 4.74e-02 | 0.157000 | 1.19e-01 |
| Signaling by NOTCH1 in Cancer | 53 | 4.74e-02 | 0.157000 | 1.19e-01 |
| p38MAPK events | 13 | 3.26e-01 | 0.157000 | 4.70e-01 |
| Constitutive Signaling by EGFRvIII | 14 | 3.09e-01 | 0.157000 | 4.54e-01 |
| Signaling by EGFRvIII in Cancer | 14 | 3.09e-01 | 0.157000 | 4.54e-01 |
| VEGFR2 mediated vascular permeability | 27 | 1.58e-01 | 0.157000 | 2.79e-01 |
| Signaling by Non-Receptor Tyrosine Kinases | 48 | 6.06e-02 | 0.157000 | 1.41e-01 |
| Signaling by PTK6 | 48 | 6.06e-02 | 0.157000 | 1.41e-01 |
| Potassium Channels | 63 | 3.16e-02 | 0.157000 | 8.77e-02 |
| Hemostasis | 548 | 3.99e-10 | 0.156000 | 1.21e-08 |
| Metabolism of Angiotensinogen to Angiotensins | 11 | 3.71e-01 | 0.156000 | 5.13e-01 |
| G1/S Transition | 130 | 2.21e-03 | -0.155000 | 1.07e-02 |
| Synaptic adhesion-like molecules | 14 | 3.17e-01 | 0.154000 | 4.62e-01 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | 48 | 6.53e-02 | 0.154000 | 1.49e-01 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 3.77e-01 | -0.154000 | 5.19e-01 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | 11 | 3.80e-01 | -0.153000 | 5.20e-01 |
| RA biosynthesis pathway | 13 | 3.41e-01 | -0.153000 | 4.87e-01 |
| Vitamin B5 (pantothenate) metabolism | 17 | 2.77e-01 | 0.152000 | 4.22e-01 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 13 | 3.43e-01 | 0.152000 | 4.87e-01 |
| Stimuli-sensing channels | 73 | 2.55e-02 | 0.151000 | 7.44e-02 |
| Synthesis, secretion, and deacylation of Ghrelin | 12 | 3.67e-01 | -0.150000 | 5.09e-01 |
| Immune System | 1893 | 2.18e-27 | 0.150000 | 1.19e-25 |
| Degradation of DVL | 54 | 5.61e-02 | 0.150000 | 1.33e-01 |
| Establishment of Sister Chromatid Cohesion | 11 | 3.89e-01 | -0.150000 | 5.29e-01 |
| Interleukin-4 and Interleukin-13 signaling | 92 | 1.30e-02 | 0.150000 | 4.33e-02 |
| Assembly of collagen fibrils and other multimeric structures | 42 | 9.28e-02 | 0.150000 | 1.95e-01 |
| APC/C:Cdc20 mediated degradation of Cyclin B | 24 | 2.05e-01 | -0.150000 | 3.37e-01 |
| Nucleotide Excision Repair | 110 | 6.75e-03 | -0.150000 | 2.57e-02 |
| Formation of Incision Complex in GG-NER | 43 | 9.14e-02 | -0.149000 | 1.93e-01 |
| SHC1 events in ERBB2 signaling | 17 | 2.89e-01 | 0.148000 | 4.34e-01 |
| Signaling by WNT | 253 | 4.93e-05 | 0.148000 | 4.94e-04 |
| ISG15 antiviral mechanism | 72 | 3.02e-02 | -0.148000 | 8.52e-02 |
| p75 NTR receptor-mediated signalling | 89 | 1.61e-02 | 0.148000 | 5.18e-02 |
| Olfactory Signaling Pathway | 58 | 5.21e-02 | 0.147000 | 1.28e-01 |
| Interleukin-20 family signaling | 17 | 2.93e-01 | 0.147000 | 4.37e-01 |
| Transmission across Chemical Synapses | 172 | 8.85e-04 | 0.147000 | 5.21e-03 |
| Caspase-mediated cleavage of cytoskeletal proteins | 12 | 3.81e-01 | 0.146000 | 5.21e-01 |
| Cilium Assembly | 181 | 6.95e-04 | -0.146000 | 4.24e-03 |
| Beta-catenin independent WNT signaling | 136 | 3.27e-03 | 0.146000 | 1.45e-02 |
| Defective B4GALT7 causes EDS, progeroid type | 11 | 4.03e-01 | -0.145000 | 5.43e-01 |
| Citric acid cycle (TCA cycle) | 22 | 2.40e-01 | 0.145000 | 3.79e-01 |
| Synthesis of IP3 and IP4 in the cytosol | 22 | 2.40e-01 | 0.145000 | 3.79e-01 |
| Inositol phosphate metabolism | 42 | 1.05e-01 | 0.145000 | 2.13e-01 |
| Regulation of KIT signaling | 15 | 3.32e-01 | 0.145000 | 4.78e-01 |
| Factors involved in megakaryocyte development and platelet production | 116 | 7.17e-03 | 0.145000 | 2.68e-02 |
| Hedgehog 'on' state | 75 | 3.07e-02 | 0.144000 | 8.60e-02 |
| NGF-stimulated transcription | 31 | 1.64e-01 | 0.144000 | 2.89e-01 |
| Nuclear Envelope Breakdown | 53 | 6.95e-02 | -0.144000 | 1.57e-01 |
| Regulation of TP53 Activity through Acetylation | 29 | 1.80e-01 | -0.144000 | 3.09e-01 |
| Signaling by FGFR3 in disease | 13 | 3.69e-01 | -0.144000 | 5.11e-01 |
| Signaling by FGFR3 point mutants in cancer | 13 | 3.69e-01 | -0.144000 | 5.11e-01 |
| ABC transporters in lipid homeostasis | 14 | 3.51e-01 | -0.144000 | 4.96e-01 |
| FCGR3A-mediated IL10 synthesis | 99 | 1.34e-02 | -0.144000 | 4.45e-02 |
| Binding and Uptake of Ligands by Scavenger Receptors | 92 | 1.75e-02 | -0.143000 | 5.52e-02 |
| Peroxisomal lipid metabolism | 27 | 1.99e-01 | 0.143000 | 3.30e-01 |
| SHC-mediated cascade:FGFR2 | 12 | 3.93e-01 | -0.142000 | 5.33e-01 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 36 | 1.39e-01 | 0.142000 | 2.58e-01 |
| Negative regulation of NOTCH4 signaling | 54 | 7.02e-02 | 0.142000 | 1.58e-01 |
| Degradation of GLI1 by the proteasome | 57 | 6.35e-02 | 0.142000 | 1.46e-01 |
| Vif-mediated degradation of APOBEC3G | 52 | 7.88e-02 | 0.141000 | 1.72e-01 |
| Other semaphorin interactions | 16 | 3.31e-01 | 0.141000 | 4.76e-01 |
| GP1b-IX-V activation signalling | 10 | 4.42e-01 | 0.140000 | 5.81e-01 |
| Glyoxylate metabolism and glycine degradation | 24 | 2.34e-01 | -0.140000 | 3.73e-01 |
| mRNA 3'-end processing | 56 | 6.95e-02 | -0.140000 | 1.57e-01 |
| ABC transporter disorders | 70 | 4.25e-02 | 0.140000 | 1.11e-01 |
| Acetylcholine Neurotransmitter Release Cycle | 11 | 4.21e-01 | -0.140000 | 5.61e-01 |
| Retrograde transport at the Trans-Golgi-Network | 49 | 9.02e-02 | 0.140000 | 1.91e-01 |
| Negative regulation of MAPK pathway | 42 | 1.17e-01 | 0.140000 | 2.26e-01 |
| Extracellular matrix organization | 219 | 3.70e-04 | 0.140000 | 2.74e-03 |
| Signaling by FGFR1 in disease | 31 | 1.81e-01 | 0.139000 | 3.09e-01 |
| The role of Nef in HIV-1 replication and disease pathogenesis | 28 | 2.04e-01 | 0.139000 | 3.37e-01 |
| CaM pathway | 27 | 2.12e-01 | 0.139000 | 3.47e-01 |
| Calmodulin induced events | 27 | 2.12e-01 | 0.139000 | 3.47e-01 |
| Glutathione conjugation | 26 | 2.21e-01 | 0.139000 | 3.58e-01 |
| Peroxisomal protein import | 57 | 7.04e-02 | 0.139000 | 1.58e-01 |
| Chaperonin-mediated protein folding | 84 | 2.83e-02 | 0.138000 | 8.08e-02 |
| TICAM1, RIP1-mediated IKK complex recruitment | 19 | 2.99e-01 | 0.138000 | 4.44e-01 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 14 | 3.73e-01 | -0.137000 | 5.14e-01 |
| FGFR2 alternative splicing | 25 | 2.36e-01 | -0.137000 | 3.75e-01 |
| C-type lectin receptors (CLRs) | 128 | 7.55e-03 | 0.137000 | 2.81e-02 |
| UCH proteinases | 86 | 2.86e-02 | 0.137000 | 8.15e-02 |
| Phosphorylation of the APC/C | 20 | 2.92e-01 | -0.136000 | 4.37e-01 |
| The phototransduction cascade | 25 | 2.40e-01 | -0.136000 | 3.79e-01 |
| Signaling by NOTCH2 | 30 | 1.98e-01 | 0.136000 | 3.29e-01 |
| The canonical retinoid cycle in rods (twilight vision) | 10 | 4.57e-01 | 0.136000 | 5.91e-01 |
| Metabolism of carbohydrates | 244 | 2.62e-04 | 0.136000 | 2.05e-03 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 18 | 3.21e-01 | 0.135000 | 4.66e-01 |
| Fatty acyl-CoA biosynthesis | 34 | 1.73e-01 | 0.135000 | 3.01e-01 |
| Protein methylation | 15 | 3.66e-01 | -0.135000 | 5.08e-01 |
| TGF-beta receptor signaling activates SMADs | 32 | 1.87e-01 | 0.135000 | 3.17e-01 |
| Protein folding | 90 | 2.73e-02 | 0.135000 | 7.84e-02 |
| Apoptotic factor-mediated response | 18 | 3.23e-01 | 0.134000 | 4.67e-01 |
| Activation of HOX genes during differentiation | 68 | 5.56e-02 | 0.134000 | 1.33e-01 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | 68 | 5.56e-02 | 0.134000 | 1.33e-01 |
| Activation of kainate receptors upon glutamate binding | 26 | 2.39e-01 | 0.134000 | 3.78e-01 |
| HS-GAG biosynthesis | 20 | 3.02e-01 | 0.133000 | 4.48e-01 |
| Nicotinate metabolism | 25 | 2.49e-01 | 0.133000 | 3.89e-01 |
| Lysine catabolism | 11 | 4.47e-01 | 0.132000 | 5.83e-01 |
| Neuronal System | 258 | 2.50e-04 | 0.132000 | 2.00e-03 |
| Acyl chain remodelling of PG | 11 | 4.49e-01 | 0.132000 | 5.84e-01 |
| TCF dependent signaling in response to WNT | 165 | 3.49e-03 | 0.132000 | 1.51e-02 |
| NOTCH1 Intracellular Domain Regulates Transcription | 44 | 1.30e-01 | 0.132000 | 2.45e-01 |
| Transport of small molecules | 557 | 1.08e-07 | 0.132000 | 2.12e-06 |
| Formation of the beta-catenin:TCF transactivating complex | 46 | 1.23e-01 | 0.131000 | 2.35e-01 |
| TNFR1-induced proapoptotic signaling | 12 | 4.32e-01 | -0.131000 | 5.71e-01 |
| CDC6 association with the ORC:origin complex | 11 | 4.53e-01 | -0.131000 | 5.86e-01 |
| CD209 (DC-SIGN) signaling | 20 | 3.12e-01 | 0.131000 | 4.56e-01 |
| DNA Damage/Telomere Stress Induced Senescence | 44 | 1.34e-01 | 0.131000 | 2.50e-01 |
| Signaling by FGFR4 | 31 | 2.09e-01 | 0.130000 | 3.43e-01 |
| Transcriptional regulation by RUNX2 | 101 | 2.37e-02 | 0.130000 | 7.00e-02 |
| Antiviral mechanism by IFN-stimulated genes | 80 | 4.44e-02 | -0.130000 | 1.15e-01 |
| Unblocking of NMDA receptors, glutamate binding and activation | 12 | 4.36e-01 | -0.130000 | 5.74e-01 |
| Adrenaline,noradrenaline inhibits insulin secretion | 24 | 2.71e-01 | 0.130000 | 4.14e-01 |
| Xenobiotics | 11 | 4.56e-01 | -0.130000 | 5.90e-01 |
| Regulation of Apoptosis | 51 | 1.10e-01 | 0.129000 | 2.17e-01 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 52 | 1.07e-01 | 0.129000 | 2.14e-01 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 4.03e-01 | 0.129000 | 5.42e-01 |
| PECAM1 interactions | 12 | 4.39e-01 | 0.129000 | 5.77e-01 |
| Transcriptional regulation by RUNX3 | 90 | 3.44e-02 | 0.129000 | 9.34e-02 |
| Degradation of GLI2 by the proteasome | 56 | 9.69e-02 | 0.128000 | 2.03e-01 |
| Metabolic disorders of biological oxidation enzymes | 25 | 2.68e-01 | 0.128000 | 4.11e-01 |
| Keratinization | 32 | 2.10e-01 | 0.128000 | 3.45e-01 |
| Alpha-protein kinase 1 signaling pathway | 11 | 4.62e-01 | 0.128000 | 5.96e-01 |
| E3 ubiquitin ligases ubiquitinate target proteins | 52 | 1.10e-01 | 0.128000 | 2.18e-01 |
| DNA Replication Pre-Initiation | 82 | 4.52e-02 | -0.128000 | 1.16e-01 |
| cGMP effects | 13 | 4.25e-01 | 0.128000 | 5.65e-01 |
| Regulation of MECP2 expression and activity | 28 | 2.42e-01 | 0.128000 | 3.82e-01 |
| Transport of vitamins, nucleosides, and related molecules | 33 | 2.05e-01 | 0.128000 | 3.37e-01 |
| Signaling by FGFR2 in disease | 32 | 2.12e-01 | -0.127000 | 3.47e-01 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 80 | 4.92e-02 | 0.127000 | 1.22e-01 |
| Extra-nuclear estrogen signaling | 67 | 7.23e-02 | 0.127000 | 1.62e-01 |
| Cell recruitment (pro-inflammatory response) | 22 | 3.03e-01 | 0.127000 | 4.49e-01 |
| Purinergic signaling in leishmaniasis infection | 22 | 3.03e-01 | 0.127000 | 4.49e-01 |
| Cellular Senescence | 144 | 8.71e-03 | 0.127000 | 3.15e-02 |
| Gene expression (Transcription) | 1326 | 1.11e-14 | -0.126000 | 4.43e-13 |
| Signaling by PDGF | 44 | 1.48e-01 | 0.126000 | 2.69e-01 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 182 | 3.37e-03 | -0.126000 | 1.47e-02 |
| Cytosolic sulfonation of small molecules | 19 | 3.42e-01 | 0.126000 | 4.87e-01 |
| Response of EIF2AK1 (HRI) to heme deficiency | 14 | 4.15e-01 | 0.126000 | 5.54e-01 |
| Regulation of Complement cascade | 95 | 3.42e-02 | -0.126000 | 9.32e-02 |
| RUNX2 regulates osteoblast differentiation | 18 | 3.56e-01 | 0.126000 | 5.00e-01 |
| Complement cascade | 99 | 3.13e-02 | -0.125000 | 8.70e-02 |
| Macroautophagy | 110 | 2.33e-02 | 0.125000 | 6.92e-02 |
| Signal Transduction | 1882 | 2.53e-19 | 0.125000 | 1.19e-17 |
| G alpha (s) signalling events | 141 | 1.07e-02 | 0.124000 | 3.74e-02 |
| Interleukin-12 signaling | 44 | 1.54e-01 | 0.124000 | 2.77e-01 |
| Depolymerisation of the Nuclear Lamina | 15 | 4.05e-01 | 0.124000 | 5.44e-01 |
| Regulation of RUNX3 expression and activity | 55 | 1.11e-01 | 0.124000 | 2.19e-01 |
| Inhibition of DNA recombination at telomere | 35 | 2.05e-01 | 0.124000 | 3.37e-01 |
| Intracellular signaling by second messengers | 271 | 4.61e-04 | 0.124000 | 3.18e-03 |
| Keratan sulfate/keratin metabolism | 27 | 2.66e-01 | 0.124000 | 4.09e-01 |
| Interleukin-12 family signaling | 53 | 1.20e-01 | 0.123000 | 2.31e-01 |
| CLEC7A (Dectin-1) signaling | 96 | 3.67e-02 | 0.123000 | 9.82e-02 |
| CRMPs in Sema3A signaling | 14 | 4.26e-01 | 0.123000 | 5.66e-01 |
| Translation of structural proteins | 28 | 2.61e-01 | 0.123000 | 4.03e-01 |
| PTEN Regulation | 138 | 1.30e-02 | 0.122000 | 4.34e-02 |
| PIP3 activates AKT signaling | 239 | 1.12e-03 | 0.122000 | 6.36e-03 |
| ATF4 activates genes in response to endoplasmic reticulum stress | 25 | 2.90e-01 | -0.122000 | 4.34e-01 |
| Cell death signalling via NRAGE, NRIF and NADE | 70 | 7.76e-02 | 0.122000 | 1.71e-01 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | 53 | 1.25e-01 | 0.122000 | 2.37e-01 |
| Circadian Clock | 67 | 8.49e-02 | 0.122000 | 1.82e-01 |
| Protein ubiquitination | 72 | 7.48e-02 | 0.121000 | 1.66e-01 |
| Deubiquitination | 241 | 1.27e-03 | 0.121000 | 6.99e-03 |
| DNA Repair | 289 | 4.35e-04 | -0.120000 | 3.04e-03 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 26 | 2.90e-01 | -0.120000 | 4.34e-01 |
| VEGFR2 mediated cell proliferation | 18 | 3.79e-01 | 0.120000 | 5.20e-01 |
| Degradation of cysteine and homocysteine | 12 | 4.73e-01 | 0.120000 | 6.07e-01 |
| Fatty acid metabolism | 152 | 1.09e-02 | 0.120000 | 3.78e-02 |
| Degradation of beta-catenin by the destruction complex | 83 | 6.01e-02 | 0.119000 | 1.41e-01 |
| Regulation of RAS by GAPs | 66 | 9.41e-02 | 0.119000 | 1.98e-01 |
| Class I MHC mediated antigen processing & presentation | 349 | 1.35e-04 | 0.119000 | 1.19e-03 |
| Activation of NF-kappaB in B cells | 65 | 9.75e-02 | 0.119000 | 2.04e-01 |
| Tryptophan catabolism | 12 | 4.76e-01 | 0.119000 | 6.09e-01 |
| Collagen biosynthesis and modifying enzymes | 48 | 1.55e-01 | 0.119000 | 2.78e-01 |
| Ubiquitin-dependent degradation of Cyclin D | 50 | 1.50e-01 | 0.118000 | 2.72e-01 |
| Ion transport by P-type ATPases | 42 | 1.88e-01 | 0.117000 | 3.18e-01 |
| FCERI mediated MAPK activation | 90 | 5.57e-02 | -0.117000 | 1.33e-01 |
| Regulation of innate immune responses to cytosolic DNA | 14 | 4.51e-01 | -0.116000 | 5.85e-01 |
| Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 50 | 1.56e-01 | 0.116000 | 2.78e-01 |
| p53-Independent DNA Damage Response | 50 | 1.56e-01 | 0.116000 | 2.78e-01 |
| p53-Independent G1/S DNA damage checkpoint | 50 | 1.56e-01 | 0.116000 | 2.78e-01 |
| Defective B3GAT3 causes JDSSDHD | 11 | 5.05e-01 | -0.116000 | 6.35e-01 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | 58 | 1.29e-01 | 0.115000 | 2.43e-01 |
| HSF1 activation | 26 | 3.10e-01 | -0.115000 | 4.54e-01 |
| RNA Polymerase I Promoter Clearance | 66 | 1.06e-01 | -0.115000 | 2.13e-01 |
| RNA Polymerase I Transcription | 66 | 1.06e-01 | -0.115000 | 2.13e-01 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | 11 | 5.10e-01 | -0.115000 | 6.39e-01 |
| Cleavage of the damaged pyrimidine | 29 | 2.87e-01 | 0.114000 | 4.31e-01 |
| Depyrimidination | 29 | 2.87e-01 | 0.114000 | 4.31e-01 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 29 | 2.87e-01 | 0.114000 | 4.31e-01 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 16 | 4.30e-01 | 0.114000 | 5.69e-01 |
| Regulation of TP53 Activity through Phosphorylation | 88 | 6.46e-02 | -0.114000 | 1.48e-01 |
| Heparan sulfate/heparin (HS-GAG) metabolism | 37 | 2.32e-01 | 0.114000 | 3.70e-01 |
| DAG and IP3 signaling | 33 | 2.60e-01 | 0.113000 | 4.02e-01 |
| Biosynthesis of DHA-derived SPMs | 14 | 4.63e-01 | 0.113000 | 5.97e-01 |
| Methylation | 12 | 4.99e-01 | -0.113000 | 6.29e-01 |
| Regulation of TP53 Activity | 151 | 1.68e-02 | -0.113000 | 5.33e-02 |
| Degradation of AXIN | 53 | 1.56e-01 | 0.113000 | 2.78e-01 |
| Signaling by TGF-beta Receptor Complex | 72 | 9.86e-02 | 0.113000 | 2.06e-01 |
| Inactivation, recovery and regulation of the phototransduction cascade | 24 | 3.40e-01 | -0.112000 | 4.87e-01 |
| Elevation of cytosolic Ca2+ levels | 12 | 5.00e-01 | 0.112000 | 6.30e-01 |
| Homology Directed Repair | 110 | 4.17e-02 | -0.112000 | 1.10e-01 |
| Insulin receptor signalling cascade | 39 | 2.25e-01 | 0.112000 | 3.63e-01 |
| Processing and activation of SUMO | 10 | 5.39e-01 | -0.112000 | 6.66e-01 |
| Signaling by PDGFR in disease | 19 | 3.98e-01 | 0.112000 | 5.37e-01 |
| Generic Transcription Pathway | 1077 | 5.38e-10 | -0.112000 | 1.56e-08 |
| Deadenylation of mRNA | 22 | 3.63e-01 | -0.112000 | 5.08e-01 |
| ECM proteoglycans | 35 | 2.53e-01 | 0.112000 | 3.93e-01 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 30 | 2.90e-01 | 0.112000 | 4.34e-01 |
| Repression of WNT target genes | 14 | 4.70e-01 | -0.112000 | 6.04e-01 |
| Other interleukin signaling | 18 | 4.13e-01 | 0.111000 | 5.52e-01 |
| ESR-mediated signaling | 162 | 1.46e-02 | 0.111000 | 4.80e-02 |
| MAPK6/MAPK4 signaling | 82 | 8.26e-02 | 0.111000 | 1.79e-01 |
| GLI3 is processed to GLI3R by the proteasome | 57 | 1.48e-01 | 0.111000 | 2.69e-01 |
| Synthesis of PIPs at the early endosome membrane | 16 | 4.44e-01 | 0.110000 | 5.83e-01 |
| FOXO-mediated transcription | 58 | 1.47e-01 | 0.110000 | 2.69e-01 |
| Gene Silencing by RNA | 87 | 7.73e-02 | -0.110000 | 1.70e-01 |
| Signaling by ERBB4 | 44 | 2.09e-01 | 0.110000 | 3.43e-01 |
| PERK regulates gene expression | 30 | 3.00e-01 | -0.109000 | 4.46e-01 |
| Asymmetric localization of PCP proteins | 60 | 1.44e-01 | 0.109000 | 2.66e-01 |
| Signaling by GPCR | 536 | 1.59e-05 | 0.109000 | 1.86e-04 |
| Formation of TC-NER Pre-Incision Complex | 53 | 1.70e-01 | -0.109000 | 2.97e-01 |
| Death Receptor Signalling | 132 | 3.10e-02 | 0.109000 | 8.66e-02 |
| Negative regulation of the PI3K/AKT network | 87 | 7.98e-02 | 0.109000 | 1.74e-01 |
| Positive epigenetic regulation of rRNA expression | 62 | 1.39e-01 | -0.109000 | 2.58e-01 |
| DNA Double-Strand Break Repair | 135 | 2.98e-02 | -0.108000 | 8.46e-02 |
| Ras activation upon Ca2+ influx through NMDA receptor | 15 | 4.70e-01 | -0.108000 | 6.04e-01 |
| TP53 Regulates Metabolic Genes | 84 | 8.83e-02 | 0.108000 | 1.88e-01 |
| FRS-mediated FGFR2 signaling | 14 | 4.87e-01 | -0.107000 | 6.19e-01 |
| Cytochrome P450 - arranged by substrate type | 34 | 2.81e-01 | 0.107000 | 4.25e-01 |
| Signaling by Nuclear Receptors | 218 | 6.89e-03 | 0.106000 | 2.61e-02 |
| RNA Polymerase II Transcription | 1196 | 7.42e-10 | -0.106000 | 2.10e-08 |
| Activation of SMO | 13 | 5.09e-01 | 0.106000 | 6.39e-01 |
| Metal ion SLC transporters | 21 | 4.05e-01 | 0.105000 | 5.44e-01 |
| NIK-->noncanonical NF-kB signaling | 57 | 1.71e-01 | 0.105000 | 2.97e-01 |
| Post-translational protein modification | 1190 | 1.08e-09 | 0.105000 | 2.83e-08 |
| Ovarian tumor domain proteases | 37 | 2.69e-01 | 0.105000 | 4.12e-01 |
| Class I peroxisomal membrane protein import | 20 | 4.17e-01 | -0.105000 | 5.56e-01 |
| Nucleobase catabolism | 28 | 3.37e-01 | 0.105000 | 4.84e-01 |
| NF-kB is activated and signals survival | 12 | 5.30e-01 | 0.105000 | 6.58e-01 |
| WNT ligand biogenesis and trafficking | 21 | 4.07e-01 | 0.105000 | 5.45e-01 |
| Voltage gated Potassium channels | 25 | 3.66e-01 | 0.105000 | 5.08e-01 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 27 | 3.47e-01 | -0.104000 | 4.92e-01 |
| Receptor Mediated Mitophagy | 11 | 5.49e-01 | 0.104000 | 6.76e-01 |
| Cardiac conduction | 92 | 8.40e-02 | 0.104000 | 1.81e-01 |
| Signaling by EGFR in Cancer | 23 | 3.89e-01 | 0.104000 | 5.29e-01 |
| SUMOylation | 165 | 2.19e-02 | -0.103000 | 6.62e-02 |
| NRAGE signals death through JNK | 53 | 1.94e-01 | 0.103000 | 3.24e-01 |
| Deposition of new CENPA-containing nucleosomes at the centromere | 40 | 2.60e-01 | -0.103000 | 4.02e-01 |
| Nucleosome assembly | 40 | 2.60e-01 | -0.103000 | 4.02e-01 |
| O-glycosylation of TSR domain-containing proteins | 27 | 3.57e-01 | -0.102000 | 5.01e-01 |
| Dectin-1 mediated noncanonical NF-kB signaling | 58 | 1.80e-01 | 0.102000 | 3.09e-01 |
| Organelle biogenesis and maintenance | 269 | 4.21e-03 | -0.101000 | 1.74e-02 |
| Base-Excision Repair, AP Site Formation | 31 | 3.29e-01 | 0.101000 | 4.74e-01 |
| Cellular hexose transport | 15 | 4.97e-01 | -0.101000 | 6.28e-01 |
| Metabolism of polyamines | 57 | 1.88e-01 | 0.101000 | 3.17e-01 |
| SLC-mediated transmembrane transport | 180 | 1.98e-02 | 0.101000 | 6.09e-02 |
| Unfolded Protein Response (UPR) | 86 | 1.07e-01 | 0.101000 | 2.13e-01 |
| Signalling to RAS | 19 | 4.48e-01 | 0.101000 | 5.83e-01 |
| Mitotic G1 phase and G1/S transition | 148 | 3.50e-02 | -0.100000 | 9.45e-02 |
| DNA Damage Recognition in GG-NER | 38 | 2.86e-01 | -0.100000 | 4.31e-01 |
| GPCR downstream signalling | 494 | 1.40e-04 | 0.100000 | 1.23e-03 |
| Autodegradation of the E3 ubiquitin ligase COP1 | 49 | 2.26e-01 | 0.099900 | 3.65e-01 |
| Nephrin family interactions | 17 | 4.76e-01 | -0.099800 | 6.09e-01 |
| Purine catabolism | 16 | 4.92e-01 | -0.099200 | 6.25e-01 |
| DAP12 signaling | 28 | 3.65e-01 | 0.098900 | 5.08e-01 |
| G alpha (q) signalling events | 131 | 5.23e-02 | 0.098200 | 1.28e-01 |
| Cristae formation | 31 | 3.44e-01 | -0.098100 | 4.89e-01 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 36 | 3.10e-01 | 0.097800 | 4.54e-01 |
| SIRT1 negatively regulates rRNA expression | 24 | 4.07e-01 | 0.097700 | 5.46e-01 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 11 | 5.75e-01 | 0.097600 | 7.01e-01 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 10 | 5.93e-01 | -0.097500 | 7.17e-01 |
| Transcriptional Regulation by MECP2 | 47 | 2.48e-01 | 0.097400 | 3.89e-01 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | 20 | 4.51e-01 | -0.097300 | 5.85e-01 |
| SUMO E3 ligases SUMOylate target proteins | 159 | 3.45e-02 | -0.097200 | 9.35e-02 |
| MASTL Facilitates Mitotic Progression | 10 | 5.95e-01 | 0.097100 | 7.17e-01 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 10 | 5.95e-01 | -0.097000 | 7.17e-01 |
| Defective EXT2 causes exostoses 2 | 10 | 5.95e-01 | -0.097000 | 7.17e-01 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | 32 | 3.43e-01 | -0.096900 | 4.87e-01 |
| Vpu mediated degradation of CD4 | 50 | 2.39e-01 | 0.096200 | 3.79e-01 |
| Negative regulation of FGFR2 signaling | 23 | 4.26e-01 | 0.095800 | 5.66e-01 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | 20 | 4.60e-01 | 0.095500 | 5.93e-01 |
| Leishmania infection | 245 | 1.01e-02 | 0.095500 | 3.58e-02 |
| PKA-mediated phosphorylation of CREB | 17 | 4.98e-01 | 0.095000 | 6.28e-01 |
| Meiotic synapsis | 45 | 2.70e-01 | 0.095000 | 4.13e-01 |
| Epigenetic regulation of gene expression | 103 | 9.73e-02 | -0.094600 | 2.04e-01 |
| Nuclear signaling by ERBB4 | 24 | 4.25e-01 | 0.094200 | 5.65e-01 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 22 | 4.45e-01 | 0.094000 | 5.83e-01 |
| Metabolism of nucleotides | 86 | 1.32e-01 | -0.094000 | 2.46e-01 |
| p75NTR signals via NF-kB | 15 | 5.31e-01 | 0.093500 | 6.58e-01 |
| Signaling by FGFR2 IIIa TM | 18 | 4.93e-01 | -0.093400 | 6.25e-01 |
| Peptide ligand-binding receptors | 92 | 1.24e-01 | 0.092800 | 2.36e-01 |
| Pexophagy | 11 | 5.94e-01 | 0.092800 | 7.17e-01 |
| TP53 Regulates Transcription of DNA Repair Genes | 61 | 2.14e-01 | -0.092000 | 3.49e-01 |
| Heme biosynthesis | 14 | 5.51e-01 | 0.091900 | 6.79e-01 |
| Integrin cell surface interactions | 52 | 2.53e-01 | 0.091600 | 3.93e-01 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 104 | 1.07e-01 | -0.091400 | 2.14e-01 |
| Recruitment of NuMA to mitotic centrosomes | 80 | 1.61e-01 | -0.090700 | 2.83e-01 |
| Metabolism of cofactors | 19 | 4.95e-01 | 0.090500 | 6.26e-01 |
| Fcgamma receptor (FCGR) dependent phagocytosis | 147 | 5.88e-02 | 0.090300 | 1.38e-01 |
| FLT3 Signaling | 244 | 1.52e-02 | 0.090200 | 4.96e-02 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 72 | 1.88e-01 | 0.089600 | 3.18e-01 |
| PI-3K cascade:FGFR4 | 10 | 6.25e-01 | -0.089200 | 7.41e-01 |
| Anchoring of the basal body to the plasma membrane | 97 | 1.29e-01 | -0.089100 | 2.43e-01 |
| Ub-specific processing proteases | 170 | 4.52e-02 | 0.089000 | 1.16e-01 |
| Termination of O-glycan biosynthesis | 16 | 5.39e-01 | 0.088700 | 6.66e-01 |
| Processing of DNA double-strand break ends | 71 | 1.98e-01 | -0.088400 | 3.28e-01 |
| Mitotic Telophase/Cytokinesis | 13 | 5.83e-01 | 0.088000 | 7.08e-01 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 17 | 5.31e-01 | 0.087800 | 6.58e-01 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 17 | 5.31e-01 | 0.087800 | 6.58e-01 |
| Branched-chain amino acid catabolism | 21 | 4.86e-01 | -0.087700 | 6.19e-01 |
| Stabilization of p53 | 54 | 2.66e-01 | 0.087400 | 4.09e-01 |
| Mitotic Prometaphase | 185 | 4.05e-02 | -0.087400 | 1.07e-01 |
| Ca2+ pathway | 57 | 2.57e-01 | 0.086800 | 3.98e-01 |
| Condensation of Prometaphase Chromosomes | 11 | 6.18e-01 | 0.086800 | 7.37e-01 |
| Pregnenolone biosynthesis | 10 | 6.36e-01 | 0.086500 | 7.52e-01 |
| FRS-mediated FGFR1 signaling | 14 | 5.77e-01 | 0.086100 | 7.02e-01 |
| MAPK1/MAPK3 signaling | 235 | 2.31e-02 | 0.086000 | 6.88e-02 |
| MAPK family signaling cascades | 269 | 1.56e-02 | 0.085700 | 5.03e-02 |
| Regulation of necroptotic cell death | 14 | 5.80e-01 | -0.085400 | 7.05e-01 |
| Mitotic Spindle Checkpoint | 108 | 1.26e-01 | -0.085300 | 2.38e-01 |
| Centrosome maturation | 81 | 1.85e-01 | -0.085200 | 3.16e-01 |
| Recruitment of mitotic centrosome proteins and complexes | 81 | 1.85e-01 | -0.085200 | 3.16e-01 |
| Regulation of PTEN mRNA translation | 13 | 5.96e-01 | 0.084800 | 7.18e-01 |
| Downstream signaling of activated FGFR2 | 19 | 5.22e-01 | -0.084800 | 6.51e-01 |
| Signaling by Hedgehog | 120 | 1.09e-01 | 0.084800 | 2.16e-01 |
| FCERI mediated NF-kB activation | 137 | 8.72e-02 | -0.084600 | 1.86e-01 |
| mRNA Capping | 29 | 4.31e-01 | -0.084600 | 5.69e-01 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | 87 | 1.74e-01 | 0.084300 | 3.03e-01 |
| Synthesis of very long-chain fatty acyl-CoAs | 21 | 5.04e-01 | 0.084200 | 6.34e-01 |
| HCMV Early Events | 74 | 2.11e-01 | -0.084100 | 3.46e-01 |
| DCC mediated attractive signaling | 13 | 6.00e-01 | -0.084000 | 7.22e-01 |
| G alpha (i) signalling events | 244 | 2.46e-02 | 0.083600 | 7.23e-02 |
| Regulation of TP53 Expression and Degradation | 36 | 3.86e-01 | -0.083500 | 5.27e-01 |
| SHC-mediated cascade:FGFR1 | 12 | 6.18e-01 | 0.083200 | 7.37e-01 |
| RAF-independent MAPK1/3 activation | 21 | 5.09e-01 | 0.083200 | 6.39e-01 |
| Signaling by NTRK2 (TRKB) | 20 | 5.23e-01 | 0.082500 | 6.52e-01 |
| Endosomal/Vacuolar pathway | 12 | 6.22e-01 | -0.082100 | 7.39e-01 |
| Intrinsic Pathway for Apoptosis | 52 | 3.06e-01 | 0.082000 | 4.53e-01 |
| Laminin interactions | 21 | 5.15e-01 | 0.082000 | 6.45e-01 |
| Zinc transporters | 14 | 5.95e-01 | 0.082000 | 7.17e-01 |
| Signaling by TGFB family members | 91 | 1.78e-01 | 0.081800 | 3.07e-01 |
| SCF-beta-TrCP mediated degradation of Emi1 | 53 | 3.04e-01 | 0.081700 | 4.49e-01 |
| CD28 dependent Vav1 pathway | 12 | 6.27e-01 | 0.081100 | 7.42e-01 |
| Downstream TCR signaling | 100 | 1.63e-01 | -0.080700 | 2.87e-01 |
| HCMV Late Events | 69 | 2.46e-01 | 0.080700 | 3.87e-01 |
| RAF/MAP kinase cascade | 230 | 3.61e-02 | 0.080200 | 9.73e-02 |
| Transcriptional regulation by RUNX1 | 184 | 6.06e-02 | 0.080200 | 1.41e-01 |
| SUMOylation of transcription factors | 16 | 5.79e-01 | 0.080200 | 7.04e-01 |
| CLEC7A (Dectin-1) induces NFAT activation | 11 | 6.46e-01 | -0.080100 | 7.61e-01 |
| NCAM signaling for neurite out-growth | 43 | 3.65e-01 | -0.079900 | 5.08e-01 |
| Interleukin-2 signaling | 11 | 6.49e-01 | 0.079200 | 7.65e-01 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 32 | 4.43e-01 | 0.078400 | 5.81e-01 |
| Phase I - Functionalization of compounds | 63 | 2.85e-01 | 0.077900 | 4.31e-01 |
| ABC-family proteins mediated transport | 93 | 1.96e-01 | 0.077600 | 3.26e-01 |
| Collagen chain trimerization | 27 | 4.85e-01 | -0.077600 | 6.19e-01 |
| Cytokine Signaling in Immune system | 735 | 3.43e-04 | 0.077600 | 2.56e-03 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 18 | 5.69e-01 | 0.077500 | 6.94e-01 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | 18 | 5.69e-01 | 0.077500 | 6.94e-01 |
| Defective B3GALTL causes Peters-plus syndrome (PpS) | 26 | 4.94e-01 | -0.077400 | 6.26e-01 |
| Resolution of D-Loop Structures | 33 | 4.44e-01 | -0.076900 | 5.83e-01 |
| RNA Polymerase I Promoter Escape | 47 | 3.62e-01 | -0.076900 | 5.06e-01 |
| ADORA2B mediated anti-inflammatory cytokines production | 73 | 2.57e-01 | 0.076800 | 3.98e-01 |
| Regulation of TNFR1 signaling | 32 | 4.53e-01 | -0.076600 | 5.86e-01 |
| Acyl chain remodelling of PE | 20 | 5.54e-01 | 0.076400 | 6.82e-01 |
| Post-translational modification: synthesis of GPI-anchored proteins | 57 | 3.19e-01 | 0.076300 | 4.64e-01 |
| Estrogen-dependent gene expression | 99 | 1.93e-01 | 0.075700 | 3.23e-01 |
| Regulation of actin dynamics for phagocytic cup formation | 123 | 1.49e-01 | 0.075300 | 2.71e-01 |
| Peptide hormone metabolism | 51 | 3.52e-01 | 0.075300 | 4.96e-01 |
| PRC2 methylates histones and DNA | 29 | 4.83e-01 | 0.075200 | 6.17e-01 |
| Synthesis of PE | 12 | 6.53e-01 | -0.075000 | 7.66e-01 |
| ERBB2 Regulates Cell Motility | 10 | 6.82e-01 | 0.074900 | 7.83e-01 |
| Nicotinamide salvaging | 14 | 6.31e-01 | 0.074200 | 7.46e-01 |
| Signaling by ERBB2 | 44 | 3.95e-01 | 0.074200 | 5.34e-01 |
| Pyruvate metabolism | 28 | 4.98e-01 | 0.074100 | 6.28e-01 |
| Class B/2 (Secretin family receptors) | 56 | 3.38e-01 | 0.074000 | 4.85e-01 |
| Regulation of TP53 Degradation | 35 | 4.51e-01 | -0.073700 | 5.85e-01 |
| p53-Dependent G1 DNA Damage Response | 63 | 3.13e-01 | 0.073600 | 4.56e-01 |
| p53-Dependent G1/S DNA damage checkpoint | 63 | 3.13e-01 | 0.073600 | 4.56e-01 |
| Neurotransmitter release cycle | 39 | 4.27e-01 | 0.073500 | 5.66e-01 |
| Activation of RAC1 | 11 | 6.74e-01 | 0.073200 | 7.76e-01 |
| G2/M DNA damage checkpoint | 68 | 2.99e-01 | -0.072900 | 4.44e-01 |
| Cell junction organization | 59 | 3.40e-01 | 0.071800 | 4.87e-01 |
| Cell Cycle | 624 | 2.23e-03 | -0.071700 | 1.07e-02 |
| Negative regulators of DDX58/IFIH1 signaling | 34 | 4.75e-01 | -0.070700 | 6.09e-01 |
| GABA synthesis, release, reuptake and degradation | 13 | 6.61e-01 | -0.070300 | 7.70e-01 |
| Eicosanoid ligand-binding receptors | 13 | 6.61e-01 | -0.070200 | 7.70e-01 |
| Glucose metabolism | 84 | 2.66e-01 | 0.070200 | 4.09e-01 |
| Regulation of PTEN gene transcription | 59 | 3.54e-01 | 0.069800 | 4.97e-01 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 91 | 2.52e-01 | -0.069500 | 3.92e-01 |
| Amplification of signal from the kinetochores | 91 | 2.52e-01 | -0.069500 | 3.92e-01 |
| p75NTR recruits signalling complexes | 12 | 6.77e-01 | 0.069400 | 7.79e-01 |
| HIV Life Cycle | 144 | 1.51e-01 | -0.069400 | 2.73e-01 |
| NRIF signals cell death from the nucleus | 15 | 6.43e-01 | 0.069200 | 7.58e-01 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 18 | 6.11e-01 | -0.069200 | 7.32e-01 |
| Host Interactions of HIV factors | 129 | 1.75e-01 | -0.069200 | 3.03e-01 |
| Downstream signaling events of B Cell Receptor (BCR) | 79 | 2.89e-01 | 0.069000 | 4.34e-01 |
| Basigin interactions | 23 | 5.68e-01 | -0.068800 | 6.94e-01 |
| SHC1 events in ERBB4 signaling | 10 | 7.06e-01 | 0.068800 | 7.97e-01 |
| Synthesis of substrates in N-glycan biosythesis | 58 | 3.66e-01 | 0.068700 | 5.08e-01 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 13 | 6.70e-01 | -0.068200 | 7.76e-01 |
| Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 3.97e-01 | 0.068000 | 5.36e-01 |
| Cell Cycle Checkpoints | 259 | 6.16e-02 | -0.067500 | 1.43e-01 |
| Switching of origins to a post-replicative state | 89 | 2.76e-01 | -0.066900 | 4.20e-01 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 36 | 4.88e-01 | 0.066800 | 6.20e-01 |
| APC/C:Cdc20 mediated degradation of Securin | 66 | 3.48e-01 | 0.066700 | 4.93e-01 |
| Cell-Cell communication | 87 | 2.84e-01 | 0.066400 | 4.30e-01 |
| PI3K/AKT Signaling in Cancer | 80 | 3.08e-01 | 0.065900 | 4.54e-01 |
| Aflatoxin activation and detoxification | 14 | 6.70e-01 | 0.065700 | 7.76e-01 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | 63 | 3.74e-01 | 0.064700 | 5.15e-01 |
| SCF(Skp2)-mediated degradation of p27/p21 | 60 | 3.87e-01 | 0.064600 | 5.27e-01 |
| MicroRNA (miRNA) biogenesis | 24 | 5.85e-01 | -0.064400 | 7.09e-01 |
| GPCR ligand binding | 229 | 9.37e-02 | 0.064300 | 1.97e-01 |
| RNA polymerase II transcribes snRNA genes | 72 | 3.48e-01 | 0.064000 | 4.93e-01 |
| Negative epigenetic regulation of rRNA expression | 65 | 3.78e-01 | -0.063200 | 5.19e-01 |
| FCGR3A-mediated phagocytosis | 121 | 2.31e-01 | 0.063000 | 3.70e-01 |
| Leishmania phagocytosis | 121 | 2.31e-01 | 0.063000 | 3.70e-01 |
| Parasite infection | 121 | 2.31e-01 | 0.063000 | 3.70e-01 |
| Regulation of RUNX2 expression and activity | 66 | 3.79e-01 | 0.062600 | 5.20e-01 |
| Molecules associated with elastic fibres | 22 | 6.12e-01 | 0.062500 | 7.32e-01 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | 23 | 6.04e-01 | 0.062500 | 7.25e-01 |
| Protein localization | 157 | 1.80e-01 | -0.062000 | 3.09e-01 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 21 | 6.24e-01 | 0.061900 | 7.40e-01 |
| Resolution of Sister Chromatid Cohesion | 104 | 2.77e-01 | -0.061700 | 4.22e-01 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | 11 | 7.23e-01 | 0.061700 | 8.12e-01 |
| Autodegradation of Cdh1 by Cdh1:APC/C | 64 | 3.95e-01 | 0.061500 | 5.34e-01 |
| Class A/1 (Rhodopsin-like receptors) | 162 | 1.78e-01 | 0.061300 | 3.08e-01 |
| G1/S DNA Damage Checkpoints | 65 | 3.94e-01 | 0.061100 | 5.34e-01 |
| TRP channels | 17 | 6.63e-01 | 0.061000 | 7.71e-01 |
| Sema3A PAK dependent Axon repulsion | 16 | 6.73e-01 | 0.060900 | 7.76e-01 |
| B-WICH complex positively regulates rRNA expression | 47 | 4.71e-01 | -0.060800 | 6.05e-01 |
| G2/M Checkpoints | 139 | 2.17e-01 | -0.060600 | 3.53e-01 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 23 | 6.21e-01 | 0.059500 | 7.39e-01 |
| Signaling by the B Cell Receptor (BCR) | 162 | 1.92e-01 | -0.059400 | 3.22e-01 |
| Ephrin signaling | 17 | 6.72e-01 | 0.059300 | 7.76e-01 |
| Ion homeostasis | 40 | 5.18e-01 | 0.059000 | 6.48e-01 |
| EML4 and NUDC in mitotic spindle formation | 95 | 3.21e-01 | -0.058900 | 4.66e-01 |
| Regulation of PLK1 Activity at G2/M Transition | 87 | 3.43e-01 | -0.058800 | 4.88e-01 |
| Cargo trafficking to the periciliary membrane | 47 | 4.86e-01 | -0.058700 | 6.19e-01 |
| RAS processing | 19 | 6.60e-01 | -0.058400 | 7.70e-01 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | 11 | 7.40e-01 | -0.057800 | 8.26e-01 |
| Signaling by FGFR4 in disease | 11 | 7.43e-01 | -0.057100 | 8.27e-01 |
| Synthesis of glycosylphosphatidylinositol (GPI) | 17 | 6.84e-01 | -0.057000 | 7.85e-01 |
| Downstream signaling of activated FGFR1 | 20 | 6.61e-01 | 0.056700 | 7.70e-01 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 43 | 5.21e-01 | 0.056500 | 6.51e-01 |
| CDK-mediated phosphorylation and removal of Cdc6 | 71 | 4.11e-01 | 0.056500 | 5.49e-01 |
| Transport of inorganic cations/anions and amino acids/oligopeptides | 79 | 3.89e-01 | 0.056100 | 5.29e-01 |
| Antigen processing: Ubiquitination & Proteasome degradation | 288 | 1.03e-01 | 0.055800 | 2.12e-01 |
| Glycolysis | 67 | 4.33e-01 | 0.055300 | 5.72e-01 |
| Interleukin-7 signaling | 21 | 6.64e-01 | 0.054800 | 7.71e-01 |
| Polo-like kinase mediated events | 16 | 7.05e-01 | 0.054700 | 7.97e-01 |
| Phase II - Conjugation of compounds | 68 | 4.47e-01 | 0.053300 | 5.83e-01 |
| Loss of Nlp from mitotic centrosomes | 69 | 4.46e-01 | -0.053100 | 5.83e-01 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 69 | 4.46e-01 | -0.053100 | 5.83e-01 |
| Metabolism of folate and pterines | 16 | 7.13e-01 | 0.053100 | 8.02e-01 |
| Metabolism of nitric oxide: NOS3 activation and regulation | 12 | 7.51e-01 | 0.052900 | 8.33e-01 |
| Neddylation | 218 | 1.87e-01 | 0.051800 | 3.17e-01 |
| TCR signaling | 121 | 3.28e-01 | -0.051500 | 4.73e-01 |
| Metabolism | 1768 | 3.32e-04 | 0.051400 | 2.50e-03 |
| Prolactin receptor signaling | 11 | 7.68e-01 | -0.051300 | 8.46e-01 |
| Cell Cycle, Mitotic | 502 | 5.21e-02 | -0.050600 | 1.28e-01 |
| RNA Pol II CTD phosphorylation and interaction with CE | 27 | 6.52e-01 | -0.050100 | 7.66e-01 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 27 | 6.52e-01 | -0.050100 | 7.66e-01 |
| Prefoldin mediated transfer of substrate to CCT/TriC | 26 | 6.59e-01 | -0.050000 | 7.70e-01 |
| Diseases of metabolism | 190 | 2.35e-01 | 0.050000 | 3.74e-01 |
| Developmental Biology | 727 | 2.27e-02 | 0.049600 | 6.80e-02 |
| RMTs methylate histone arginines | 37 | 6.02e-01 | -0.049600 | 7.23e-01 |
| Maturation of nucleoprotein | 10 | 7.86e-01 | 0.049500 | 8.57e-01 |
| Signaling by NODAL | 13 | 7.59e-01 | -0.049200 | 8.39e-01 |
| Signaling by BMP | 21 | 7.03e-01 | -0.048000 | 7.96e-01 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 75 | 4.77e-01 | 0.047500 | 6.09e-01 |
| Metabolism of vitamins and cofactors | 155 | 3.07e-01 | 0.047500 | 4.53e-01 |
| HCMV Infection | 96 | 4.23e-01 | 0.047300 | 5.64e-01 |
| Orc1 removal from chromatin | 69 | 4.99e-01 | -0.047100 | 6.29e-01 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 31 | 6.51e-01 | -0.047000 | 7.66e-01 |
| Downregulation of ERBB2:ERBB3 signaling | 12 | 7.81e-01 | -0.046400 | 8.52e-01 |
| Diseases associated with N-glycosylation of proteins | 17 | 7.42e-01 | -0.046200 | 8.27e-01 |
| Phase 2 - plateau phase | 18 | 7.35e-01 | 0.046100 | 8.23e-01 |
| Diseases associated with glycosaminoglycan metabolism | 26 | 6.86e-01 | 0.045800 | 7.86e-01 |
| HATs acetylate histones | 93 | 4.47e-01 | -0.045600 | 5.83e-01 |
| Biological oxidations | 136 | 3.64e-01 | 0.045100 | 5.08e-01 |
| TP53 Regulates Transcription of Cell Cycle Genes | 48 | 5.90e-01 | -0.044900 | 7.15e-01 |
| PI-3K cascade:FGFR1 | 12 | 7.88e-01 | 0.044900 | 8.58e-01 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | 14 | 7.71e-01 | 0.044900 | 8.48e-01 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | 14 | 7.71e-01 | 0.044900 | 8.48e-01 |
| Formation of RNA Pol II elongation complex | 57 | 5.58e-01 | 0.044900 | 6.84e-01 |
| RNA Polymerase II Transcription Elongation | 57 | 5.58e-01 | 0.044900 | 6.84e-01 |
| CDT1 association with the CDC6:ORC:origin complex | 57 | 5.58e-01 | 0.044800 | 6.84e-01 |
| Processing of Intronless Pre-mRNAs | 19 | 7.36e-01 | -0.044700 | 8.23e-01 |
| Disorders of transmembrane transporters | 147 | 3.53e-01 | 0.044400 | 4.96e-01 |
| Nonhomologous End-Joining (NHEJ) | 42 | 6.21e-01 | 0.044100 | 7.39e-01 |
| Adaptive Immune System | 756 | 3.94e-02 | 0.044000 | 1.05e-01 |
| Interferon Signaling | 177 | 3.12e-01 | -0.044000 | 4.56e-01 |
| Signaling by ERBB2 ECD mutants | 15 | 7.68e-01 | 0.044000 | 8.46e-01 |
| Mitotic Prophase | 98 | 4.52e-01 | 0.044000 | 5.85e-01 |
| Chondroitin sulfate/dermatan sulfate metabolism | 38 | 6.42e-01 | 0.043500 | 7.58e-01 |
| SHC-mediated cascade:FGFR4 | 10 | 8.13e-01 | -0.043200 | 8.80e-01 |
| SLC transporter disorders | 77 | 5.13e-01 | -0.043100 | 6.42e-01 |
| HIV elongation arrest and recovery | 32 | 6.73e-01 | 0.043100 | 7.76e-01 |
| Pausing and recovery of HIV elongation | 32 | 6.73e-01 | 0.043100 | 7.76e-01 |
| Late Phase of HIV Life Cycle | 131 | 4.03e-01 | -0.042300 | 5.43e-01 |
| Neurexins and neuroligins | 37 | 6.56e-01 | -0.042300 | 7.69e-01 |
| Transcriptional regulation by small RNAs | 63 | 5.62e-01 | -0.042300 | 6.88e-01 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | 74 | 5.30e-01 | 0.042200 | 6.58e-01 |
| Nitric oxide stimulates guanylate cyclase | 16 | 7.72e-01 | 0.041900 | 8.48e-01 |
| Disease | 1299 | 1.13e-02 | 0.041900 | 3.89e-02 |
| Transcriptional activation of mitochondrial biogenesis | 51 | 6.13e-01 | 0.040900 | 7.33e-01 |
| Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 124 | 4.32e-01 | -0.040800 | 5.71e-01 |
| RIPK1-mediated regulated necrosis | 16 | 7.79e-01 | 0.040600 | 8.50e-01 |
| Regulated Necrosis | 16 | 7.79e-01 | 0.040600 | 8.50e-01 |
| TP53 Regulates Transcription of Death Receptors and Ligands | 11 | 8.16e-01 | -0.040500 | 8.82e-01 |
| Dopamine Neurotransmitter Release Cycle | 20 | 7.55e-01 | -0.040400 | 8.36e-01 |
| Netrin-1 signaling | 40 | 6.61e-01 | 0.040000 | 7.70e-01 |
| Cyclin A/B1/B2 associated events during G2/M transition | 25 | 7.30e-01 | 0.039800 | 8.20e-01 |
| Mitochondrial Fatty Acid Beta-Oxidation | 36 | 6.80e-01 | -0.039700 | 7.82e-01 |
| Gamma carboxylation, hypusine formation and arylsulfatase activation | 34 | 6.89e-01 | -0.039700 | 7.89e-01 |
| Interleukin-35 Signalling | 12 | 8.12e-01 | -0.039600 | 8.80e-01 |
| TP53 Regulates Transcription of Cell Death Genes | 42 | 6.57e-01 | 0.039600 | 7.69e-01 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 72 | 5.65e-01 | 0.039200 | 6.92e-01 |
| Hedgehog 'off' state | 92 | 5.28e-01 | 0.038100 | 6.57e-01 |
| Purine salvage | 12 | 8.21e-01 | 0.037800 | 8.84e-01 |
| Post NMDA receptor activation events | 48 | 6.51e-01 | 0.037700 | 7.66e-01 |
| Amino acid transport across the plasma membrane | 23 | 7.54e-01 | 0.037700 | 8.36e-01 |
| Visual phototransduction | 59 | 6.18e-01 | 0.037600 | 7.37e-01 |
| Glutathione synthesis and recycling | 10 | 8.39e-01 | -0.037100 | 8.99e-01 |
| IGF1R signaling cascade | 36 | 7.01e-01 | 0.037000 | 7.94e-01 |
| Keratan sulfate biosynthesis | 22 | 7.65e-01 | 0.036700 | 8.44e-01 |
| AURKA Activation by TPX2 | 72 | 5.90e-01 | -0.036700 | 7.15e-01 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | 36 | 7.07e-01 | -0.036200 | 7.97e-01 |
| Diseases of mitotic cell cycle | 36 | 7.07e-01 | -0.036200 | 7.97e-01 |
| TNFR2 non-canonical NF-kB pathway | 95 | 5.43e-01 | -0.036100 | 6.70e-01 |
| N-glycan antennae elongation in the medial/trans-Golgi | 21 | 7.75e-01 | 0.036000 | 8.49e-01 |
| O-linked glycosylation | 84 | 5.69e-01 | 0.035900 | 6.94e-01 |
| Transcriptional Regulation by VENTX | 38 | 7.04e-01 | -0.035600 | 7.96e-01 |
| Cyclin D associated events in G1 | 47 | 6.73e-01 | 0.035500 | 7.76e-01 |
| G1 Phase | 47 | 6.73e-01 | 0.035500 | 7.76e-01 |
| Diseases associated with O-glycosylation of proteins | 49 | 6.67e-01 | -0.035500 | 7.75e-01 |
| Chromatin modifying enzymes | 217 | 3.72e-01 | 0.035100 | 5.14e-01 |
| Chromatin organization | 217 | 3.72e-01 | 0.035100 | 5.14e-01 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 18 | 7.98e-01 | 0.034900 | 8.66e-01 |
| Transcription of the HIV genome | 67 | 6.23e-01 | -0.034800 | 7.39e-01 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 71 | 6.13e-01 | 0.034800 | 7.33e-01 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 46 | 6.84e-01 | 0.034700 | 7.85e-01 |
| Respiratory electron transport | 101 | 5.48e-01 | -0.034600 | 6.76e-01 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | 42 | 6.99e-01 | -0.034500 | 7.93e-01 |
| HIV Transcription Elongation | 42 | 6.99e-01 | -0.034500 | 7.93e-01 |
| Tat-mediated elongation of the HIV-1 transcript | 42 | 6.99e-01 | -0.034500 | 7.93e-01 |
| IRAK2 mediated activation of TAK1 complex | 10 | 8.51e-01 | 0.034400 | 9.06e-01 |
| Formation of the Early Elongation Complex | 33 | 7.34e-01 | -0.034200 | 8.22e-01 |
| Formation of the HIV-1 Early Elongation Complex | 33 | 7.34e-01 | -0.034200 | 8.22e-01 |
| Nef mediated downregulation of MHC class I complex cell surface expression | 10 | 8.52e-01 | -0.034000 | 9.07e-01 |
| Downregulation of TGF-beta receptor signaling | 26 | 7.65e-01 | 0.033900 | 8.44e-01 |
| CASP8 activity is inhibited | 11 | 8.47e-01 | -0.033500 | 9.03e-01 |
| Dimerization of procaspase-8 | 11 | 8.47e-01 | -0.033500 | 9.03e-01 |
| Regulation by c-FLIP | 11 | 8.47e-01 | -0.033500 | 9.03e-01 |
| HIV Transcription Initiation | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
| RNA Polymerase II HIV Promoter Escape | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
| RNA Polymerase II Promoter Escape | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
| RNA Polymerase II Transcription Initiation | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 45 | 6.99e-01 | -0.033300 | 7.93e-01 |
| PI3K events in ERBB2 signaling | 11 | 8.53e-01 | -0.032300 | 9.07e-01 |
| NoRC negatively regulates rRNA expression | 62 | 6.60e-01 | -0.032300 | 7.70e-01 |
| Signaling by FGFR in disease | 51 | 6.94e-01 | 0.031900 | 7.93e-01 |
| GRB2 events in ERBB2 signaling | 11 | 8.61e-01 | -0.030600 | 9.09e-01 |
| Acyl chain remodelling of PS | 14 | 8.46e-01 | 0.030000 | 9.03e-01 |
| Chaperone Mediated Autophagy | 20 | 8.19e-01 | -0.029600 | 8.83e-01 |
| Cellular responses to stress | 499 | 2.59e-01 | -0.029500 | 4.01e-01 |
| Formation of ATP by chemiosmotic coupling | 18 | 8.29e-01 | 0.029500 | 8.89e-01 |
| Signaling by FGFR | 69 | 6.74e-01 | 0.029300 | 7.76e-01 |
| Complex I biogenesis | 55 | 7.09e-01 | -0.029100 | 7.98e-01 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 13 | 8.56e-01 | -0.029000 | 9.08e-01 |
| Transcriptional Regulation by TP53 | 351 | 3.52e-01 | -0.028900 | 4.96e-01 |
| Mitochondrial iron-sulfur cluster biogenesis | 13 | 8.59e-01 | -0.028500 | 9.08e-01 |
| Lewis blood group biosynthesis | 13 | 8.59e-01 | 0.028500 | 9.08e-01 |
| Glutamate Neurotransmitter Release Cycle | 20 | 8.30e-01 | -0.027700 | 8.89e-01 |
| Anti-inflammatory response favouring Leishmania parasite infection | 169 | 5.34e-01 | -0.027700 | 6.61e-01 |
| Leishmania parasite growth and survival | 169 | 5.34e-01 | -0.027700 | 6.61e-01 |
| DNA Double Strand Break Response | 47 | 7.43e-01 | 0.027700 | 8.27e-01 |
| Pausing and recovery of Tat-mediated HIV elongation | 30 | 7.97e-01 | 0.027100 | 8.66e-01 |
| Tat-mediated HIV elongation arrest and recovery | 30 | 7.97e-01 | 0.027100 | 8.66e-01 |
| Blood group systems biosynthesis | 17 | 8.47e-01 | 0.027100 | 9.03e-01 |
| Meiotic recombination | 38 | 7.76e-01 | 0.026700 | 8.49e-01 |
| MECP2 regulates neuronal receptors and channels | 13 | 8.68e-01 | 0.026600 | 9.13e-01 |
| HS-GAG degradation | 16 | 8.55e-01 | 0.026300 | 9.08e-01 |
| Nuclear Envelope (NE) Reassembly | 69 | 7.08e-01 | 0.026100 | 7.98e-01 |
| Fertilization | 12 | 8.77e-01 | 0.025800 | 9.20e-01 |
| Activation of BH3-only proteins | 29 | 8.13e-01 | 0.025400 | 8.80e-01 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 24 | 8.29e-01 | 0.025400 | 8.89e-01 |
| Signaling by ERBB2 TMD/JMD mutants | 17 | 8.57e-01 | -0.025200 | 9.08e-01 |
| PKMTs methylate histone lysines | 44 | 7.72e-01 | -0.025200 | 8.48e-01 |
| Serotonin Neurotransmitter Release Cycle | 15 | 8.67e-01 | 0.025000 | 9.13e-01 |
| Interferon alpha/beta signaling | 57 | 7.47e-01 | 0.024700 | 8.31e-01 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 73 | 7.22e-01 | 0.024100 | 8.11e-01 |
| Syndecan interactions | 19 | 8.60e-01 | 0.023300 | 9.09e-01 |
| FRS-mediated FGFR3 signaling | 11 | 8.94e-01 | 0.023200 | 9.31e-01 |
| Signaling by Retinoic Acid | 31 | 8.25e-01 | -0.022900 | 8.86e-01 |
| Cellular responses to external stimuli | 505 | 3.81e-01 | -0.022800 | 5.21e-01 |
| Cell surface interactions at the vascular wall | 174 | 6.11e-01 | -0.022400 | 7.32e-01 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 12 | 8.95e-01 | -0.022000 | 9.31e-01 |
| Protein-protein interactions at synapses | 57 | 7.76e-01 | 0.021800 | 8.49e-01 |
| Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) | 10 | 9.05e-01 | 0.021700 | 9.38e-01 |
| Signaling by ERBB2 KD Mutants | 20 | 8.69e-01 | -0.021400 | 9.13e-01 |
| Sulfur amino acid metabolism | 23 | 8.61e-01 | 0.021000 | 9.09e-01 |
| Signaling by FGFR2 | 60 | 7.84e-01 | -0.020400 | 8.55e-01 |
| Constitutive Signaling by Aberrant PI3K in Cancer | 54 | 7.97e-01 | -0.020300 | 8.66e-01 |
| Formation of HIV elongation complex in the absence of HIV Tat | 44 | 8.18e-01 | -0.020100 | 8.82e-01 |
| Synthesis of PA | 32 | 8.44e-01 | 0.020100 | 9.03e-01 |
| RNA Polymerase II Pre-transcription Events | 78 | 7.60e-01 | 0.020000 | 8.39e-01 |
| Downstream signaling of activated FGFR4 | 17 | 8.89e-01 | -0.019600 | 9.28e-01 |
| Interferon gamma signaling | 83 | 7.59e-01 | -0.019400 | 8.39e-01 |
| FRS-mediated FGFR4 signaling | 12 | 9.10e-01 | -0.018800 | 9.42e-01 |
| Phase 0 - rapid depolarisation | 28 | 8.64e-01 | -0.018700 | 9.11e-01 |
| Formation of tubulin folding intermediates by CCT/TriC | 22 | 8.80e-01 | 0.018600 | 9.21e-01 |
| Infectious disease | 723 | 3.99e-01 | -0.018400 | 5.38e-01 |
| Activation of NMDA receptors and postsynaptic events | 58 | 8.13e-01 | 0.017900 | 8.80e-01 |
| Diseases of glycosylation | 109 | 7.47e-01 | 0.017900 | 8.31e-01 |
| The citric acid (TCA) cycle and respiratory electron transport | 172 | 6.94e-01 | -0.017400 | 7.93e-01 |
| Cytosolic sensors of pathogen-associated DNA | 62 | 8.16e-01 | -0.017100 | 8.82e-01 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 37 | 8.57e-01 | 0.017100 | 9.08e-01 |
| Glucagon-type ligand receptors | 20 | 8.96e-01 | 0.016800 | 9.31e-01 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | 12 | 9.20e-01 | -0.016700 | 9.47e-01 |
| Miscellaneous transport and binding events | 20 | 8.99e-01 | 0.016400 | 9.33e-01 |
| FOXO-mediated transcription of cell cycle genes | 15 | 9.14e-01 | -0.016200 | 9.43e-01 |
| STING mediated induction of host immune responses | 15 | 9.14e-01 | -0.016000 | 9.43e-01 |
| Aggrephagy | 22 | 8.97e-01 | 0.016000 | 9.31e-01 |
| N-Glycan antennae elongation | 13 | 9.20e-01 | 0.016000 | 9.47e-01 |
| Signaling by NTRK3 (TRKC) | 16 | 9.14e-01 | -0.015600 | 9.43e-01 |
| Regulation of RUNX1 Expression and Activity | 18 | 9.09e-01 | 0.015600 | 9.41e-01 |
| Antimicrobial peptides | 33 | 8.83e-01 | 0.014900 | 9.23e-01 |
| MET activates PTK2 signaling | 15 | 9.22e-01 | 0.014600 | 9.48e-01 |
| IRS-related events triggered by IGF1R | 35 | 8.82e-01 | 0.014500 | 9.22e-01 |
| Separation of Sister Chromatids | 167 | 7.49e-01 | -0.014400 | 8.31e-01 |
| Cyclin E associated events during G1/S transition | 83 | 8.25e-01 | 0.014000 | 8.86e-01 |
| Metabolism of proteins | 1715 | 3.50e-01 | 0.013600 | 4.93e-01 |
| Fc epsilon receptor (FCERI) signaling | 190 | 7.48e-01 | -0.013500 | 8.31e-01 |
| Mitotic Anaphase | 223 | 7.37e-01 | 0.013100 | 8.23e-01 |
| Selective autophagy | 58 | 8.71e-01 | -0.012400 | 9.14e-01 |
| TNF signaling | 42 | 8.92e-01 | 0.012200 | 9.30e-01 |
| Downregulation of ERBB2 signaling | 24 | 9.19e-01 | -0.011900 | 9.47e-01 |
| Meiosis | 68 | 8.65e-01 | -0.011900 | 9.11e-01 |
| Signaling by ERBB2 in Cancer | 21 | 9.32e-01 | 0.010800 | 9.55e-01 |
| Norepinephrine Neurotransmitter Release Cycle | 14 | 9.44e-01 | -0.010800 | 9.66e-01 |
| Cell-cell junction organization | 38 | 9.11e-01 | 0.010500 | 9.42e-01 |
| Receptor-type tyrosine-protein phosphatases | 12 | 9.50e-01 | 0.010500 | 9.68e-01 |
| CTLA4 inhibitory signaling | 21 | 9.34e-01 | 0.010500 | 9.56e-01 |
| Metabolism of water-soluble vitamins and cofactors | 109 | 8.54e-01 | 0.010200 | 9.08e-01 |
| Lysosphingolipid and LPA receptors | 11 | 9.56e-01 | -0.009620 | 9.74e-01 |
| APC/C-mediated degradation of cell cycle proteins | 86 | 8.79e-01 | 0.009490 | 9.21e-01 |
| Regulation of mitotic cell cycle | 86 | 8.79e-01 | 0.009490 | 9.21e-01 |
| Downstream signaling of activated FGFR3 | 16 | 9.49e-01 | 0.009200 | 9.68e-01 |
| M Phase | 360 | 7.73e-01 | 0.008860 | 8.48e-01 |
| Mitotic Metaphase and Anaphase | 224 | 8.20e-01 | 0.008840 | 8.83e-01 |
| HIV Infection | 224 | 8.23e-01 | -0.008660 | 8.86e-01 |
| IL-6-type cytokine receptor ligand interactions | 12 | 9.61e-01 | 0.008150 | 9.77e-01 |
| Mitochondrial biogenesis | 88 | 8.97e-01 | -0.008020 | 9.31e-01 |
| Cohesin Loading onto Chromatin | 10 | 9.67e-01 | 0.007580 | 9.81e-01 |
| Assembly of the pre-replicative complex | 66 | 9.21e-01 | 0.007080 | 9.47e-01 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 29 | 9.49e-01 | 0.006810 | 9.68e-01 |
| TICAM1-dependent activation of IRF3/IRF7 | 12 | 9.69e-01 | -0.006580 | 9.81e-01 |
| Deactivation of the beta-catenin transactivating complex | 36 | 9.46e-01 | 0.006500 | 9.67e-01 |
| Non-integrin membrane-ECM interactions | 37 | 9.46e-01 | 0.006400 | 9.67e-01 |
| Attenuation phase | 23 | 9.58e-01 | 0.006360 | 9.75e-01 |
| Reproduction | 80 | 9.23e-01 | -0.006240 | 9.48e-01 |
| G2/M Transition | 180 | 8.88e-01 | -0.006060 | 9.28e-01 |
| Cyclin A:Cdk2-associated events at S phase entry | 85 | 9.24e-01 | 0.005970 | 9.49e-01 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 14 | 9.70e-01 | -0.005800 | 9.82e-01 |
| HSF1-dependent transactivation | 29 | 9.59e-01 | -0.005520 | 9.75e-01 |
| Interaction between L1 and Ankyrins | 22 | 9.65e-01 | 0.005380 | 9.80e-01 |
| RHO GTPases Activate Formins | 117 | 9.27e-01 | 0.004880 | 9.51e-01 |
| Signaling by KIT in disease | 20 | 9.74e-01 | 0.004280 | 9.82e-01 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 20 | 9.74e-01 | 0.004280 | 9.82e-01 |
| Kinesins | 39 | 9.64e-01 | 0.004220 | 9.79e-01 |
| TNFR1-induced NFkappaB signaling pathway | 25 | 9.74e-01 | -0.003800 | 9.82e-01 |
| Axon guidance | 455 | 8.96e-01 | -0.003570 | 9.31e-01 |
| SUMOylation of transcription cofactors | 44 | 9.72e-01 | 0.003100 | 9.82e-01 |
| PI3K Cascade | 30 | 9.78e-01 | -0.002900 | 9.85e-01 |
| CD28 co-stimulation | 33 | 9.77e-01 | -0.002840 | 9.85e-01 |
| IRS-mediated signalling | 34 | 9.83e-01 | -0.002090 | 9.88e-01 |
| Regulation of APC/C activators between G1/S and early anaphase | 79 | 9.80e-01 | -0.001670 | 9.85e-01 |
| Mitotic G2-G2/M phases | 182 | 9.70e-01 | 0.001630 | 9.82e-01 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | 23 | 9.90e-01 | 0.001450 | 9.93e-01 |
| Association of TriC/CCT with target proteins during biosynthesis | 37 | 9.90e-01 | -0.001170 | 9.93e-01 |
| Nuclear Receptor transcription pathway | 36 | 9.90e-01 | 0.001150 | 9.93e-01 |
| Regulation of pyruvate dehydrogenase (PDH) complex | 15 | 9.95e-01 | -0.000919 | 9.97e-01 |
| Nucleotide-like (purinergic) receptors | 12 | 9.96e-01 | 0.000917 | 9.97e-01 |
| Nervous system development | 474 | 9.80e-01 | 0.000685 | 9.85e-01 |
| Incretin synthesis, secretion, and inactivation | 10 | 9.99e-01 | -0.000241 | 9.99e-01 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 10 | 9.99e-01 | -0.000241 | 9.99e-01 |
IRAK4 deficiency (TLR2/4)
| 511 | |
|---|---|
| set | IRAK4 deficiency (TLR2/4) |
| setSize | 10 |
| pANOVA | 2.19e-06 |
| s.dist | 0.864 |
| p.adjustANOVA | 3.11e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MYD88 | 11331 |
| CD36 | 10947 |
| BTK | 10849 |
| TLR2 | 10535 |
| TLR1 | 10059 |
| TLR4 | 9549 |
| CD14 | 9466 |
| LY96 | 9322 |
| TLR6 | 9070 |
| TIRAP | 8858 |
| GeneID | Gene Rank |
|---|---|
| MYD88 | 11331 |
| CD36 | 10947 |
| BTK | 10849 |
| TLR2 | 10535 |
| TLR1 | 10059 |
| TLR4 | 9549 |
| CD14 | 9466 |
| LY96 | 9322 |
| TLR6 | 9070 |
| TIRAP | 8858 |
MyD88 deficiency (TLR2/4)
| 684 | |
|---|---|
| set | MyD88 deficiency (TLR2/4) |
| setSize | 10 |
| pANOVA | 2.19e-06 |
| s.dist | 0.864 |
| p.adjustANOVA | 3.11e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MYD88 | 11331 |
| CD36 | 10947 |
| BTK | 10849 |
| TLR2 | 10535 |
| TLR1 | 10059 |
| TLR4 | 9549 |
| CD14 | 9466 |
| LY96 | 9322 |
| TLR6 | 9070 |
| TIRAP | 8858 |
| GeneID | Gene Rank |
|---|---|
| MYD88 | 11331 |
| CD36 | 10947 |
| BTK | 10849 |
| TLR2 | 10535 |
| TLR1 | 10059 |
| TLR4 | 9549 |
| CD14 | 9466 |
| LY96 | 9322 |
| TLR6 | 9070 |
| TIRAP | 8858 |
Peptide chain elongation
| 806 | |
|---|---|
| set | Peptide chain elongation |
| setSize | 88 |
| pANOVA | 5.06e-36 |
| s.dist | -0.771 |
| p.adjustANOVA | 6.88e-34 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| EEF1A1 | -9751 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| EEF1A1 | -9751 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| EEF2 | -6279 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| RPL39L | -1661 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| RPS9 | 1841 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
Eukaryotic Translation Elongation
| 349 | |
|---|---|
| set | Eukaryotic Translation Elongation |
| setSize | 93 |
| pANOVA | 1.44e-37 |
| s.dist | -0.767 |
| p.adjustANOVA | 2.18e-35 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| EEF1A1 | -9751 |
| EEF1B2 | -9732 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| EEF1A1 | -9751 |
| EEF1B2 | -9732 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| EEF1G | -9293 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| EEF2 | -6279 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| EEF1A1P5 | -5877 |
| EEF1D | -5664 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| EEF1A2 | -3246 |
| RPL39L | -1661 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| RPS9 | 1841 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
Selenocysteine synthesis
| 1058 | |
|---|---|
| set | Selenocysteine synthesis |
| setSize | 92 |
| pANOVA | 1.36e-35 |
| s.dist | -0.75 |
| p.adjustANOVA | 1.68e-33 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| SEPSECS | -7958 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| SECISBP2 | -6992 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| EEFSEC | -6493 |
| RPL8 | -6101 |
| SARS1 | -6044 |
| RPLP1 | -6018 |
| PSTK | -5710 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| RPL39L | -1661 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| RPS9 | 1841 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
| SEPHS2 | 8084 |
Viral mRNA Translation
| 1313 | |
|---|---|
| set | Viral mRNA Translation |
| setSize | 88 |
| pANOVA | 6.76e-34 |
| s.dist | -0.747 |
| p.adjustANOVA | 6.14e-32 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| GRSF1 | -2923 |
| RPL39L | -1661 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| RPS9 | 1841 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
| DNAJC3 | 9831 |
Formation of a pool of free 40S subunits
| 391 | |
|---|---|
| set | Formation of a pool of free 40S subunits |
| setSize | 100 |
| pANOVA | 4.05e-38 |
| s.dist | -0.746 |
| p.adjustANOVA | 6.88e-36 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| EIF3E | -9049 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| EIF1AX | -8383 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| EIF3L | -8255 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| EIF3H | -7091 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| EIF3M | -6817 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| EIF3J | -6448 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| EIF3F | -5200 |
| EIF3D | -5158 |
| EIF3C | -4716 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| EIF3G | -2746 |
| EIF3I | -2580 |
| EIF3K | -2369 |
| RPL39L | -1661 |
| EIF3A | -1276 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| RPS9 | 1841 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
Eukaryotic Translation Termination
| 351 | |
|---|---|
| set | Eukaryotic Translation Termination |
| setSize | 92 |
| pANOVA | 3.3e-34 |
| s.dist | -0.734 |
| p.adjustANOVA | 3.21e-32 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| N6AMT1 | -9282 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| GSPT2 | -7995 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| TRMT112 | -2296 |
| GSPT1 | -2025 |
| RPL39L | -1661 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| RPS9 | 1841 |
| APEH | 4945 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
| ETF1 | 6835 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism
| 1328 | |
|---|---|
| set | alpha-linolenic (omega3) and linoleic (omega6) acid metabolism |
| setSize | 12 |
| pANOVA | 1.52e-05 |
| s.dist | 0.721 |
| p.adjustANOVA | 0.000179 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACSL1 | 11102 |
| ACAA1 | 11076 |
| FADS1 | 10870 |
| ACOT8 | 10822 |
| ACOX1 | 10277 |
| ELOVL1 | 9841 |
| ELOVL3 | 9553 |
| HSD17B4 | 8942 |
| ABCD1 | 7994 |
| FADS2 | 7216 |
| ELOVL5 | 5665 |
| SCP2 | -1980 |
| GeneID | Gene Rank |
|---|---|
| ACSL1 | 11102 |
| ACAA1 | 11076 |
| FADS1 | 10870 |
| ACOT8 | 10822 |
| ACOX1 | 10277 |
| ELOVL1 | 9841 |
| ELOVL3 | 9553 |
| HSD17B4 | 8942 |
| ABCD1 | 7994 |
| FADS2 | 7216 |
| ELOVL5 | 5665 |
| SCP2 | -1980 |
alpha-linolenic acid (ALA) metabolism
| 1329 | |
|---|---|
| set | alpha-linolenic acid (ALA) metabolism |
| setSize | 12 |
| pANOVA | 1.52e-05 |
| s.dist | 0.721 |
| p.adjustANOVA | 0.000179 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ACSL1 | 11102 |
| ACAA1 | 11076 |
| FADS1 | 10870 |
| ACOT8 | 10822 |
| ACOX1 | 10277 |
| ELOVL1 | 9841 |
| ELOVL3 | 9553 |
| HSD17B4 | 8942 |
| ABCD1 | 7994 |
| FADS2 | 7216 |
| ELOVL5 | 5665 |
| SCP2 | -1980 |
| GeneID | Gene Rank |
|---|---|
| ACSL1 | 11102 |
| ACAA1 | 11076 |
| FADS1 | 10870 |
| ACOT8 | 10822 |
| ACOX1 | 10277 |
| ELOVL1 | 9841 |
| ELOVL3 | 9553 |
| HSD17B4 | 8942 |
| ABCD1 | 7994 |
| FADS2 | 7216 |
| ELOVL5 | 5665 |
| SCP2 | -1980 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
| 742 | |
|---|---|
| set | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) |
| setSize | 94 |
| pANOVA | 1.58e-32 |
| s.dist | -0.708 |
| p.adjustANOVA | 1.2e-30 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| NCBP2 | -9631 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| NCBP2 | -9631 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| GSPT2 | -7995 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| PABPC1 | -2991 |
| GSPT1 | -2025 |
| RPL39L | -1661 |
| RPS26 | -1154 |
| NCBP1 | -942 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| RPS9 | 1841 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
| ETF1 | 6835 |
| UPF1 | 9103 |
| EIF4G1 | 10506 |
Translocation of ZAP-70 to Immunological synapse
| 1276 | |
|---|---|
| set | Translocation of ZAP-70 to Immunological synapse |
| setSize | 24 |
| pANOVA | 1.98e-09 |
| s.dist | -0.707 |
| p.adjustANOVA | 5.09e-08 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TRBV12-3 | -9971 |
| TRAC | -9703 |
| HLA-DQB2 | -9656 |
| LCK | -9556 |
| TRBC1 | -9303 |
| TRAV29DV5 | -9278 |
| CD3E | -9249 |
| TRAV19 | -9248 |
| HLA-DRA | -9006 |
| HLA-DQA2 | -8774 |
| ZAP70 | -8755 |
| CD247 | -8741 |
| HLA-DPB1 | -8397 |
| TRBV7-9 | -8303 |
| CD3D | -8297 |
| HLA-DPA1 | -8217 |
| CD3G | -8111 |
| CD4 | -6881 |
| HLA-DQA1 | -6389 |
| TRAV8-4 | -4769 |
| GeneID | Gene Rank |
|---|---|
| TRBV12-3 | -9971 |
| TRAC | -9703 |
| HLA-DQB2 | -9656 |
| LCK | -9556 |
| TRBC1 | -9303 |
| TRAV29DV5 | -9278 |
| CD3E | -9249 |
| TRAV19 | -9248 |
| HLA-DRA | -9006 |
| HLA-DQA2 | -8774 |
| ZAP70 | -8755 |
| CD247 | -8741 |
| HLA-DPB1 | -8397 |
| TRBV7-9 | -8303 |
| CD3D | -8297 |
| HLA-DPA1 | -8217 |
| CD3G | -8111 |
| CD4 | -6881 |
| HLA-DQA1 | -6389 |
| TRAV8-4 | -4769 |
| HLA-DQB1 | -4459 |
| HLA-DRB1 | -334 |
| HLA-DRB5 | 748 |
| PTPN22 | 6966 |
L13a-mediated translational silencing of Ceruloplasmin expression
| 587 | |
|---|---|
| set | L13a-mediated translational silencing of Ceruloplasmin expression |
| setSize | 110 |
| pANOVA | 7.55e-35 |
| s.dist | -0.678 |
| p.adjustANOVA | 8.56e-33 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| EIF3E | -9049 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| EIF1AX | -8383 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| EIF3L | -8255 |
| RPL22L1 | -8202 |
| EIF4B | -8190 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| EIF3H | -7091 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| EIF3M | -6817 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| EIF3J | -6448 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| EIF3F | -5200 |
| EIF3D | -5158 |
| EIF3C | -4716 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| PABPC1 | -2991 |
| EIF3G | -2746 |
| EIF3I | -2580 |
| EIF3K | -2369 |
| RPL39L | -1661 |
| EIF2S1 | -1649 |
| EIF3A | -1276 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| EIF2S2 | 554 |
| EIF4E | 1661 |
| RPS9 | 1841 |
| EIF2S3 | 2500 |
| RPL3L | 5150 |
| EIF4A1 | 5541 |
| RPL26L1 | 6001 |
| EIF4H | 7768 |
| EIF4G1 | 10506 |
GTP hydrolysis and joining of the 60S ribosomal subunit
| 433 | |
|---|---|
| set | GTP hydrolysis and joining of the 60S ribosomal subunit |
| setSize | 111 |
| pANOVA | 1.11e-34 |
| s.dist | -0.674 |
| p.adjustANOVA | 1.16e-32 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| EIF3E | -9049 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| EIF1AX | -8383 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| EIF3L | -8255 |
| RPL22L1 | -8202 |
| EIF4B | -8190 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| EIF3H | -7091 |
| EIF5B | -6867 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| EIF3M | -6817 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| EIF3J | -6448 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| EIF3F | -5200 |
| EIF3D | -5158 |
| EIF3C | -4716 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| EIF3G | -2746 |
| EIF3I | -2580 |
| EIF3K | -2369 |
| RPL39L | -1661 |
| EIF2S1 | -1649 |
| EIF3A | -1276 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| EIF2S2 | 554 |
| EIF4E | 1661 |
| RPS9 | 1841 |
| EIF2S3 | 2500 |
| EIF5 | 2937 |
| RPL3L | 5150 |
| EIF4A1 | 5541 |
| RPL26L1 | 6001 |
| EIF4H | 7768 |
| EIF4G1 | 10506 |
Response of EIF2AK4 (GCN2) to amino acid deficiency
| 1006 | |
|---|---|
| set | Response of EIF2AK4 (GCN2) to amino acid deficiency |
| setSize | 100 |
| pANOVA | 3.17e-31 |
| s.dist | -0.672 |
| p.adjustANOVA | 2.27e-29 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| ASNS | -7772 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| GCN1 | -5625 |
| IMPACT | -5597 |
| ATF3 | -4287 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| RPL39L | -1661 |
| EIF2AK4 | -1656 |
| EIF2S1 | -1649 |
| RPS26 | -1154 |
| ATF2 | -657 |
| RPS27L | -496 |
| ATF4 | -54 |
| RPS4Y1 | 331 |
| EIF2S2 | 554 |
| RPS9 | 1841 |
| TRIB3 | 2492 |
| EIF2S3 | 2500 |
| CEBPG | 4210 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
| DDIT3 | 6480 |
| CEBPB | 11136 |
Formation of the ternary complex, and subsequently, the 43S complex
| 397 | |
|---|---|
| set | Formation of the ternary complex, and subsequently, the 43S complex |
| setSize | 51 |
| pANOVA | 1.92e-16 |
| s.dist | -0.665 |
| p.adjustANOVA | 8.41e-15 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS3A | -9834 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPS25 | -9664 |
| RPS2 | -9591 |
| EIF3B | -9526 |
| RPS20 | -9413 |
| RPS23 | -9387 |
| RPS3 | -9298 |
| RPS12 | -9270 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| EIF3E | -9049 |
| RPS5 | -9042 |
| RPS15A | -8883 |
| RPS8 | -8861 |
| RPS13 | -8724 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPS16 | -8579 |
| GeneID | Gene Rank |
|---|---|
| RPS3A | -9834 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPS25 | -9664 |
| RPS2 | -9591 |
| EIF3B | -9526 |
| RPS20 | -9413 |
| RPS23 | -9387 |
| RPS3 | -9298 |
| RPS12 | -9270 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| EIF3E | -9049 |
| RPS5 | -9042 |
| RPS15A | -8883 |
| RPS8 | -8861 |
| RPS13 | -8724 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| EIF1AX | -8383 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPS17 | -8281 |
| EIF3L | -8255 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPS19 | -7806 |
| EIF3H | -7091 |
| RPS24 | -6818 |
| EIF3M | -6817 |
| RPS15 | -6703 |
| RPSA | -6629 |
| EIF3J | -6448 |
| EIF3F | -5200 |
| EIF3D | -5158 |
| EIF3C | -4716 |
| FAU | -3618 |
| EIF3G | -2746 |
| EIF3I | -2580 |
| EIF3K | -2369 |
| EIF2S1 | -1649 |
| EIF3A | -1276 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| EIF2S2 | 554 |
| RPS9 | 1841 |
| EIF2S3 | 2500 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2
| 1321 | |
|---|---|
| set | WNT5A-dependent internalization of FZD2, FZD5 and ROR2 |
| setSize | 11 |
| pANOVA | 0.000155 |
| s.dist | 0.659 |
| p.adjustANOVA | 0.00133 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FZD5 | 11440 |
| AP2A1 | 11340 |
| CLTC | 10304 |
| AP2A2 | 10223 |
| AP2M1 | 8799 |
| AP2S1 | 8045 |
| CLTB | 7968 |
| CLTA | 7164 |
| FZD2 | 5116 |
| AP2B1 | 2910 |
| ROR1 | 2194 |
| GeneID | Gene Rank |
|---|---|
| FZD5 | 11440 |
| AP2A1 | 11340 |
| CLTC | 10304 |
| AP2A2 | 10223 |
| AP2M1 | 8799 |
| AP2S1 | 8045 |
| CLTB | 7968 |
| CLTA | 7164 |
| FZD2 | 5116 |
| AP2B1 | 2910 |
| ROR1 | 2194 |
Regulation of TLR by endogenous ligand
| 966 | |
|---|---|
| set | Regulation of TLR by endogenous ligand |
| setSize | 11 |
| pANOVA | 0.000234 |
| s.dist | 0.641 |
| p.adjustANOVA | 0.00188 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| S100A8 | 11184 |
| CD36 | 10947 |
| S100A9 | 10613 |
| TLR2 | 10535 |
| TLR1 | 10059 |
| TLR4 | 9549 |
| CD14 | 9466 |
| LY96 | 9322 |
| TLR6 | 9070 |
| S100A1 | -688 |
| HMGB1 | -6699 |
| GeneID | Gene Rank |
|---|---|
| S100A8 | 11184 |
| CD36 | 10947 |
| S100A9 | 10613 |
| TLR2 | 10535 |
| TLR1 | 10059 |
| TLR4 | 9549 |
| CD14 | 9466 |
| LY96 | 9322 |
| TLR6 | 9070 |
| S100A1 | -688 |
| HMGB1 | -6699 |
Major pathway of rRNA processing in the nucleolus and cytosol
| 624 | |
|---|---|
| set | Major pathway of rRNA processing in the nucleolus and cytosol |
| setSize | 180 |
| pANOVA | 6.06e-50 |
| s.dist | -0.641 |
| p.adjustANOVA | 2.06e-47 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPP40 | -10069 |
| NOP58 | -10031 |
| RPL23A | -9979 |
| GNL3 | -9960 |
| RPL3 | -9957 |
| FBL | -9942 |
| NOL11 | -9932 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| WDR75 | -9823 |
| RPL7 | -9765 |
| EXOSC2 | -9753 |
| TSR1 | -9724 |
| RPS27A | -9723 |
| UTP4 | -9700 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| LAS1L | -9679 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| GeneID | Gene Rank |
|---|---|
| RPP40 | -10069 |
| NOP58 | -10031 |
| RPL23A | -9979 |
| GNL3 | -9960 |
| RPL3 | -9957 |
| FBL | -9942 |
| NOL11 | -9932 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| WDR75 | -9823 |
| RPL7 | -9765 |
| EXOSC2 | -9753 |
| TSR1 | -9724 |
| RPS27A | -9723 |
| UTP4 | -9700 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| LAS1L | -9679 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| NOP14 | -9641 |
| BMS1 | -9626 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| NOP56 | -9444 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| WDR43 | -9395 |
| RPS23 | -9387 |
| EXOSC8 | -9379 |
| RPL32 | -9345 |
| NCL | -9336 |
| DDX47 | -9334 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| UTP15 | -9156 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| WDR46 | -9056 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| TEX10 | -8915 |
| RPL36A | -8909 |
| NOB1 | -8908 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| MPHOSPH10 | -8840 |
| EXOSC9 | -8793 |
| NOL9 | -8786 |
| RPL31 | -8769 |
| EMG1 | -8744 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPP25 | -8688 |
| RPS4X | -8648 |
| RPP30 | -8640 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| UTP6 | -8616 |
| RRP9 | -8598 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| SNU13 | -8495 |
| RPS10 | -8494 |
| EXOSC7 | -8473 |
| EXOSC5 | -8394 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| PELP1 | -8232 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RIOK2 | -8079 |
| PNO1 | -8004 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| EBNA1BP2 | -7916 |
| RPL37 | -7861 |
| NOL6 | -7834 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| NIP7 | -7779 |
| KRR1 | -7720 |
| RCL1 | -7690 |
| RPP38 | -7683 |
| RPL13 | -7671 |
| DCAF13 | -7564 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| EXOSC6 | -7458 |
| UTP20 | -7427 |
| HEATR1 | -7278 |
| IMP4 | -7155 |
| PES1 | -7148 |
| LTV1 | -7119 |
| WDR3 | -7016 |
| IMP3 | -6912 |
| RPL37A | -6833 |
| EXOSC10 | -6829 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| BOP1 | -6593 |
| PDCD11 | -6547 |
| CSNK1E | -6526 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| RBM28 | -5712 |
| PWP2 | -5423 |
| RRP7A | -5246 |
| WDR36 | -5072 |
| BYSL | -4898 |
| RIOK1 | -4858 |
| UTP3 | -4821 |
| DHX37 | -4742 |
| MTREX | -4495 |
| RPP21 | -4260 |
| DIS3 | -4140 |
| RPL28 | -3873 |
| WDR18 | -3817 |
| FAU | -3618 |
| UBA52 | -3490 |
| UTP14A | -3323 |
| MPHOSPH6 | -3194 |
| RRP1 | -3051 |
| UTP14C | -2415 |
| RPP14 | -2204 |
| RPL39L | -1661 |
| FTSJ3 | -1199 |
| DDX21 | -1198 |
| RPS26 | -1154 |
| WDR12 | -731 |
| RPS27L | -496 |
| EXOSC1 | -493 |
| RRP36 | -395 |
| C1D | -325 |
| EXOSC3 | -40 |
| UTP11 | -37 |
| SENP3 | 78 |
| RPS4Y1 | 331 |
| FCF1 | 453 |
| TBL3 | 739 |
| NOC4L | 1606 |
| DDX52 | 1795 |
| RPS9 | 1841 |
| ISG20L2 | 3150 |
| UTP18 | 3850 |
| DDX49 | 4083 |
| NOL12 | 4277 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
| ERI1 | 6679 |
| RIOK3 | 7088 |
| CSNK1D | 8475 |
| EXOSC4 | 10040 |
| XRN2 | 10267 |
| SNORD3A | 10596 |
Cap-dependent Translation Initiation
| 142 | |
|---|---|
| set | Cap-dependent Translation Initiation |
| setSize | 118 |
| pANOVA | 2.65e-33 |
| s.dist | -0.64 |
| p.adjustANOVA | 2.12e-31 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| EIF3E | -9049 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| EIF1AX | -8383 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| EIF3L | -8255 |
| RPL22L1 | -8202 |
| EIF4B | -8190 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| EIF3H | -7091 |
| EIF5B | -6867 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| EIF3M | -6817 |
| RPS15 | -6703 |
| EIF2B3 | -6649 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| EIF3J | -6448 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| EIF2B5 | -5580 |
| EIF3F | -5200 |
| EIF3D | -5158 |
| EIF3C | -4716 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| PABPC1 | -2991 |
| EIF3G | -2746 |
| EIF3I | -2580 |
| EIF3K | -2369 |
| EIF2B1 | -2228 |
| RPL39L | -1661 |
| EIF2S1 | -1649 |
| EIF3A | -1276 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| EIF2S2 | 554 |
| EIF4E | 1661 |
| RPS9 | 1841 |
| EIF2S3 | 2500 |
| EIF4EBP1 | 2825 |
| EIF5 | 2937 |
| EIF2B4 | 4294 |
| RPL3L | 5150 |
| EIF4A1 | 5541 |
| RPL26L1 | 6001 |
| EIF2B2 | 7498 |
| EIF4H | 7768 |
| EIF4G1 | 10506 |
Eukaryotic Translation Initiation
| 350 | |
|---|---|
| set | Eukaryotic Translation Initiation |
| setSize | 118 |
| pANOVA | 2.65e-33 |
| s.dist | -0.64 |
| p.adjustANOVA | 2.12e-31 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| EIF3E | -9049 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| EIF1AX | -8383 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| EIF3L | -8255 |
| RPL22L1 | -8202 |
| EIF4B | -8190 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| EIF3H | -7091 |
| EIF5B | -6867 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| EIF3M | -6817 |
| RPS15 | -6703 |
| EIF2B3 | -6649 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| EIF3J | -6448 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| EIF2B5 | -5580 |
| EIF3F | -5200 |
| EIF3D | -5158 |
| EIF3C | -4716 |
| RPL28 | -3873 |
| FAU | -3618 |
| UBA52 | -3490 |
| PABPC1 | -2991 |
| EIF3G | -2746 |
| EIF3I | -2580 |
| EIF3K | -2369 |
| EIF2B1 | -2228 |
| RPL39L | -1661 |
| EIF2S1 | -1649 |
| EIF3A | -1276 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| EIF2S2 | 554 |
| EIF4E | 1661 |
| RPS9 | 1841 |
| EIF2S3 | 2500 |
| EIF4EBP1 | 2825 |
| EIF5 | 2937 |
| EIF2B4 | 4294 |
| RPL3L | 5150 |
| EIF4A1 | 5541 |
| RPL26L1 | 6001 |
| EIF2B2 | 7498 |
| EIF4H | 7768 |
| EIF4G1 | 10506 |
rRNA processing in the nucleus and cytosol
| 1353 | |
|---|---|
| set | rRNA processing in the nucleus and cytosol |
| setSize | 190 |
| pANOVA | 7.19e-52 |
| s.dist | -0.636 |
| p.adjustANOVA | 4.89e-49 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DKC1 | -10139 |
| RPP40 | -10069 |
| NOP58 | -10031 |
| RPL23A | -9979 |
| GNL3 | -9960 |
| RPL3 | -9957 |
| FBL | -9942 |
| NOL11 | -9932 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| NAT10 | -9828 |
| WDR75 | -9823 |
| THUMPD1 | -9782 |
| RPL7 | -9765 |
| EXOSC2 | -9753 |
| TSR1 | -9724 |
| RPS27A | -9723 |
| UTP4 | -9700 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| GeneID | Gene Rank |
|---|---|
| DKC1 | -10139 |
| RPP40 | -10069 |
| NOP58 | -10031 |
| RPL23A | -9979 |
| GNL3 | -9960 |
| RPL3 | -9957 |
| FBL | -9942 |
| NOL11 | -9932 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| NAT10 | -9828 |
| WDR75 | -9823 |
| THUMPD1 | -9782 |
| RPL7 | -9765 |
| EXOSC2 | -9753 |
| TSR1 | -9724 |
| RPS27A | -9723 |
| UTP4 | -9700 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| LAS1L | -9679 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| DIMT1 | -9652 |
| NOP14 | -9641 |
| BMS1 | -9626 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| NOP56 | -9444 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| WDR43 | -9395 |
| RPS23 | -9387 |
| EXOSC8 | -9379 |
| RPL32 | -9345 |
| NCL | -9336 |
| DDX47 | -9334 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| UTP15 | -9156 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| WDR46 | -9056 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| TEX10 | -8915 |
| RPL36A | -8909 |
| NOB1 | -8908 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| MPHOSPH10 | -8840 |
| EXOSC9 | -8793 |
| NOL9 | -8786 |
| RPL31 | -8769 |
| EMG1 | -8744 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPP25 | -8688 |
| RPS4X | -8648 |
| RPP30 | -8640 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| UTP6 | -8616 |
| RRP9 | -8598 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| SNU13 | -8495 |
| RPS10 | -8494 |
| EXOSC7 | -8473 |
| EXOSC5 | -8394 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| NOP2 | -8307 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| PELP1 | -8232 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RIOK2 | -8079 |
| PNO1 | -8004 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| EBNA1BP2 | -7916 |
| RPL37 | -7861 |
| NOL6 | -7834 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| NIP7 | -7779 |
| KRR1 | -7720 |
| RCL1 | -7690 |
| RPP38 | -7683 |
| RPL13 | -7671 |
| DCAF13 | -7564 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| EXOSC6 | -7458 |
| UTP20 | -7427 |
| GAR1 | -7407 |
| HEATR1 | -7278 |
| IMP4 | -7155 |
| PES1 | -7148 |
| LTV1 | -7119 |
| WDR3 | -7016 |
| IMP3 | -6912 |
| RPL37A | -6833 |
| EXOSC10 | -6829 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| BOP1 | -6593 |
| PDCD11 | -6547 |
| NHP2 | -6535 |
| CSNK1E | -6526 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| RBM28 | -5712 |
| PWP2 | -5423 |
| RRP7A | -5246 |
| WDR36 | -5072 |
| BYSL | -4898 |
| RIOK1 | -4858 |
| UTP3 | -4821 |
| DHX37 | -4742 |
| MTREX | -4495 |
| RPP21 | -4260 |
| DIS3 | -4140 |
| RPL28 | -3873 |
| WDR18 | -3817 |
| FAU | -3618 |
| UBA52 | -3490 |
| UTP14A | -3323 |
| MPHOSPH6 | -3194 |
| RRP1 | -3051 |
| UTP14C | -2415 |
| TRMT112 | -2296 |
| RPP14 | -2204 |
| RPL39L | -1661 |
| FTSJ3 | -1199 |
| DDX21 | -1198 |
| RPS26 | -1154 |
| WDR12 | -731 |
| RPS27L | -496 |
| EXOSC1 | -493 |
| RRP36 | -395 |
| C1D | -325 |
| EXOSC3 | -40 |
| UTP11 | -37 |
| SENP3 | 78 |
| RPS4Y1 | 331 |
| FCF1 | 453 |
| TBL3 | 739 |
| TSR3 | 1498 |
| NOC4L | 1606 |
| DDX52 | 1795 |
| RPS9 | 1841 |
| ISG20L2 | 3150 |
| UTP18 | 3850 |
| DDX49 | 4083 |
| NOL12 | 4277 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
| ERI1 | 6679 |
| RIOK3 | 7088 |
| CSNK1D | 8475 |
| EXOSC4 | 10040 |
| XRN2 | 10267 |
| NOP10 | 10379 |
| SNORD3A | 10596 |
Selenoamino acid metabolism
| 1057 | |
|---|---|
| set | Selenoamino acid metabolism |
| setSize | 114 |
| pANOVA | 2.44e-30 |
| s.dist | -0.62 |
| p.adjustANOVA | 1.58e-28 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| LARS1 | -9637 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| LARS1 | -9637 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| IARS1 | -8999 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| KARS1 | -8380 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| AIMP1 | -7990 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| SEPSECS | -7958 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| SCLY | -7645 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| SECISBP2 | -6992 |
| DARS1 | -6939 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| EEFSEC | -6493 |
| EPRS1 | -6350 |
| RPL8 | -6101 |
| SARS1 | -6044 |
| RPLP1 | -6018 |
| PSTK | -5710 |
| RARS1 | -3944 |
| RPL28 | -3873 |
| QARS1 | -3758 |
| FAU | -3618 |
| UBA52 | -3490 |
| AIMP2 | -3343 |
| EEF1E1 | -2716 |
| AHCY | -2510 |
| RPL39L | -1661 |
| RPS26 | -1154 |
| CTH | -637 |
| RPS27L | -496 |
| INMT | -384 |
| RPS4Y1 | 331 |
| RPS9 | 1841 |
| GNMT | 2920 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
| HNMT | 6423 |
| MARS1 | 7358 |
| SEPHS2 | 8084 |
| TXNRD1 | 9890 |
| PAPSS1 | 10336 |
| GSR | 11051 |
| CBS | 11232 |
| PAPSS2 | 11267 |
RHO GTPases Activate ROCKs
| 886 | |
|---|---|
| set | RHO GTPases Activate ROCKs |
| setSize | 18 |
| pANOVA | 6.3e-06 |
| s.dist | 0.615 |
| p.adjustANOVA | 8.41e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MYL6 | 10185 |
| PAK1 | 10043 |
| CFL1 | 9794 |
| LIMK2 | 9689 |
| RHOA | 9401 |
| MYH9 | 9224 |
| ROCK1 | 8695 |
| MYH10 | 8632 |
| PPP1R12B | 8489 |
| LIMK1 | 8062 |
| RHOB | 7921 |
| PPP1R12A | 7801 |
| PPP1CB | 6745 |
| ROCK2 | 6611 |
| MYL12B | 5703 |
| RHOC | 4639 |
| MYL9 | 1931 |
| MYH11 | -2243 |
| GeneID | Gene Rank |
|---|---|
| MYL6 | 10185 |
| PAK1 | 10043 |
| CFL1 | 9794 |
| LIMK2 | 9689 |
| RHOA | 9401 |
| MYH9 | 9224 |
| ROCK1 | 8695 |
| MYH10 | 8632 |
| PPP1R12B | 8489 |
| LIMK1 | 8062 |
| RHOB | 7921 |
| PPP1R12A | 7801 |
| PPP1CB | 6745 |
| ROCK2 | 6611 |
| MYL12B | 5703 |
| RHOC | 4639 |
| MYL9 | 1931 |
| MYH11 | -2243 |
Uptake and function of anthrax toxins
| 1304 | |
|---|---|
| set | Uptake and function of anthrax toxins |
| setSize | 10 |
| pANOVA | 0.000817 |
| s.dist | 0.611 |
| p.adjustANOVA | 0.00492 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MAP2K6 | 10958 |
| FURIN | 10905 |
| MAP2K3 | 10377 |
| MAP2K1 | 10148 |
| PDCD6IP | 9293 |
| MAP2K4 | 7754 |
| MAP2K2 | 7222 |
| ANTXR2 | 5636 |
| MAP2K7 | 1550 |
| CALM1 | -1245 |
| GeneID | Gene Rank |
|---|---|
| MAP2K6 | 10958 |
| FURIN | 10905 |
| MAP2K3 | 10377 |
| MAP2K1 | 10148 |
| PDCD6IP | 9293 |
| MAP2K4 | 7754 |
| MAP2K2 | 7222 |
| ANTXR2 | 5636 |
| MAP2K7 | 1550 |
| CALM1 | -1245 |
Activation of the pre-replicative complex
| 50 | |
|---|---|
| set | Activation of the pre-replicative complex |
| setSize | 32 |
| pANOVA | 2.71e-09 |
| s.dist | -0.607 |
| p.adjustANOVA | 6.59e-08 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MCM3 | -9943 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| MCM7 | -9325 |
| POLE3 | -9287 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| DBF4 | -8907 |
| MCM6 | -8631 |
| ORC5 | -8539 |
| ORC2 | -8256 |
| POLA2 | -7950 |
| ORC3 | -7889 |
| POLE2 | -7763 |
| PRIM2 | -7112 |
| MCM4 | -7086 |
| MCM2 | -6880 |
| ORC4 | -6267 |
| MCM8 | -5713 |
| CDC45 | -5132 |
| GeneID | Gene Rank |
|---|---|
| MCM3 | -9943 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| MCM7 | -9325 |
| POLE3 | -9287 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| DBF4 | -8907 |
| MCM6 | -8631 |
| ORC5 | -8539 |
| ORC2 | -8256 |
| POLA2 | -7950 |
| ORC3 | -7889 |
| POLE2 | -7763 |
| PRIM2 | -7112 |
| MCM4 | -7086 |
| MCM2 | -6880 |
| ORC4 | -6267 |
| MCM8 | -5713 |
| CDC45 | -5132 |
| RPA2 | -4811 |
| MCM10 | -4587 |
| CDC7 | -4493 |
| POLE | -4081 |
| CDK2 | -3614 |
| CDT1 | -3436 |
| ORC1 | -2973 |
| MCM5 | -2327 |
| POLE4 | -1856 |
| CDC6 | -1597 |
| GMNN | 2164 |
| ORC6 | 5337 |
MET activates RAP1 and RAC1
| 618 | |
|---|---|
| set | MET activates RAP1 and RAC1 |
| setSize | 10 |
| pANOVA | 0.00102 |
| s.dist | 0.6 |
| p.adjustANOVA | 0.00589 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GRB2 | 10733 |
| RAC1 | 10624 |
| HGF | 10417 |
| CRK | 10387 |
| GAB1 | 8670 |
| RAP1A | 7335 |
| RAP1B | 6962 |
| CRKL | 5250 |
| RAPGEF1 | 5102 |
| DOCK7 | -4084 |
| GeneID | Gene Rank |
|---|---|
| GRB2 | 10733 |
| RAC1 | 10624 |
| HGF | 10417 |
| CRK | 10387 |
| GAB1 | 8670 |
| RAP1A | 7335 |
| RAP1B | 6962 |
| CRKL | 5250 |
| RAPGEF1 | 5102 |
| DOCK7 | -4084 |
rRNA processing
| 1351 | |
|---|---|
| set | rRNA processing |
| setSize | 217 |
| pANOVA | 2.08e-51 |
| s.dist | -0.593 |
| p.adjustANOVA | 9.44e-49 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DKC1 | -10139 |
| RPP40 | -10069 |
| NOP58 | -10031 |
| RPL23A | -9979 |
| GNL3 | -9960 |
| RPL3 | -9957 |
| FBL | -9942 |
| NOL11 | -9932 |
| MTERF4 | -9917 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| NAT10 | -9828 |
| WDR75 | -9823 |
| THUMPD1 | -9782 |
| RPL7 | -9765 |
| EXOSC2 | -9753 |
| TSR1 | -9724 |
| RPS27A | -9723 |
| UTP4 | -9700 |
| RPS6 | -9699 |
| GeneID | Gene Rank |
|---|---|
| DKC1 | -10139 |
| RPP40 | -10069 |
| NOP58 | -10031 |
| RPL23A | -9979 |
| GNL3 | -9960 |
| RPL3 | -9957 |
| FBL | -9942 |
| NOL11 | -9932 |
| MTERF4 | -9917 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| NAT10 | -9828 |
| WDR75 | -9823 |
| THUMPD1 | -9782 |
| RPL7 | -9765 |
| EXOSC2 | -9753 |
| TSR1 | -9724 |
| RPS27A | -9723 |
| UTP4 | -9700 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| LAS1L | -9679 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| DIMT1 | -9652 |
| NOP14 | -9641 |
| BMS1 | -9626 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| NOP56 | -9444 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| WDR43 | -9395 |
| RPS23 | -9387 |
| EXOSC8 | -9379 |
| RPL32 | -9345 |
| NCL | -9336 |
| DDX47 | -9334 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| UTP15 | -9156 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| WDR46 | -9056 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| TEX10 | -8915 |
| RPL36A | -8909 |
| NOB1 | -8908 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| MPHOSPH10 | -8840 |
| EXOSC9 | -8793 |
| NOL9 | -8786 |
| RPL31 | -8769 |
| EMG1 | -8744 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPP25 | -8688 |
| RPS4X | -8648 |
| RPP30 | -8640 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| UTP6 | -8616 |
| RRP9 | -8598 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| MRM1 | -8526 |
| SNU13 | -8495 |
| RPS10 | -8494 |
| EXOSC7 | -8473 |
| EXOSC5 | -8394 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| NOP2 | -8307 |
| TRMT10C | -8306 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| PELP1 | -8232 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RIOK2 | -8079 |
| PNO1 | -8004 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| EBNA1BP2 | -7916 |
| RPL37 | -7861 |
| NOL6 | -7834 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| NIP7 | -7779 |
| KRR1 | -7720 |
| RCL1 | -7690 |
| RPP38 | -7683 |
| RPL13 | -7671 |
| DCAF13 | -7564 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| EXOSC6 | -7458 |
| UTP20 | -7427 |
| GAR1 | -7407 |
| HEATR1 | -7278 |
| IMP4 | -7155 |
| PES1 | -7148 |
| LTV1 | -7119 |
| WDR3 | -7016 |
| IMP3 | -6912 |
| TFB1M | -6859 |
| RPL37A | -6833 |
| EXOSC10 | -6829 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| BOP1 | -6593 |
| PDCD11 | -6547 |
| NHP2 | -6535 |
| CSNK1E | -6526 |
| RPL8 | -6101 |
| MT-ND2 | -6095 |
| RPLP1 | -6018 |
| RBM28 | -5712 |
| MRM3 | -5709 |
| MT-ND3 | -5522 |
| PWP2 | -5423 |
| ELAC2 | -5385 |
| RRP7A | -5246 |
| MRM2 | -5169 |
| MT-CO3 | -5157 |
| MT-RNR1 | -5094 |
| MT-ND1 | -5075 |
| WDR36 | -5072 |
| BYSL | -4898 |
| RIOK1 | -4858 |
| UTP3 | -4821 |
| DHX37 | -4742 |
| MTREX | -4495 |
| RPP21 | -4260 |
| DIS3 | -4140 |
| RPL28 | -3873 |
| WDR18 | -3817 |
| FAU | -3618 |
| UBA52 | -3490 |
| UTP14A | -3323 |
| MPHOSPH6 | -3194 |
| RRP1 | -3051 |
| MT-CO2 | -2523 |
| UTP14C | -2415 |
| TRMT112 | -2296 |
| RPP14 | -2204 |
| MT-ATP6 | -2202 |
| MT-CYB | -2032 |
| PRORP | -1720 |
| RPL39L | -1661 |
| FTSJ3 | -1199 |
| DDX21 | -1198 |
| RPS26 | -1154 |
| MT-ND5 | -931 |
| WDR12 | -731 |
| RPS27L | -496 |
| EXOSC1 | -493 |
| MT-CO1 | -454 |
| MT-RNR2 | -408 |
| RRP36 | -395 |
| C1D | -325 |
| EXOSC3 | -40 |
| UTP11 | -37 |
| SENP3 | 78 |
| MT-ATP8 | 189 |
| RPS4Y1 | 331 |
| FCF1 | 453 |
| TBL3 | 739 |
| TSR3 | 1498 |
| NOC4L | 1606 |
| DDX52 | 1795 |
| RPS9 | 1841 |
| MT-ND4L | 2323 |
| NSUN4 | 2338 |
| MT-TF | 2765 |
| HSD17B10 | 2981 |
| ISG20L2 | 3150 |
| MT-TV | 3363 |
| UTP18 | 3850 |
| DDX49 | 4083 |
| NOL12 | 4277 |
| MT-ND4 | 4493 |
| MT-TL1 | 4517 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
| ERI1 | 6679 |
| RIOK3 | 7088 |
| CSNK1D | 8475 |
| EXOSC4 | 10040 |
| XRN2 | 10267 |
| NOP10 | 10379 |
| SNORD3A | 10596 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
| 741 | |
|---|---|
| set | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) |
| setSize | 114 |
| pANOVA | 1.63e-27 |
| s.dist | -0.588 |
| p.adjustANOVA | 9.23e-26 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| NCBP2 | -9631 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| NCBP2 | -9631 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| UPF3A | -8795 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RNPS1 | -8030 |
| GSPT2 | -7995 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| MAGOHB | -6726 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| UPF3B | -5843 |
| DCP1A | -4839 |
| MAGOH | -4678 |
| RPL28 | -3873 |
| PNRC2 | -3729 |
| FAU | -3618 |
| UBA52 | -3490 |
| PABPC1 | -2991 |
| GSPT1 | -2025 |
| RPL39L | -1661 |
| RBM8A | -1499 |
| RPS26 | -1154 |
| NCBP1 | -942 |
| RPS27L | -496 |
| SMG1 | -489 |
| SMG6 | -480 |
| RPS4Y1 | 331 |
| UPF2 | 1281 |
| EIF4A3 | 1507 |
| PPP2R2A | 1788 |
| RPS9 | 1841 |
| SMG5 | 4864 |
| SMG8 | 4994 |
| RPL3L | 5150 |
| PPP2R1A | 5189 |
| RPL26L1 | 6001 |
| SMG9 | 6262 |
| PPP2CA | 6806 |
| ETF1 | 6835 |
| UPF1 | 9103 |
| CASC3 | 9610 |
| SMG7 | 10376 |
| EIF4G1 | 10506 |
Nonsense-Mediated Decay (NMD)
| 743 | |
|---|---|
| set | Nonsense-Mediated Decay (NMD) |
| setSize | 114 |
| pANOVA | 1.63e-27 |
| s.dist | -0.588 |
| p.adjustANOVA | 9.23e-26 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| NCBP2 | -9631 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| NCBP2 | -9631 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| UPF3A | -8795 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RNPS1 | -8030 |
| GSPT2 | -7995 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| RPL36 | -7493 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| MAGOHB | -6726 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| UPF3B | -5843 |
| DCP1A | -4839 |
| MAGOH | -4678 |
| RPL28 | -3873 |
| PNRC2 | -3729 |
| FAU | -3618 |
| UBA52 | -3490 |
| PABPC1 | -2991 |
| GSPT1 | -2025 |
| RPL39L | -1661 |
| RBM8A | -1499 |
| RPS26 | -1154 |
| NCBP1 | -942 |
| RPS27L | -496 |
| SMG1 | -489 |
| SMG6 | -480 |
| RPS4Y1 | 331 |
| UPF2 | 1281 |
| EIF4A3 | 1507 |
| PPP2R2A | 1788 |
| RPS9 | 1841 |
| SMG5 | 4864 |
| SMG8 | 4994 |
| RPL3L | 5150 |
| PPP2R1A | 5189 |
| RPL26L1 | 6001 |
| SMG9 | 6262 |
| PPP2CA | 6806 |
| ETF1 | 6835 |
| UPF1 | 9103 |
| CASC3 | 9610 |
| SMG7 | 10376 |
| EIF4G1 | 10506 |
rRNA modification in the nucleus and cytosol
| 1350 | |
|---|---|
| set | rRNA modification in the nucleus and cytosol |
| setSize | 59 |
| pANOVA | 5.93e-15 |
| s.dist | -0.587 |
| p.adjustANOVA | 2.45e-13 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DKC1 | -10139 |
| NOP58 | -10031 |
| FBL | -9942 |
| NOL11 | -9932 |
| NAT10 | -9828 |
| WDR75 | -9823 |
| THUMPD1 | -9782 |
| UTP4 | -9700 |
| RPS6 | -9699 |
| DIMT1 | -9652 |
| NOP14 | -9641 |
| BMS1 | -9626 |
| RPS2 | -9591 |
| NOP56 | -9444 |
| WDR43 | -9395 |
| DDX47 | -9334 |
| RPS7 | -9165 |
| UTP15 | -9156 |
| WDR46 | -9056 |
| MPHOSPH10 | -8840 |
| GeneID | Gene Rank |
|---|---|
| DKC1 | -10139 |
| NOP58 | -10031 |
| FBL | -9942 |
| NOL11 | -9932 |
| NAT10 | -9828 |
| WDR75 | -9823 |
| THUMPD1 | -9782 |
| UTP4 | -9700 |
| RPS6 | -9699 |
| DIMT1 | -9652 |
| NOP14 | -9641 |
| BMS1 | -9626 |
| RPS2 | -9591 |
| NOP56 | -9444 |
| WDR43 | -9395 |
| DDX47 | -9334 |
| RPS7 | -9165 |
| UTP15 | -9156 |
| WDR46 | -9056 |
| MPHOSPH10 | -8840 |
| EMG1 | -8744 |
| UTP6 | -8616 |
| RRP9 | -8598 |
| RPS14 | -8541 |
| SNU13 | -8495 |
| NOP2 | -8307 |
| PNO1 | -8004 |
| NOL6 | -7834 |
| KRR1 | -7720 |
| RCL1 | -7690 |
| DCAF13 | -7564 |
| UTP20 | -7427 |
| GAR1 | -7407 |
| HEATR1 | -7278 |
| IMP4 | -7155 |
| WDR3 | -7016 |
| IMP3 | -6912 |
| PDCD11 | -6547 |
| NHP2 | -6535 |
| PWP2 | -5423 |
| RRP7A | -5246 |
| WDR36 | -5072 |
| UTP3 | -4821 |
| DHX37 | -4742 |
| UTP14A | -3323 |
| UTP14C | -2415 |
| TRMT112 | -2296 |
| RRP36 | -395 |
| UTP11 | -37 |
| FCF1 | 453 |
| TBL3 | 739 |
| TSR3 | 1498 |
| NOC4L | 1606 |
| DDX52 | 1795 |
| RPS9 | 1841 |
| UTP18 | 3850 |
| DDX49 | 4083 |
| NOP10 | 10379 |
| SNORD3A | 10596 |
SRP-dependent cotranslational protein targeting to membrane
| 1038 | |
|---|---|
| set | SRP-dependent cotranslational protein targeting to membrane |
| setSize | 111 |
| pANOVA | 1.23e-26 |
| s.dist | -0.586 |
| p.adjustANOVA | 6.19e-25 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| SRPRB | -7520 |
| RPL36 | -7493 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| TRAM1 | -6480 |
| RPL8 | -6101 |
| SEC11C | -6046 |
| RPLP1 | -6018 |
| SEC61A2 | -5333 |
| RPL28 | -3873 |
| FAU | -3618 |
| SRP72 | -3562 |
| UBA52 | -3490 |
| SRP9 | -3414 |
| SEC61G | -3152 |
| SSR2 | -2917 |
| SPCS1 | -1700 |
| RPL39L | -1661 |
| RPS26 | -1154 |
| SPCS2 | -977 |
| SRP19 | -625 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| SRP68 | 787 |
| SSR1 | 1143 |
| SSR4 | 1294 |
| RPS9 | 1841 |
| SPCS3 | 1967 |
| SSR3 | 2510 |
| SEC61B | 4322 |
| SRP14 | 5022 |
| RPL3L | 5150 |
| RPL26L1 | 6001 |
| SEC11A | 6634 |
| RPN1 | 7151 |
| SEC61A1 | 7486 |
| SRP54 | 7912 |
| SRPRA | 8301 |
| DDOST | 8464 |
| RPN2 | 8874 |
Translation initiation complex formation
| 1267 | |
|---|---|
| set | Translation initiation complex formation |
| setSize | 58 |
| pANOVA | 1.23e-14 |
| s.dist | -0.585 |
| p.adjustANOVA | 4.8e-13 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS3A | -9834 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPS25 | -9664 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| EIF3B | -9526 |
| RPS20 | -9413 |
| RPS23 | -9387 |
| RPS3 | -9298 |
| RPS12 | -9270 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| EIF3E | -9049 |
| RPS5 | -9042 |
| RPS15A | -8883 |
| RPS8 | -8861 |
| RPS13 | -8724 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| GeneID | Gene Rank |
|---|---|
| RPS3A | -9834 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPS25 | -9664 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| EIF3B | -9526 |
| RPS20 | -9413 |
| RPS23 | -9387 |
| RPS3 | -9298 |
| RPS12 | -9270 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| EIF3E | -9049 |
| RPS5 | -9042 |
| RPS15A | -8883 |
| RPS8 | -8861 |
| RPS13 | -8724 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| EIF1AX | -8383 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPS17 | -8281 |
| EIF3L | -8255 |
| EIF4B | -8190 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPS19 | -7806 |
| EIF3H | -7091 |
| RPS24 | -6818 |
| EIF3M | -6817 |
| RPS15 | -6703 |
| RPSA | -6629 |
| EIF3J | -6448 |
| EIF3F | -5200 |
| EIF3D | -5158 |
| EIF3C | -4716 |
| FAU | -3618 |
| PABPC1 | -2991 |
| EIF3G | -2746 |
| EIF3I | -2580 |
| EIF3K | -2369 |
| EIF2S1 | -1649 |
| EIF3A | -1276 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| EIF2S2 | 554 |
| EIF4E | 1661 |
| RPS9 | 1841 |
| EIF2S3 | 2500 |
| EIF4A1 | 5541 |
| EIF4H | 7768 |
| EIF4G1 | 10506 |
Nucleobase biosynthesis
| 753 | |
|---|---|
| set | Nucleobase biosynthesis |
| setSize | 13 |
| pANOVA | 0.000288 |
| s.dist | -0.581 |
| p.adjustANOVA | 0.00222 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IMPDH2 | -10126 |
| ATIC | -10062 |
| PPAT | -10019 |
| UMPS | -9982 |
| PAICS | -9454 |
| PFAS | -9385 |
| CAD | -8818 |
| ADSL | -6382 |
| DHODH | -5973 |
| GMPS | -5196 |
| LHPP | -3573 |
| GART | 4563 |
| IMPDH1 | 11303 |
| GeneID | Gene Rank |
|---|---|
| IMPDH2 | -10126 |
| ATIC | -10062 |
| PPAT | -10019 |
| UMPS | -9982 |
| PAICS | -9454 |
| PFAS | -9385 |
| CAD | -8818 |
| ADSL | -6382 |
| DHODH | -5973 |
| GMPS | -5196 |
| LHPP | -3573 |
| GART | 4563 |
| IMPDH1 | 11303 |
Influenza Viral RNA Transcription and Replication
| 526 | |
|---|---|
| set | Influenza Viral RNA Transcription and Replication |
| setSize | 135 |
| pANOVA | 5.44e-31 |
| s.dist | -0.576 |
| p.adjustANOVA | 3.7e-29 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IPO5 | -10129 |
| NDC1 | -10077 |
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| NUP35 | -9726 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| NUP88 | -9668 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| SEH1L | -9574 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| GeneID | Gene Rank |
|---|---|
| IPO5 | -10129 |
| NDC1 | -10077 |
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| NUP35 | -9726 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| NUP88 | -9668 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| SEH1L | -9574 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| PARP1 | -8391 |
| RPL23 | -8373 |
| NUP43 | -8368 |
| NUP160 | -8357 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| NUP107 | -8285 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| NUP188 | -7953 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| NUP205 | -7516 |
| RPL36 | -7493 |
| NUP54 | -7131 |
| NUP155 | -7061 |
| POLR2D | -6856 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| NUP93 | -6458 |
| POLR2H | -6200 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| NUP133 | -5346 |
| POLR2K | -4907 |
| NUP42 | -4045 |
| HSP90AA1 | -4016 |
| NUP210 | -3949 |
| POLR2I | -3929 |
| RPL28 | -3873 |
| TPR | -3744 |
| FAU | -3618 |
| UBA52 | -3490 |
| NUP85 | -3427 |
| POLR2B | -3384 |
| AAAS | -3332 |
| GRSF1 | -2923 |
| NUP62 | -2410 |
| NUP37 | -2275 |
| POM121C | -1710 |
| RPL39L | -1661 |
| RPS26 | -1154 |
| RANBP2 | -1141 |
| RPS27L | -496 |
| POLR2C | -494 |
| POM121 | -142 |
| NUP153 | 254 |
| RPS4Y1 | 331 |
| RPS9 | 1841 |
| POLR2L | 2016 |
| NUP50 | 2638 |
| POLR2G | 4175 |
| POLR2F | 4256 |
| RAE1 | 5007 |
| POLR2E | 5109 |
| RPL3L | 5150 |
| POLR2J | 5598 |
| NUP98 | 5874 |
| RPL26L1 | 6001 |
| GTF2F2 | 6257 |
| GTF2F1 | 6738 |
| SEC13 | 7506 |
| POLR2A | 7852 |
| NUP58 | 9577 |
| DNAJC3 | 9831 |
| NUP214 | 10131 |
Ribosomal scanning and start codon recognition
| 1014 | |
|---|---|
| set | Ribosomal scanning and start codon recognition |
| setSize | 58 |
| pANOVA | 3.26e-14 |
| s.dist | -0.576 |
| p.adjustANOVA | 1.2e-12 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS3A | -9834 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPS25 | -9664 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| EIF3B | -9526 |
| RPS20 | -9413 |
| RPS23 | -9387 |
| RPS3 | -9298 |
| RPS12 | -9270 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| EIF3E | -9049 |
| RPS5 | -9042 |
| RPS15A | -8883 |
| RPS8 | -8861 |
| RPS13 | -8724 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| GeneID | Gene Rank |
|---|---|
| RPS3A | -9834 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPS25 | -9664 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| EIF3B | -9526 |
| RPS20 | -9413 |
| RPS23 | -9387 |
| RPS3 | -9298 |
| RPS12 | -9270 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| EIF3E | -9049 |
| RPS5 | -9042 |
| RPS15A | -8883 |
| RPS8 | -8861 |
| RPS13 | -8724 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| EIF1AX | -8383 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPS17 | -8281 |
| EIF3L | -8255 |
| EIF4B | -8190 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPS19 | -7806 |
| EIF3H | -7091 |
| RPS24 | -6818 |
| EIF3M | -6817 |
| RPS15 | -6703 |
| RPSA | -6629 |
| EIF3J | -6448 |
| EIF3F | -5200 |
| EIF3D | -5158 |
| EIF3C | -4716 |
| FAU | -3618 |
| EIF3G | -2746 |
| EIF3I | -2580 |
| EIF3K | -2369 |
| EIF2S1 | -1649 |
| EIF3A | -1276 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| EIF2S2 | 554 |
| EIF4E | 1661 |
| RPS9 | 1841 |
| EIF2S3 | 2500 |
| EIF5 | 2937 |
| EIF4A1 | 5541 |
| EIF4H | 7768 |
| EIF4G1 | 10506 |
Hyaluronan uptake and degradation
| 503 | |
|---|---|
| set | Hyaluronan uptake and degradation |
| setSize | 12 |
| pANOVA | 0.000572 |
| s.dist | 0.574 |
| p.adjustANOVA | 0.00374 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC9A1 | 11350 |
| HYAL2 | 11213 |
| GUSB | 11175 |
| LYVE1 | 10724 |
| CHP1 | 10038 |
| CD44 | 9255 |
| HYAL1 | 8371 |
| HEXB | 7695 |
| STAB2 | 3499 |
| HMMR | 1858 |
| HYAL3 | -893 |
| HEXA | -1967 |
| GeneID | Gene Rank |
|---|---|
| SLC9A1 | 11350 |
| HYAL2 | 11213 |
| GUSB | 11175 |
| LYVE1 | 10724 |
| CHP1 | 10038 |
| CD44 | 9255 |
| HYAL1 | 8371 |
| HEXB | 7695 |
| STAB2 | 3499 |
| HMMR | 1858 |
| HYAL3 | -893 |
| HEXA | -1967 |
Unwinding of DNA
| 1302 | |
|---|---|
| set | Unwinding of DNA |
| setSize | 12 |
| pANOVA | 0.000597 |
| s.dist | -0.572 |
| p.adjustANOVA | 0.00387 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MCM3 | -9943 |
| MCM7 | -9325 |
| MCM6 | -8631 |
| GINS4 | -8275 |
| MCM4 | -7086 |
| MCM2 | -6880 |
| MCM8 | -5713 |
| CDC45 | -5132 |
| GINS3 | -3875 |
| GINS2 | -3476 |
| MCM5 | -2327 |
| GINS1 | 4263 |
| GeneID | Gene Rank |
|---|---|
| MCM3 | -9943 |
| MCM7 | -9325 |
| MCM6 | -8631 |
| GINS4 | -8275 |
| MCM4 | -7086 |
| MCM2 | -6880 |
| MCM8 | -5713 |
| CDC45 | -5132 |
| GINS3 | -3875 |
| GINS2 | -3476 |
| MCM5 | -2327 |
| GINS1 | 4263 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
| 49 | |
|---|---|
| set | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| setSize | 59 |
| pANOVA | 2.93e-14 |
| s.dist | -0.572 |
| p.adjustANOVA | 1.11e-12 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS3A | -9834 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPS25 | -9664 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| EIF3B | -9526 |
| RPS20 | -9413 |
| RPS23 | -9387 |
| RPS3 | -9298 |
| RPS12 | -9270 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| EIF3E | -9049 |
| RPS5 | -9042 |
| RPS15A | -8883 |
| RPS8 | -8861 |
| RPS13 | -8724 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| GeneID | Gene Rank |
|---|---|
| RPS3A | -9834 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPS25 | -9664 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| EIF3B | -9526 |
| RPS20 | -9413 |
| RPS23 | -9387 |
| RPS3 | -9298 |
| RPS12 | -9270 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| EIF3E | -9049 |
| RPS5 | -9042 |
| RPS15A | -8883 |
| RPS8 | -8861 |
| RPS13 | -8724 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| EIF1AX | -8383 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPS17 | -8281 |
| EIF3L | -8255 |
| EIF4B | -8190 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPS19 | -7806 |
| EIF3H | -7091 |
| RPS24 | -6818 |
| EIF3M | -6817 |
| RPS15 | -6703 |
| RPSA | -6629 |
| EIF3J | -6448 |
| EIF3F | -5200 |
| EIF3D | -5158 |
| EIF3C | -4716 |
| FAU | -3618 |
| PABPC1 | -2991 |
| EIF3G | -2746 |
| EIF3I | -2580 |
| EIF3K | -2369 |
| EIF2S1 | -1649 |
| EIF3A | -1276 |
| RPS26 | -1154 |
| RPS27L | -496 |
| RPS4Y1 | 331 |
| EIF2S2 | 554 |
| EIF4E | 1661 |
| RPS9 | 1841 |
| EIF2S3 | 2500 |
| EIF4EBP1 | 2825 |
| EIF4A1 | 5541 |
| EIF4H | 7768 |
| EIF4G1 | 10506 |
NOTCH4 Activation and Transmission of Signal to the Nucleus
| 705 | |
|---|---|
| set | NOTCH4 Activation and Transmission of Signal to the Nucleus |
| setSize | 10 |
| pANOVA | 0.00174 |
| s.dist | 0.572 |
| p.adjustANOVA | 0.00887 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCSTN | 11452 |
| PSEN1 | 10429 |
| NOTCH4 | 10293 |
| ADAM10 | 9992 |
| APH1B | 9474 |
| JAG1 | 8240 |
| PSENEN | 7091 |
| YWHAZ | 5202 |
| APH1A | 2563 |
| PSEN2 | -6393 |
| GeneID | Gene Rank |
|---|---|
| NCSTN | 11452 |
| PSEN1 | 10429 |
| NOTCH4 | 10293 |
| ADAM10 | 9992 |
| APH1B | 9474 |
| JAG1 | 8240 |
| PSENEN | 7091 |
| YWHAZ | 5202 |
| APH1A | 2563 |
| PSEN2 | -6393 |
VLDLR internalisation and degradation
| 1308 | |
|---|---|
| set | VLDLR internalisation and degradation |
| setSize | 12 |
| pANOVA | 0.000642 |
| s.dist | 0.569 |
| p.adjustANOVA | 0.00406 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AP2A1 | 11340 |
| PCSK9 | 11027 |
| CLTC | 10304 |
| AP2A2 | 10223 |
| NR1H2 | 9521 |
| AP2M1 | 8799 |
| AP2S1 | 8045 |
| CLTA | 7164 |
| VLDLR | 6242 |
| AP2B1 | 2910 |
| NR1H3 | 954 |
| MYLIP | -4888 |
| GeneID | Gene Rank |
|---|---|
| AP2A1 | 11340 |
| PCSK9 | 11027 |
| CLTC | 10304 |
| AP2A2 | 10223 |
| NR1H2 | 9521 |
| AP2M1 | 8799 |
| AP2S1 | 8045 |
| CLTA | 7164 |
| VLDLR | 6242 |
| AP2B1 | 2910 |
| NR1H3 | 954 |
| MYLIP | -4888 |
PD-1 signaling
| 777 | |
|---|---|
| set | PD-1 signaling |
| setSize | 28 |
| pANOVA | 2.24e-07 |
| s.dist | -0.565 |
| p.adjustANOVA | 4.12e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TRBV12-3 | -9971 |
| TRAC | -9703 |
| HLA-DQB2 | -9656 |
| LCK | -9556 |
| TRBC1 | -9303 |
| TRAV29DV5 | -9278 |
| CD3E | -9249 |
| TRAV19 | -9248 |
| HLA-DRA | -9006 |
| HLA-DQA2 | -8774 |
| CD247 | -8741 |
| HLA-DPB1 | -8397 |
| TRBV7-9 | -8303 |
| CD3D | -8297 |
| HLA-DPA1 | -8217 |
| CD3G | -8111 |
| CD274 | -7895 |
| CD4 | -6881 |
| HLA-DQA1 | -6389 |
| PDCD1 | -5516 |
| GeneID | Gene Rank |
|---|---|
| TRBV12-3 | -9971 |
| TRAC | -9703 |
| HLA-DQB2 | -9656 |
| LCK | -9556 |
| TRBC1 | -9303 |
| TRAV29DV5 | -9278 |
| CD3E | -9249 |
| TRAV19 | -9248 |
| HLA-DRA | -9006 |
| HLA-DQA2 | -8774 |
| CD247 | -8741 |
| HLA-DPB1 | -8397 |
| TRBV7-9 | -8303 |
| CD3D | -8297 |
| HLA-DPA1 | -8217 |
| CD3G | -8111 |
| CD274 | -7895 |
| CD4 | -6881 |
| HLA-DQA1 | -6389 |
| PDCD1 | -5516 |
| TRAV8-4 | -4769 |
| HLA-DQB1 | -4459 |
| HLA-DRB1 | -334 |
| PDCD1LG2 | 273 |
| HLA-DRB5 | 748 |
| PTPN11 | 6524 |
| CSK | 9400 |
| PTPN6 | 10446 |
Platelet sensitization by LDL
| 831 | |
|---|---|
| set | Platelet sensitization by LDL |
| setSize | 16 |
| pANOVA | 0.000104 |
| s.dist | 0.56 |
| p.adjustANOVA | 0.000947 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FGR | 11323 |
| MAPK14 | 11115 |
| PTPN6 | 10446 |
| PECAM1 | 10414 |
| PPP2R5B | 9913 |
| PPP2R5A | 9827 |
| PLA2G4A | 9803 |
| LRP8 | 9649 |
| PPP2CB | 7451 |
| PPP2CA | 6806 |
| PPP2R5D | 6601 |
| PTPN11 | 6524 |
| PPP2R1A | 5189 |
| PPP2R1B | 89 |
| PPP2R5E | -2595 |
| PPP2R5C | -5198 |
| GeneID | Gene Rank |
|---|---|
| FGR | 11323 |
| MAPK14 | 11115 |
| PTPN6 | 10446 |
| PECAM1 | 10414 |
| PPP2R5B | 9913 |
| PPP2R5A | 9827 |
| PLA2G4A | 9803 |
| LRP8 | 9649 |
| PPP2CB | 7451 |
| PPP2CA | 6806 |
| PPP2R5D | 6601 |
| PTPN11 | 6524 |
| PPP2R1A | 5189 |
| PPP2R1B | 89 |
| PPP2R5E | -2595 |
| PPP2R5C | -5198 |
DNA strand elongation
| 245 | |
|---|---|
| set | DNA strand elongation |
| setSize | 32 |
| pANOVA | 4.6e-08 |
| s.dist | -0.558 |
| p.adjustANOVA | 1.01e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| MCM3 | -9943 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| LIG1 | -9469 |
| RFC3 | -9405 |
| MCM7 | -9325 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| RFC4 | -8897 |
| MCM6 | -8631 |
| GINS4 | -8275 |
| POLA2 | -7950 |
| RFC5 | -7574 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| MCM4 | -7086 |
| MCM2 | -6880 |
| FEN1 | -6485 |
| DNA2 | -6307 |
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| MCM3 | -9943 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| LIG1 | -9469 |
| RFC3 | -9405 |
| MCM7 | -9325 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| RFC4 | -8897 |
| MCM6 | -8631 |
| GINS4 | -8275 |
| POLA2 | -7950 |
| RFC5 | -7574 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| MCM4 | -7086 |
| MCM2 | -6880 |
| FEN1 | -6485 |
| DNA2 | -6307 |
| MCM8 | -5713 |
| CDC45 | -5132 |
| RFC1 | -5080 |
| RPA2 | -4811 |
| GINS3 | -3875 |
| GINS2 | -3476 |
| POLD1 | -2573 |
| MCM5 | -2327 |
| GINS1 | 4263 |
| RFC2 | 5478 |
| POLD4 | 9079 |
| POLD3 | 10698 |
Processive synthesis on the lagging strand
| 858 | |
|---|---|
| set | Processive synthesis on the lagging strand |
| setSize | 15 |
| pANOVA | 2e-04 |
| s.dist | -0.555 |
| p.adjustANOVA | 0.00167 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| LIG1 | -9469 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| POLA2 | -7950 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| FEN1 | -6485 |
| DNA2 | -6307 |
| RPA2 | -4811 |
| POLD1 | -2573 |
| POLD4 | 9079 |
| POLD3 | 10698 |
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| LIG1 | -9469 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| POLA2 | -7950 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| FEN1 | -6485 |
| DNA2 | -6307 |
| RPA2 | -4811 |
| POLD1 | -2573 |
| POLD4 | 9079 |
| POLD3 | 10698 |
Lagging Strand Synthesis
| 590 | |
|---|---|
| set | Lagging Strand Synthesis |
| setSize | 20 |
| pANOVA | 2.12e-05 |
| s.dist | -0.549 |
| p.adjustANOVA | 0.000241 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| LIG1 | -9469 |
| RFC3 | -9405 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| RFC4 | -8897 |
| POLA2 | -7950 |
| RFC5 | -7574 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| FEN1 | -6485 |
| DNA2 | -6307 |
| RFC1 | -5080 |
| RPA2 | -4811 |
| POLD1 | -2573 |
| RFC2 | 5478 |
| POLD4 | 9079 |
| POLD3 | 10698 |
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| LIG1 | -9469 |
| RFC3 | -9405 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| RFC4 | -8897 |
| POLA2 | -7950 |
| RFC5 | -7574 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| FEN1 | -6485 |
| DNA2 | -6307 |
| RFC1 | -5080 |
| RPA2 | -4811 |
| POLD1 | -2573 |
| RFC2 | 5478 |
| POLD4 | 9079 |
| POLD3 | 10698 |
Gap junction trafficking
| 435 | |
|---|---|
| set | Gap junction trafficking |
| setSize | 13 |
| pANOVA | 0.00064 |
| s.dist | 0.547 |
| p.adjustANOVA | 0.00406 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| DAB2 | 10645 |
| GJD3 | 10584 |
| DNM2 | 10373 |
| CLTC | 10304 |
| CLTCL1 | 9201 |
| AP2M1 | 8799 |
| CLTB | 7968 |
| CLTA | 7164 |
| DNM1 | 5998 |
| GJC1 | 4969 |
| GJB6 | 3533 |
| GJC2 | -694 |
| MYO6 | -3522 |
| GeneID | Gene Rank |
|---|---|
| DAB2 | 10645 |
| GJD3 | 10584 |
| DNM2 | 10373 |
| CLTC | 10304 |
| CLTCL1 | 9201 |
| AP2M1 | 8799 |
| CLTB | 7968 |
| CLTA | 7164 |
| DNM1 | 5998 |
| GJC1 | 4969 |
| GJB6 | 3533 |
| GJC2 | -694 |
| MYO6 | -3522 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
| 344 | |
|---|---|
| set | Erythropoietin activates Phosphoinositide-3-kinase (PI3K) |
| setSize | 11 |
| pANOVA | 0.00179 |
| s.dist | 0.544 |
| p.adjustANOVA | 0.00907 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LYN | 10810 |
| EPOR | 10409 |
| IRS2 | 9427 |
| PIK3CG | 9128 |
| PIK3CB | 9126 |
| PIK3CD | 8956 |
| GAB1 | 8670 |
| PIK3R5 | 7579 |
| JAK2 | 4428 |
| PIK3CA | 2133 |
| PIK3R1 | -8831 |
| GeneID | Gene Rank |
|---|---|
| LYN | 10810 |
| EPOR | 10409 |
| IRS2 | 9427 |
| PIK3CG | 9128 |
| PIK3CB | 9126 |
| PIK3CD | 8956 |
| GAB1 | 8670 |
| PIK3R5 | 7579 |
| JAK2 | 4428 |
| PIK3CA | 2133 |
| PIK3R1 | -8831 |
RHO GTPases Activate WASPs and WAVEs
| 887 | |
|---|---|
| set | RHO GTPases Activate WASPs and WAVEs |
| setSize | 35 |
| pANOVA | 3.78e-08 |
| s.dist | 0.537 |
| p.adjustANOVA | 8.44e-07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| WASF1 | 11328 |
| NCKAP1L | 11304 |
| MAPK1 | 11193 |
| ARPC1A | 10981 |
| BTK | 10849 |
| WASF2 | 10807 |
| ARPC1B | 10781 |
| WAS | 10777 |
| GRB2 | 10733 |
| RAC1 | 10624 |
| ACTB | 10606 |
| CYFIP1 | 10420 |
| ARPC5 | 10102 |
| MAPK3 | 9750 |
| ACTG1 | 9678 |
| ARPC4 | 9592 |
| ABI1 | 9373 |
| ARPC2 | 9016 |
| ACTR2 | 8895 |
| ACTR3 | 8873 |
| GeneID | Gene Rank |
|---|---|
| WASF1 | 11328 |
| NCKAP1L | 11304 |
| MAPK1 | 11193 |
| ARPC1A | 10981 |
| BTK | 10849 |
| WASF2 | 10807 |
| ARPC1B | 10781 |
| WAS | 10777 |
| GRB2 | 10733 |
| RAC1 | 10624 |
| ACTB | 10606 |
| CYFIP1 | 10420 |
| ARPC5 | 10102 |
| MAPK3 | 9750 |
| ACTG1 | 9678 |
| ARPC4 | 9592 |
| ABI1 | 9373 |
| ARPC2 | 9016 |
| ACTR2 | 8895 |
| ACTR3 | 8873 |
| NCKAP1 | 8861 |
| ARPC3 | 8726 |
| WIPF2 | 8699 |
| CDC42 | 8342 |
| ABL1 | 6127 |
| WASL | 3297 |
| WIPF1 | 3137 |
| PTK2 | 388 |
| CYFIP2 | -775 |
| WASF3 | -1364 |
| BAIAP2 | -1877 |
| BRK1 | -2561 |
| NCKIPSD | -3692 |
| ABI2 | -8174 |
| NCK1 | -8975 |
Advanced glycosylation endproduct receptor signaling
| 60 | |
|---|---|
| set | Advanced glycosylation endproduct receptor signaling |
| setSize | 12 |
| pANOVA | 0.00128 |
| s.dist | 0.537 |
| p.adjustANOVA | 0.00701 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| S100A12 | 11206 |
| MAPK1 | 11193 |
| MAPK3 | 9750 |
| CAPZA1 | 9530 |
| LGALS3 | 9180 |
| DDOST | 8464 |
| CAPZA2 | 8225 |
| PRKCSH | 6831 |
| APP | 6245 |
| AGER | 4895 |
| S100B | -1351 |
| HMGB1 | -6699 |
| GeneID | Gene Rank |
|---|---|
| S100A12 | 11206 |
| MAPK1 | 11193 |
| MAPK3 | 9750 |
| CAPZA1 | 9530 |
| LGALS3 | 9180 |
| DDOST | 8464 |
| CAPZA2 | 8225 |
| PRKCSH | 6831 |
| APP | 6245 |
| AGER | 4895 |
| S100B | -1351 |
| HMGB1 | -6699 |
PCNA-Dependent Long Patch Base Excision Repair
| 775 | |
|---|---|
| set | PCNA-Dependent Long Patch Base Excision Repair |
| setSize | 21 |
| pANOVA | 2.52e-05 |
| s.dist | -0.531 |
| p.adjustANOVA | 0.000277 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APEX1 | -10111 |
| POLD2 | -10054 |
| RPA1 | -9799 |
| LIG1 | -9469 |
| RFC3 | -9405 |
| POLE3 | -9287 |
| RPA3 | -9220 |
| RFC4 | -8897 |
| POLB | -8449 |
| POLE2 | -7763 |
| RFC5 | -7574 |
| PCNA | -7101 |
| FEN1 | -6485 |
| RFC1 | -5080 |
| RPA2 | -4811 |
| POLE | -4081 |
| POLD1 | -2573 |
| POLE4 | -1856 |
| RFC2 | 5478 |
| POLD4 | 9079 |
| GeneID | Gene Rank |
|---|---|
| APEX1 | -10111 |
| POLD2 | -10054 |
| RPA1 | -9799 |
| LIG1 | -9469 |
| RFC3 | -9405 |
| POLE3 | -9287 |
| RPA3 | -9220 |
| RFC4 | -8897 |
| POLB | -8449 |
| POLE2 | -7763 |
| RFC5 | -7574 |
| PCNA | -7101 |
| FEN1 | -6485 |
| RFC1 | -5080 |
| RPA2 | -4811 |
| POLE | -4081 |
| POLD1 | -2573 |
| POLE4 | -1856 |
| RFC2 | 5478 |
| POLD4 | 9079 |
| POLD3 | 10698 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
| 799 | |
|---|---|
| set | PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases |
| setSize | 13 |
| pANOVA | 0.000951 |
| s.dist | 0.529 |
| p.adjustANOVA | 0.00558 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RAC1 | 10624 |
| CRK | 10387 |
| ELMO2 | 10190 |
| PXN | 10135 |
| RHOA | 9401 |
| PTK6 | 9263 |
| DOCK1 | 7594 |
| RASA1 | 6250 |
| KRAS | 6132 |
| ELMO1 | 5455 |
| NRAS | 4907 |
| ARHGAP35 | -2201 |
| HRAS | -5273 |
| GeneID | Gene Rank |
|---|---|
| RAC1 | 10624 |
| CRK | 10387 |
| ELMO2 | 10190 |
| PXN | 10135 |
| RHOA | 9401 |
| PTK6 | 9263 |
| DOCK1 | 7594 |
| RASA1 | 6250 |
| KRAS | 6132 |
| ELMO1 | 5455 |
| NRAS | 4907 |
| ARHGAP35 | -2201 |
| HRAS | -5273 |
Removal of the Flap Intermediate
| 993 | |
|---|---|
| set | Removal of the Flap Intermediate |
| setSize | 14 |
| pANOVA | 0.000635 |
| s.dist | -0.527 |
| p.adjustANOVA | 0.00406 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| POLA2 | -7950 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| FEN1 | -6485 |
| DNA2 | -6307 |
| RPA2 | -4811 |
| POLD1 | -2573 |
| POLD4 | 9079 |
| POLD3 | 10698 |
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| POLA2 | -7950 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| FEN1 | -6485 |
| DNA2 | -6307 |
| RPA2 | -4811 |
| POLD1 | -2573 |
| POLD4 | 9079 |
| POLD3 | 10698 |
Erythrocytes take up carbon dioxide and release oxygen
| 343 | |
|---|---|
| set | Erythrocytes take up carbon dioxide and release oxygen |
| setSize | 12 |
| pANOVA | 0.00158 |
| s.dist | 0.527 |
| p.adjustANOVA | 0.00815 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CYB5R1 | 11052 |
| CA4 | 10997 |
| CYB5R4 | 8995 |
| CYB5R2 | 8743 |
| CA1 | 8217 |
| AQP1 | 7985 |
| SLC4A1 | 7532 |
| RHAG | 7023 |
| HBB | 6697 |
| HBA1 | 6237 |
| CA2 | 42 |
| CYB5RL | -7366 |
| GeneID | Gene Rank |
|---|---|
| CYB5R1 | 11052 |
| CA4 | 10997 |
| CYB5R4 | 8995 |
| CYB5R2 | 8743 |
| CA1 | 8217 |
| AQP1 | 7985 |
| SLC4A1 | 7532 |
| RHAG | 7023 |
| HBB | 6697 |
| HBA1 | 6237 |
| CA2 | 42 |
| CYB5RL | -7366 |
O2/CO2 exchange in erythrocytes
| 763 | |
|---|---|
| set | O2/CO2 exchange in erythrocytes |
| setSize | 12 |
| pANOVA | 0.00158 |
| s.dist | 0.527 |
| p.adjustANOVA | 0.00815 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CYB5R1 | 11052 |
| CA4 | 10997 |
| CYB5R4 | 8995 |
| CYB5R2 | 8743 |
| CA1 | 8217 |
| AQP1 | 7985 |
| SLC4A1 | 7532 |
| RHAG | 7023 |
| HBB | 6697 |
| HBA1 | 6237 |
| CA2 | 42 |
| CYB5RL | -7366 |
| GeneID | Gene Rank |
|---|---|
| CYB5R1 | 11052 |
| CA4 | 10997 |
| CYB5R4 | 8995 |
| CYB5R2 | 8743 |
| CA1 | 8217 |
| AQP1 | 7985 |
| SLC4A1 | 7532 |
| RHAG | 7023 |
| HBB | 6697 |
| HBA1 | 6237 |
| CA2 | 42 |
| CYB5RL | -7366 |
SLBP independent Processing of Histone Pre-mRNAs
| 1034 | |
|---|---|
| set | SLBP independent Processing of Histone Pre-mRNAs |
| setSize | 10 |
| pANOVA | 0.00433 |
| s.dist | -0.521 |
| p.adjustANOVA | 0.0178 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCBP2 | -9631 |
| ZNF473 | -9381 |
| LSM11 | -9085 |
| SNRPF | -8687 |
| SNRPE | -8564 |
| SNRPD3 | -6352 |
| SNRPB | -4187 |
| NCBP1 | -942 |
| SNRPG | 560 |
| LSM10 | 6472 |
| GeneID | Gene Rank |
|---|---|
| NCBP2 | -9631 |
| ZNF473 | -9381 |
| LSM11 | -9085 |
| SNRPF | -8687 |
| SNRPE | -8564 |
| SNRPD3 | -6352 |
| SNRPB | -4187 |
| NCBP1 | -942 |
| SNRPG | 560 |
| LSM10 | 6472 |
WNT5A-dependent internalization of FZD4
| 1322 | |
|---|---|
| set | WNT5A-dependent internalization of FZD4 |
| setSize | 13 |
| pANOVA | 0.00118 |
| s.dist | 0.519 |
| p.adjustANOVA | 0.0066 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AP2A1 | 11340 |
| ARRB2 | 10688 |
| CLTC | 10304 |
| AP2A2 | 10223 |
| AP2M1 | 8799 |
| PRKCB | 8577 |
| AP2S1 | 8045 |
| CLTB | 7968 |
| CLTA | 7164 |
| FZD4 | 3498 |
| AP2B1 | 2910 |
| PRKCA | -2408 |
| DVL2 | -5637 |
| GeneID | Gene Rank |
|---|---|
| AP2A1 | 11340 |
| ARRB2 | 10688 |
| CLTC | 10304 |
| AP2A2 | 10223 |
| AP2M1 | 8799 |
| PRKCB | 8577 |
| AP2S1 | 8045 |
| CLTB | 7968 |
| CLTA | 7164 |
| FZD4 | 3498 |
| AP2B1 | 2910 |
| PRKCA | -2408 |
| DVL2 | -5637 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway
| 997 | |
|---|---|
| set | Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| setSize | 24 |
| pANOVA | 1.17e-05 |
| s.dist | -0.517 |
| p.adjustANOVA | 0.000147 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APEX1 | -10111 |
| POLD2 | -10054 |
| RPA1 | -9799 |
| LIG1 | -9469 |
| RFC3 | -9405 |
| POLE3 | -9287 |
| RPA3 | -9220 |
| RFC4 | -8897 |
| POLB | -8449 |
| PARP1 | -8391 |
| POLE2 | -7763 |
| RFC5 | -7574 |
| PCNA | -7101 |
| FEN1 | -6485 |
| PARP2 | -6040 |
| RFC1 | -5080 |
| RPA2 | -4811 |
| POLE | -4081 |
| POLD1 | -2573 |
| POLE4 | -1856 |
| GeneID | Gene Rank |
|---|---|
| APEX1 | -10111 |
| POLD2 | -10054 |
| RPA1 | -9799 |
| LIG1 | -9469 |
| RFC3 | -9405 |
| POLE3 | -9287 |
| RPA3 | -9220 |
| RFC4 | -8897 |
| POLB | -8449 |
| PARP1 | -8391 |
| POLE2 | -7763 |
| RFC5 | -7574 |
| PCNA | -7101 |
| FEN1 | -6485 |
| PARP2 | -6040 |
| RFC1 | -5080 |
| RPA2 | -4811 |
| POLE | -4081 |
| POLD1 | -2573 |
| POLE4 | -1856 |
| PARG | 2874 |
| RFC2 | 5478 |
| POLD4 | 9079 |
| POLD3 | 10698 |
Retrograde neurotrophin signalling
| 1010 | |
|---|---|
| set | Retrograde neurotrophin signalling |
| setSize | 12 |
| pANOVA | 0.00217 |
| s.dist | 0.511 |
| p.adjustANOVA | 0.0106 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AP2A1 | 11340 |
| DNM2 | 10373 |
| CLTC | 10304 |
| AP2A2 | 10223 |
| AP2M1 | 8799 |
| AP2S1 | 8045 |
| CLTA | 7164 |
| DNM1 | 5998 |
| DNM3 | 3523 |
| AP2B1 | 2910 |
| DNAL4 | -764 |
| NTRK1 | -3793 |
| GeneID | Gene Rank |
|---|---|
| AP2A1 | 11340 |
| DNM2 | 10373 |
| CLTC | 10304 |
| AP2A2 | 10223 |
| AP2M1 | 8799 |
| AP2S1 | 8045 |
| CLTA | 7164 |
| DNM1 | 5998 |
| DNM3 | 3523 |
| AP2B1 | 2910 |
| DNAL4 | -764 |
| NTRK1 | -3793 |
Prolonged ERK activation events
| 861 | |
|---|---|
| set | Prolonged ERK activation events |
| setSize | 13 |
| pANOVA | 0.00151 |
| s.dist | 0.508 |
| p.adjustANOVA | 0.00799 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 11193 |
| CRK | 10387 |
| MAP2K1 | 10148 |
| MAPK3 | 9750 |
| KIDINS220 | 9339 |
| RAP1A | 7335 |
| MAP2K2 | 7222 |
| CRKL | 5250 |
| RAPGEF1 | 5102 |
| YWHAB | 4721 |
| BRAF | 4367 |
| FRS2 | -1144 |
| NTRK1 | -3793 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 11193 |
| CRK | 10387 |
| MAP2K1 | 10148 |
| MAPK3 | 9750 |
| KIDINS220 | 9339 |
| RAP1A | 7335 |
| MAP2K2 | 7222 |
| CRKL | 5250 |
| RAPGEF1 | 5102 |
| YWHAB | 4721 |
| BRAF | 4367 |
| FRS2 | -1144 |
| NTRK1 | -3793 |
Purine ribonucleoside monophosphate biosynthesis
| 869 | |
|---|---|
| set | Purine ribonucleoside monophosphate biosynthesis |
| setSize | 10 |
| pANOVA | 0.00545 |
| s.dist | -0.507 |
| p.adjustANOVA | 0.0219 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IMPDH2 | -10126 |
| ATIC | -10062 |
| PPAT | -10019 |
| PAICS | -9454 |
| PFAS | -9385 |
| ADSL | -6382 |
| GMPS | -5196 |
| LHPP | -3573 |
| GART | 4563 |
| IMPDH1 | 11303 |
| GeneID | Gene Rank |
|---|---|
| IMPDH2 | -10126 |
| ATIC | -10062 |
| PPAT | -10019 |
| PAICS | -9454 |
| PFAS | -9385 |
| ADSL | -6382 |
| GMPS | -5196 |
| LHPP | -3573 |
| GART | 4563 |
| IMPDH1 | 11303 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
| 1033 | |
|---|---|
| set | SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| setSize | 11 |
| pANOVA | 0.00387 |
| s.dist | -0.503 |
| p.adjustANOVA | 0.0164 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCBP2 | -9631 |
| ZNF473 | -9381 |
| LSM11 | -9085 |
| SNRPF | -8687 |
| SNRPE | -8564 |
| SNRPD3 | -6352 |
| SNRPB | -4187 |
| SLBP | -2817 |
| NCBP1 | -942 |
| SNRPG | 560 |
| LSM10 | 6472 |
| GeneID | Gene Rank |
|---|---|
| NCBP2 | -9631 |
| ZNF473 | -9381 |
| LSM11 | -9085 |
| SNRPF | -8687 |
| SNRPE | -8564 |
| SNRPD3 | -6352 |
| SNRPB | -4187 |
| SLBP | -2817 |
| NCBP1 | -942 |
| SNRPG | 560 |
| LSM10 | 6472 |
Influenza Infection
| 525 | |
|---|---|
| set | Influenza Infection |
| setSize | 154 |
| pANOVA | 4.36e-27 |
| s.dist | -0.503 |
| p.adjustANOVA | 2.28e-25 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IPO5 | -10129 |
| NDC1 | -10077 |
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| NUP35 | -9726 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| NUP88 | -9668 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| SEH1L | -9574 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| GeneID | Gene Rank |
|---|---|
| IPO5 | -10129 |
| NDC1 | -10077 |
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| NUP35 | -9726 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| NUP88 | -9668 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| RPS2 | -9591 |
| SEH1L | -9574 |
| RPL4 | -9549 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| RPS3 | -9298 |
| RPL35A | -9291 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| KPNA5 | -9017 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| RPS16 | -8579 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| RAN | -8475 |
| PARP1 | -8391 |
| RPL23 | -8373 |
| NUP43 | -8368 |
| NUP160 | -8357 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| NUP107 | -8285 |
| RPS17 | -8281 |
| RPL22L1 | -8202 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| RPS28 | -8083 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| NUP188 | -7953 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| RPL41 | -7561 |
| NUP205 | -7516 |
| RPL36 | -7493 |
| NUP54 | -7131 |
| NUP155 | -7061 |
| POLR2D | -6856 |
| RPL37A | -6833 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| RPS15 | -6703 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| NUP93 | -6458 |
| POLR2H | -6200 |
| RPL8 | -6101 |
| RPLP1 | -6018 |
| SLC25A6 | -5588 |
| NUP133 | -5346 |
| ISG15 | -5074 |
| POLR2K | -4907 |
| NUP42 | -4045 |
| CPSF4 | -4025 |
| HSP90AA1 | -4016 |
| NUP210 | -3949 |
| POLR2I | -3929 |
| RPL28 | -3873 |
| TPR | -3744 |
| FAU | -3618 |
| UBA52 | -3490 |
| NUP85 | -3427 |
| POLR2B | -3384 |
| AAAS | -3332 |
| XPO1 | -3214 |
| GRSF1 | -2923 |
| KPNA2 | -2535 |
| NUP62 | -2410 |
| NUP37 | -2275 |
| KPNA3 | -1964 |
| PABPN1 | -1789 |
| POM121C | -1710 |
| RPL39L | -1661 |
| KPNA1 | -1312 |
| RPS26 | -1154 |
| RANBP2 | -1141 |
| RPS27L | -496 |
| POLR2C | -494 |
| POM121 | -142 |
| NUP153 | 254 |
| RPS4Y1 | 331 |
| RPS9 | 1841 |
| POLR2L | 2016 |
| NUP50 | 2638 |
| CANX | 3332 |
| POLR2G | 4175 |
| POLR2F | 4256 |
| RAE1 | 5007 |
| POLR2E | 5109 |
| RPL3L | 5150 |
| TGFB1 | 5504 |
| EIF2AK2 | 5594 |
| POLR2J | 5598 |
| KPNB1 | 5604 |
| KPNA4 | 5698 |
| NUP98 | 5874 |
| RPL26L1 | 6001 |
| GTF2F2 | 6257 |
| GTF2F1 | 6738 |
| CLTA | 7164 |
| SEC13 | 7506 |
| CALR | 7713 |
| POLR2A | 7852 |
| HSPA1A | 9341 |
| NUP58 | 9577 |
| DNAJC3 | 9831 |
| NUP214 | 10131 |
| CLTC | 10304 |
Signal transduction by L1
| 1070 | |
|---|---|
| set | Signal transduction by L1 |
| setSize | 20 |
| pANOVA | 0.000105 |
| s.dist | 0.501 |
| p.adjustANOVA | 0.000953 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 11193 |
| RAC1 | 10624 |
| MAP2K1 | 10148 |
| PAK1 | 10043 |
| ITGA5 | 9848 |
| MAPK3 | 9750 |
| CSNK2A1 | 9040 |
| ITGAV | 7847 |
| ITGA9 | 7807 |
| ITGA2B | 7387 |
| CSNK2A2 | 7341 |
| MAP2K2 | 7222 |
| FGFR1 | 6607 |
| NRP1 | 6221 |
| CSNK2B | 5876 |
| ITGB3 | 2944 |
| VAV2 | 2755 |
| ITGB1 | -3073 |
| L1CAM | -3125 |
| NCAM1 | -5143 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 11193 |
| RAC1 | 10624 |
| MAP2K1 | 10148 |
| PAK1 | 10043 |
| ITGA5 | 9848 |
| MAPK3 | 9750 |
| CSNK2A1 | 9040 |
| ITGAV | 7847 |
| ITGA9 | 7807 |
| ITGA2B | 7387 |
| CSNK2A2 | 7341 |
| MAP2K2 | 7222 |
| FGFR1 | 6607 |
| NRP1 | 6221 |
| CSNK2B | 5876 |
| ITGB3 | 2944 |
| VAV2 | 2755 |
| ITGB1 | -3073 |
| L1CAM | -3125 |
| NCAM1 | -5143 |
Erythropoietin activates RAS
| 345 | |
|---|---|
| set | Erythropoietin activates RAS |
| setSize | 13 |
| pANOVA | 0.00181 |
| s.dist | 0.5 |
| p.adjustANOVA | 0.00912 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LYN | 10810 |
| GRB2 | 10733 |
| EPOR | 10409 |
| VAV1 | 10226 |
| SHC1 | 9541 |
| IRS2 | 9427 |
| KRAS | 6132 |
| CRKL | 5250 |
| RAPGEF1 | 5102 |
| NRAS | 4907 |
| JAK2 | 4428 |
| SOS1 | -2983 |
| HRAS | -5273 |
| GeneID | Gene Rank |
|---|---|
| LYN | 10810 |
| GRB2 | 10733 |
| EPOR | 10409 |
| VAV1 | 10226 |
| SHC1 | 9541 |
| IRS2 | 9427 |
| KRAS | 6132 |
| CRKL | 5250 |
| RAPGEF1 | 5102 |
| NRAS | 4907 |
| JAK2 | 4428 |
| SOS1 | -2983 |
| HRAS | -5273 |
Synthesis of Leukotrienes (LT) and Eoxins (EX)
| 1164 | |
|---|---|
| set | Synthesis of Leukotrienes (LT) and Eoxins (EX) |
| setSize | 15 |
| pANOVA | 0.000851 |
| s.dist | 0.497 |
| p.adjustANOVA | 0.00508 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GGT1 | 11459 |
| ALOX5 | 11178 |
| PTGR1 | 10862 |
| CYP4F8 | 10561 |
| LTA4H | 10541 |
| ALOX5AP | 9860 |
| MAPKAPK2 | 8852 |
| CYP4F3 | 7797 |
| ABCC1 | 5410 |
| GGT5 | 5204 |
| CYP4F22 | 4727 |
| DPEP2 | 2213 |
| DPEP3 | 1876 |
| LTC4S | -624 |
| ALOX15 | -9484 |
| GeneID | Gene Rank |
|---|---|
| GGT1 | 11459 |
| ALOX5 | 11178 |
| PTGR1 | 10862 |
| CYP4F8 | 10561 |
| LTA4H | 10541 |
| ALOX5AP | 9860 |
| MAPKAPK2 | 8852 |
| CYP4F3 | 7797 |
| ABCC1 | 5410 |
| GGT5 | 5204 |
| CYP4F22 | 4727 |
| DPEP2 | 2213 |
| DPEP3 | 1876 |
| LTC4S | -624 |
| ALOX15 | -9484 |
Activation of ATR in response to replication stress
| 33 | |
|---|---|
| set | Activation of ATR in response to replication stress |
| setSize | 37 |
| pANOVA | 2.01e-07 |
| s.dist | -0.494 |
| p.adjustANOVA | 3.75e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MCM3 | -9943 |
| RAD1 | -9896 |
| RPA1 | -9799 |
| RFC3 | -9405 |
| MCM7 | -9325 |
| RPA3 | -9220 |
| DBF4 | -8907 |
| RFC4 | -8897 |
| MCM6 | -8631 |
| ORC5 | -8539 |
| RAD17 | -8493 |
| ORC2 | -8256 |
| ORC3 | -7889 |
| RFC5 | -7574 |
| RAD9A | -7462 |
| MCM4 | -7086 |
| MCM2 | -6880 |
| ORC4 | -6267 |
| CHEK1 | -6143 |
| MCM8 | -5713 |
| GeneID | Gene Rank |
|---|---|
| MCM3 | -9943 |
| RAD1 | -9896 |
| RPA1 | -9799 |
| RFC3 | -9405 |
| MCM7 | -9325 |
| RPA3 | -9220 |
| DBF4 | -8907 |
| RFC4 | -8897 |
| MCM6 | -8631 |
| ORC5 | -8539 |
| RAD17 | -8493 |
| ORC2 | -8256 |
| ORC3 | -7889 |
| RFC5 | -7574 |
| RAD9A | -7462 |
| MCM4 | -7086 |
| MCM2 | -6880 |
| ORC4 | -6267 |
| CHEK1 | -6143 |
| MCM8 | -5713 |
| ATR | -5340 |
| CDC45 | -5132 |
| RPA2 | -4811 |
| MCM10 | -4587 |
| CDC7 | -4493 |
| CDK2 | -3614 |
| ATRIP | -3603 |
| ORC1 | -2973 |
| MCM5 | -2327 |
| CDC6 | -1597 |
| CDC25A | 317 |
| CLSPN | 1968 |
| HUS1 | 4236 |
| ORC6 | 5337 |
| RFC2 | 5478 |
| CDC25C | 5800 |
| RAD9B | 6597 |
Telomere C-strand (Lagging Strand) Synthesis
| 1217 | |
|---|---|
| set | Telomere C-strand (Lagging Strand) Synthesis |
| setSize | 34 |
| pANOVA | 6.34e-07 |
| s.dist | -0.493 |
| p.adjustANOVA | 1.04e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| STN1 | -9859 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| CHTF18 | -9602 |
| WRN | -9501 |
| LIG1 | -9469 |
| RFC3 | -9405 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| RFC4 | -8897 |
| CTC1 | -8852 |
| POLA2 | -7950 |
| RFC5 | -7574 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| FEN1 | -6485 |
| DNA2 | -6307 |
| DSCC1 | -5837 |
| ACD | -5673 |
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| STN1 | -9859 |
| POLA1 | -9841 |
| RPA1 | -9799 |
| CHTF18 | -9602 |
| WRN | -9501 |
| LIG1 | -9469 |
| RFC3 | -9405 |
| RPA3 | -9220 |
| PRIM1 | -9166 |
| RFC4 | -8897 |
| CTC1 | -8852 |
| POLA2 | -7950 |
| RFC5 | -7574 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| FEN1 | -6485 |
| DNA2 | -6307 |
| DSCC1 | -5837 |
| ACD | -5673 |
| BLM | -5151 |
| RFC1 | -5080 |
| RPA2 | -4811 |
| POT1 | -4708 |
| TERF2 | -4421 |
| TERF1 | -2831 |
| POLD1 | -2573 |
| CHTF8 | -124 |
| TEN1 | 624 |
| TERF2IP | 4065 |
| RFC2 | 5478 |
| TINF2 | 8502 |
| POLD4 | 9079 |
| POLD3 | 10698 |
Phosphorylation of CD3 and TCR zeta chains
| 819 | |
|---|---|
| set | Phosphorylation of CD3 and TCR zeta chains |
| setSize | 27 |
| pANOVA | 1.07e-05 |
| s.dist | -0.489 |
| p.adjustANOVA | 0.000138 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TRBV12-3 | -9971 |
| TRAC | -9703 |
| HLA-DQB2 | -9656 |
| LCK | -9556 |
| TRBC1 | -9303 |
| TRAV29DV5 | -9278 |
| CD3E | -9249 |
| TRAV19 | -9248 |
| HLA-DRA | -9006 |
| HLA-DQA2 | -8774 |
| CD247 | -8741 |
| HLA-DPB1 | -8397 |
| TRBV7-9 | -8303 |
| CD3D | -8297 |
| HLA-DPA1 | -8217 |
| CD3G | -8111 |
| CD4 | -6881 |
| HLA-DQA1 | -6389 |
| TRAV8-4 | -4769 |
| HLA-DQB1 | -4459 |
| GeneID | Gene Rank |
|---|---|
| TRBV12-3 | -9971 |
| TRAC | -9703 |
| HLA-DQB2 | -9656 |
| LCK | -9556 |
| TRBC1 | -9303 |
| TRAV29DV5 | -9278 |
| CD3E | -9249 |
| TRAV19 | -9248 |
| HLA-DRA | -9006 |
| HLA-DQA2 | -8774 |
| CD247 | -8741 |
| HLA-DPB1 | -8397 |
| TRBV7-9 | -8303 |
| CD3D | -8297 |
| HLA-DPA1 | -8217 |
| CD3G | -8111 |
| CD4 | -6881 |
| HLA-DQA1 | -6389 |
| TRAV8-4 | -4769 |
| HLA-DQB1 | -4459 |
| HLA-DRB1 | -334 |
| HLA-DRB5 | 748 |
| PAG1 | 6054 |
| PTPN22 | 6966 |
| PTPRC | 8021 |
| CSK | 9400 |
| PTPRJ | 10340 |
RHO GTPases activate CIT
| 888 | |
|---|---|
| set | RHO GTPases activate CIT |
| setSize | 18 |
| pANOVA | 0.000325 |
| s.dist | 0.489 |
| p.adjustANOVA | 0.00245 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RAC1 | 10624 |
| MYL6 | 10185 |
| DLG4 | 9813 |
| RHOA | 9401 |
| MYH9 | 9224 |
| MYH10 | 8632 |
| PPP1R12B | 8489 |
| RHOB | 7921 |
| PPP1R12A | 7801 |
| PPP1CB | 6745 |
| KIF14 | 5707 |
| MYL12B | 5703 |
| RHOC | 4639 |
| CIT | 3097 |
| PRC1 | 2399 |
| MYL9 | 1931 |
| MYH11 | -2243 |
| CDKN1B | -3127 |
| GeneID | Gene Rank |
|---|---|
| RAC1 | 10624 |
| MYL6 | 10185 |
| DLG4 | 9813 |
| RHOA | 9401 |
| MYH9 | 9224 |
| MYH10 | 8632 |
| PPP1R12B | 8489 |
| RHOB | 7921 |
| PPP1R12A | 7801 |
| PPP1CB | 6745 |
| KIF14 | 5707 |
| MYL12B | 5703 |
| RHOC | 4639 |
| CIT | 3097 |
| PRC1 | 2399 |
| MYL9 | 1931 |
| MYH11 | -2243 |
| CDKN1B | -3127 |
Generation of second messenger molecules
| 443 | |
|---|---|
| set | Generation of second messenger molecules |
| setSize | 38 |
| pANOVA | 2.64e-07 |
| s.dist | -0.482 |
| p.adjustANOVA | 4.67e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TRBV12-3 | -9971 |
| TRAC | -9703 |
| ITK | -9674 |
| HLA-DQB2 | -9656 |
| EVL | -9560 |
| LCK | -9556 |
| LAT | -9470 |
| PLCG1 | -9412 |
| TRBC1 | -9303 |
| TRAV29DV5 | -9278 |
| CD3E | -9249 |
| TRAV19 | -9248 |
| HLA-DRA | -9006 |
| NCK1 | -8975 |
| HLA-DQA2 | -8774 |
| ZAP70 | -8755 |
| CD247 | -8741 |
| HLA-DPB1 | -8397 |
| TRBV7-9 | -8303 |
| CD3D | -8297 |
| GeneID | Gene Rank |
|---|---|
| TRBV12-3 | -9971 |
| TRAC | -9703 |
| ITK | -9674 |
| HLA-DQB2 | -9656 |
| EVL | -9560 |
| LCK | -9556 |
| LAT | -9470 |
| PLCG1 | -9412 |
| TRBC1 | -9303 |
| TRAV29DV5 | -9278 |
| CD3E | -9249 |
| TRAV19 | -9248 |
| HLA-DRA | -9006 |
| NCK1 | -8975 |
| HLA-DQA2 | -8774 |
| ZAP70 | -8755 |
| CD247 | -8741 |
| HLA-DPB1 | -8397 |
| TRBV7-9 | -8303 |
| CD3D | -8297 |
| HLA-DPA1 | -8217 |
| CD3G | -8111 |
| CD4 | -6881 |
| HLA-DQA1 | -6389 |
| PAK3 | -5908 |
| TRAV8-4 | -4769 |
| HLA-DQB1 | -4459 |
| GRAP2 | -2088 |
| CD101 | -1089 |
| HLA-DRB1 | -334 |
| HLA-DRB5 | 748 |
| ENAH | 3578 |
| LCP2 | 3759 |
| PAK2 | 9042 |
| PAK1 | 10043 |
| PLCG2 | 10244 |
| VASP | 10286 |
| WAS | 10777 |
Pre-NOTCH Processing in Golgi
| 845 | |
|---|---|
| set | Pre-NOTCH Processing in Golgi |
| setSize | 18 |
| pANOVA | 0.000408 |
| s.dist | 0.481 |
| p.adjustANOVA | 0.00289 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NOTCH3 | 11420 |
| FURIN | 10905 |
| ATP2A2 | 10359 |
| NOTCH4 | 10293 |
| ST3GAL4 | 10218 |
| RAB6A | 9958 |
| NOTCH1 | 9499 |
| NOTCH2 | 8400 |
| SEL1L | 7883 |
| B4GALT1 | 7763 |
| TMED2 | 5345 |
| RFNG | 4095 |
| ATP2A1 | 3981 |
| ATP2A3 | 3651 |
| ST3GAL6 | 3223 |
| LFNG | 1213 |
| ST3GAL3 | -5250 |
| MFNG | -7604 |
| GeneID | Gene Rank |
|---|---|
| NOTCH3 | 11420 |
| FURIN | 10905 |
| ATP2A2 | 10359 |
| NOTCH4 | 10293 |
| ST3GAL4 | 10218 |
| RAB6A | 9958 |
| NOTCH1 | 9499 |
| NOTCH2 | 8400 |
| SEL1L | 7883 |
| B4GALT1 | 7763 |
| TMED2 | 5345 |
| RFNG | 4095 |
| ATP2A1 | 3981 |
| ATP2A3 | 3651 |
| ST3GAL6 | 3223 |
| LFNG | 1213 |
| ST3GAL3 | -5250 |
| MFNG | -7604 |
Heme degradation
| 493 | |
|---|---|
| set | Heme degradation |
| setSize | 10 |
| pANOVA | 0.00889 |
| s.dist | 0.478 |
| p.adjustANOVA | 0.032 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GUSB | 11175 |
| HMOX1 | 11030 |
| SLCO2B1 | 10681 |
| BLVRB | 9359 |
| ALB | 8630 |
| BLVRA | 7999 |
| ABCC1 | 5410 |
| ABCG2 | 1372 |
| ABCC2 | 1314 |
| HMOX2 | -8794 |
| GeneID | Gene Rank |
|---|---|
| GUSB | 11175 |
| HMOX1 | 11030 |
| SLCO2B1 | 10681 |
| BLVRB | 9359 |
| ALB | 8630 |
| BLVRA | 7999 |
| ABCC1 | 5410 |
| ABCG2 | 1372 |
| ABCC2 | 1314 |
| HMOX2 | -8794 |
BBSome-mediated cargo-targeting to cilium
| 98 | |
|---|---|
| set | BBSome-mediated cargo-targeting to cilium |
| setSize | 22 |
| pANOVA | 0.000114 |
| s.dist | -0.475 |
| p.adjustANOVA | 0.00102 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CCT2 | -10024 |
| LZTFL1 | -8558 |
| BBS9 | -8390 |
| BBS2 | -8123 |
| BBS5 | -7994 |
| MKKS | -7647 |
| BBS1 | -7348 |
| ARL6 | -7121 |
| CCT3 | -6877 |
| CCT4 | -6795 |
| BBIP1 | -5342 |
| SSTR3 | -5020 |
| TCP1 | -4240 |
| BBS4 | -3211 |
| CCT8 | -2751 |
| BBS10 | -2726 |
| BBS12 | -1657 |
| BBS7 | -934 |
| MCHR1 | -651 |
| RAB3IP | -569 |
| GeneID | Gene Rank |
|---|---|
| CCT2 | -10024 |
| LZTFL1 | -8558 |
| BBS9 | -8390 |
| BBS2 | -8123 |
| BBS5 | -7994 |
| MKKS | -7647 |
| BBS1 | -7348 |
| ARL6 | -7121 |
| CCT3 | -6877 |
| CCT4 | -6795 |
| BBIP1 | -5342 |
| SSTR3 | -5020 |
| TCP1 | -4240 |
| BBS4 | -3211 |
| CCT8 | -2751 |
| BBS10 | -2726 |
| BBS12 | -1657 |
| BBS7 | -934 |
| MCHR1 | -651 |
| RAB3IP | -569 |
| CCT5 | 3205 |
| TTC8 | 4167 |
Golgi Cisternae Pericentriolar Stack Reorganization
| 466 | |
|---|---|
| set | Golgi Cisternae Pericentriolar Stack Reorganization |
| setSize | 14 |
| pANOVA | 0.00208 |
| s.dist | 0.475 |
| p.adjustANOVA | 0.0103 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 11193 |
| RAB1B | 10055 |
| RAB1A | 9971 |
| MAPK3 | 9750 |
| GORASP1 | 9633 |
| RAB2A | 9581 |
| GOLGA2 | 9412 |
| CCNB2 | 7285 |
| PLK1 | 5400 |
| BLZF1 | 3737 |
| USO1 | 2424 |
| CCNB1 | 735 |
| CDK1 | -2593 |
| GORASP2 | -5545 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 11193 |
| RAB1B | 10055 |
| RAB1A | 9971 |
| MAPK3 | 9750 |
| GORASP1 | 9633 |
| RAB2A | 9581 |
| GOLGA2 | 9412 |
| CCNB2 | 7285 |
| PLK1 | 5400 |
| BLZF1 | 3737 |
| USO1 | 2424 |
| CCNB1 | 735 |
| CDK1 | -2593 |
| GORASP2 | -5545 |
Diseases associated with the TLR signaling cascade
| 287 | |
|---|---|
| set | Diseases associated with the TLR signaling cascade |
| setSize | 23 |
| pANOVA | 7.99e-05 |
| s.dist | 0.475 |
| p.adjustANOVA | 0.000755 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MYD88 | 11331 |
| TLR5 | 11191 |
| CD36 | 10947 |
| BTK | 10849 |
| TLR2 | 10535 |
| UNC93B1 | 10526 |
| TLR1 | 10059 |
| TLR4 | 9549 |
| CD14 | 9466 |
| IKBKG | 9441 |
| LY96 | 9322 |
| TLR6 | 9070 |
| TICAM1 | 8878 |
| TIRAP | 8858 |
| CHUK | 8723 |
| NFKBIA | 5457 |
| NFKB1 | 2860 |
| IKBKB | 1759 |
| RELA | -204 |
| NFKB2 | -3527 |
| GeneID | Gene Rank |
|---|---|
| MYD88 | 11331 |
| TLR5 | 11191 |
| CD36 | 10947 |
| BTK | 10849 |
| TLR2 | 10535 |
| UNC93B1 | 10526 |
| TLR1 | 10059 |
| TLR4 | 9549 |
| CD14 | 9466 |
| IKBKG | 9441 |
| LY96 | 9322 |
| TLR6 | 9070 |
| TICAM1 | 8878 |
| TIRAP | 8858 |
| CHUK | 8723 |
| NFKBIA | 5457 |
| NFKB1 | 2860 |
| IKBKB | 1759 |
| RELA | -204 |
| NFKB2 | -3527 |
| TLR10 | -7067 |
| TLR3 | -7411 |
| TRAF3 | -7539 |
Diseases of Immune System
| 289 | |
|---|---|
| set | Diseases of Immune System |
| setSize | 23 |
| pANOVA | 7.99e-05 |
| s.dist | 0.475 |
| p.adjustANOVA | 0.000755 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MYD88 | 11331 |
| TLR5 | 11191 |
| CD36 | 10947 |
| BTK | 10849 |
| TLR2 | 10535 |
| UNC93B1 | 10526 |
| TLR1 | 10059 |
| TLR4 | 9549 |
| CD14 | 9466 |
| IKBKG | 9441 |
| LY96 | 9322 |
| TLR6 | 9070 |
| TICAM1 | 8878 |
| TIRAP | 8858 |
| CHUK | 8723 |
| NFKBIA | 5457 |
| NFKB1 | 2860 |
| IKBKB | 1759 |
| RELA | -204 |
| NFKB2 | -3527 |
| GeneID | Gene Rank |
|---|---|
| MYD88 | 11331 |
| TLR5 | 11191 |
| CD36 | 10947 |
| BTK | 10849 |
| TLR2 | 10535 |
| UNC93B1 | 10526 |
| TLR1 | 10059 |
| TLR4 | 9549 |
| CD14 | 9466 |
| IKBKG | 9441 |
| LY96 | 9322 |
| TLR6 | 9070 |
| TICAM1 | 8878 |
| TIRAP | 8858 |
| CHUK | 8723 |
| NFKBIA | 5457 |
| NFKB1 | 2860 |
| IKBKB | 1759 |
| RELA | -204 |
| NFKB2 | -3527 |
| TLR10 | -7067 |
| TLR3 | -7411 |
| TRAF3 | -7539 |
RHO GTPases activate IQGAPs
| 889 | |
|---|---|
| set | RHO GTPases activate IQGAPs |
| setSize | 11 |
| pANOVA | 0.0068 |
| s.dist | 0.471 |
| p.adjustANOVA | 0.0258 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CTNNA1 | 11326 |
| CLIP1 | 10646 |
| RAC1 | 10624 |
| IQGAP1 | 10037 |
| CTNNB1 | 9670 |
| IQGAP2 | 8437 |
| CDC42 | 8342 |
| IQGAP3 | 1051 |
| CDH1 | -307 |
| CALM1 | -1245 |
| MEN1 | -5364 |
| GeneID | Gene Rank |
|---|---|
| CTNNA1 | 11326 |
| CLIP1 | 10646 |
| RAC1 | 10624 |
| IQGAP1 | 10037 |
| CTNNB1 | 9670 |
| IQGAP2 | 8437 |
| CDC42 | 8342 |
| IQGAP3 | 1051 |
| CDH1 | -307 |
| CALM1 | -1245 |
| MEN1 | -5364 |
EPHB-mediated forward signaling
| 323 | |
|---|---|
| set | EPHB-mediated forward signaling |
| setSize | 32 |
| pANOVA | 4.14e-06 |
| s.dist | 0.47 |
| p.adjustANOVA | 5.69e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARPC1A | 10981 |
| LYN | 10810 |
| ARPC1B | 10781 |
| ITSN1 | 10737 |
| RAC1 | 10624 |
| ACTB | 10606 |
| ARPC5 | 10102 |
| PAK1 | 10043 |
| CFL1 | 9794 |
| LIMK2 | 9689 |
| ACTG1 | 9678 |
| ARPC4 | 9592 |
| RHOA | 9401 |
| ARPC2 | 9016 |
| ACTR2 | 8895 |
| ACTR3 | 8873 |
| ARPC3 | 8726 |
| ROCK1 | 8695 |
| CDC42 | 8342 |
| LIMK1 | 8062 |
| GeneID | Gene Rank |
|---|---|
| ARPC1A | 10981 |
| LYN | 10810 |
| ARPC1B | 10781 |
| ITSN1 | 10737 |
| RAC1 | 10624 |
| ACTB | 10606 |
| ARPC5 | 10102 |
| PAK1 | 10043 |
| CFL1 | 9794 |
| LIMK2 | 9689 |
| ACTG1 | 9678 |
| ARPC4 | 9592 |
| RHOA | 9401 |
| ARPC2 | 9016 |
| ACTR2 | 8895 |
| ACTR3 | 8873 |
| ARPC3 | 8726 |
| ROCK1 | 8695 |
| CDC42 | 8342 |
| LIMK1 | 8062 |
| ROCK2 | 6611 |
| RASA1 | 6250 |
| WASL | 3297 |
| ARHGEF28 | 2384 |
| SDC2 | 2325 |
| PTK2 | 388 |
| YES1 | -2846 |
| TIAM1 | -3517 |
| FYN | -5211 |
| HRAS | -5273 |
| SRC | -6396 |
| KALRN | -8077 |
RHO GTPases Activate NADPH Oxidases
| 885 | |
|---|---|
| set | RHO GTPases Activate NADPH Oxidases |
| setSize | 21 |
| pANOVA | 0.000204 |
| s.dist | 0.468 |
| p.adjustANOVA | 0.00168 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 11193 |
| S100A8 | 11184 |
| PRKCD | 11168 |
| MAPK14 | 11115 |
| NCF4 | 10813 |
| NCF2 | 10793 |
| RAC1 | 10624 |
| S100A9 | 10613 |
| CYBA | 10173 |
| MAPK3 | 9750 |
| CYBB | 9660 |
| PRKCB | 8577 |
| RAC2 | 8237 |
| NCF1 | 7245 |
| PIN1 | 577 |
| PIK3C3 | -1718 |
| PIK3R4 | -2097 |
| PRKCA | -2408 |
| MAPK11 | -4641 |
| NOXA1 | -4914 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 11193 |
| S100A8 | 11184 |
| PRKCD | 11168 |
| MAPK14 | 11115 |
| NCF4 | 10813 |
| NCF2 | 10793 |
| RAC1 | 10624 |
| S100A9 | 10613 |
| CYBA | 10173 |
| MAPK3 | 9750 |
| CYBB | 9660 |
| PRKCB | 8577 |
| RAC2 | 8237 |
| NCF1 | 7245 |
| PIN1 | 577 |
| PIK3C3 | -1718 |
| PIK3R4 | -2097 |
| PRKCA | -2408 |
| MAPK11 | -4641 |
| NOXA1 | -4914 |
| PRKCZ | -6016 |
Telomere C-strand synthesis initiation
| 1218 | |
|---|---|
| set | Telomere C-strand synthesis initiation |
| setSize | 13 |
| pANOVA | 0.0035 |
| s.dist | -0.468 |
| p.adjustANOVA | 0.0151 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| STN1 | -9859 |
| POLA1 | -9841 |
| PRIM1 | -9166 |
| CTC1 | -8852 |
| POLA2 | -7950 |
| PRIM2 | -7112 |
| ACD | -5673 |
| POT1 | -4708 |
| TERF2 | -4421 |
| TERF1 | -2831 |
| TEN1 | 624 |
| TERF2IP | 4065 |
| TINF2 | 8502 |
| GeneID | Gene Rank |
|---|---|
| STN1 | -9859 |
| POLA1 | -9841 |
| PRIM1 | -9166 |
| CTC1 | -8852 |
| POLA2 | -7950 |
| PRIM2 | -7112 |
| ACD | -5673 |
| POT1 | -4708 |
| TERF2 | -4421 |
| TERF1 | -2831 |
| TEN1 | 624 |
| TERF2IP | 4065 |
| TINF2 | 8502 |
Sema4D in semaphorin signaling
| 1060 | |
|---|---|
| set | Sema4D in semaphorin signaling |
| setSize | 22 |
| pANOVA | 0.000152 |
| s.dist | 0.466 |
| p.adjustANOVA | 0.00132 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARHGEF11 | 11412 |
| RRAS | 10835 |
| RAC1 | 10624 |
| MYL6 | 10185 |
| LIMK2 | 9689 |
| RHOA | 9401 |
| MYH9 | 9224 |
| ROCK1 | 8695 |
| MYH10 | 8632 |
| LIMK1 | 8062 |
| RHOB | 7921 |
| ROCK2 | 6611 |
| MYL12B | 5703 |
| PLXNB1 | 5405 |
| RHOC | 4639 |
| ARHGEF12 | 4165 |
| RND1 | 3716 |
| MYL9 | 1931 |
| SEMA4D | -1019 |
| ARHGAP35 | -2201 |
| GeneID | Gene Rank |
|---|---|
| ARHGEF11 | 11412 |
| RRAS | 10835 |
| RAC1 | 10624 |
| MYL6 | 10185 |
| LIMK2 | 9689 |
| RHOA | 9401 |
| MYH9 | 9224 |
| ROCK1 | 8695 |
| MYH10 | 8632 |
| LIMK1 | 8062 |
| RHOB | 7921 |
| ROCK2 | 6611 |
| MYL12B | 5703 |
| PLXNB1 | 5405 |
| RHOC | 4639 |
| ARHGEF12 | 4165 |
| RND1 | 3716 |
| MYL9 | 1931 |
| SEMA4D | -1019 |
| ARHGAP35 | -2201 |
| MYH11 | -2243 |
| ERBB2 | -6142 |
COPI-independent Golgi-to-ER retrograde traffic
| 131 | |
|---|---|
| set | COPI-independent Golgi-to-ER retrograde traffic |
| setSize | 33 |
| pANOVA | 5.41e-06 |
| s.dist | 0.457 |
| p.adjustANOVA | 7.29e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GALNT2 | 10885 |
| DCTN4 | 10682 |
| DCTN2 | 10412 |
| ACTR1A | 10310 |
| RAB6A | 9958 |
| PLA2G4A | 9803 |
| BICD2 | 9707 |
| CAPZB | 9575 |
| DCTN1 | 9558 |
| CAPZA1 | 9530 |
| DYNC1LI1 | 8276 |
| CAPZA2 | 8225 |
| AGPAT3 | 7932 |
| PAFAH1B1 | 7857 |
| DYNC1LI2 | 7644 |
| DCTN6 | 7540 |
| RAB18 | 7038 |
| DYNC1I2 | 6705 |
| DCTN3 | 6625 |
| RAB3GAP2 | 6599 |
| GeneID | Gene Rank |
|---|---|
| GALNT2 | 10885 |
| DCTN4 | 10682 |
| DCTN2 | 10412 |
| ACTR1A | 10310 |
| RAB6A | 9958 |
| PLA2G4A | 9803 |
| BICD2 | 9707 |
| CAPZB | 9575 |
| DCTN1 | 9558 |
| CAPZA1 | 9530 |
| DYNC1LI1 | 8276 |
| CAPZA2 | 8225 |
| AGPAT3 | 7932 |
| PAFAH1B1 | 7857 |
| DYNC1LI2 | 7644 |
| DCTN6 | 7540 |
| RAB18 | 7038 |
| DYNC1I2 | 6705 |
| DCTN3 | 6625 |
| RAB3GAP2 | 6599 |
| GALNT1 | 6495 |
| PAFAH1B2 | 5996 |
| ACTR10 | 5886 |
| RAB3GAP1 | 5167 |
| DYNC1I1 | 2879 |
| DYNC1H1 | 1705 |
| DYNLL1 | 1530 |
| DCTN5 | 297 |
| RAB6B | -1849 |
| BICD1 | -2303 |
| PAFAH1B3 | -4044 |
| DYNLL2 | -4904 |
| PLA2G6 | -7168 |
Cargo concentration in the ER
| 145 | |
|---|---|
| set | Cargo concentration in the ER |
| setSize | 30 |
| pANOVA | 1.48e-05 |
| s.dist | 0.457 |
| p.adjustANOVA | 0.000179 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| F5 | 11434 |
| SERPINA1 | 11407 |
| TGFA | 10983 |
| SEC24D | 10803 |
| PREB | 10364 |
| CTSZ | 9943 |
| LMAN2 | 9480 |
| SEC24A | 9414 |
| CTSC | 9276 |
| SEC24C | 8993 |
| STX5 | 8547 |
| MIA2 | 8200 |
| F8 | 8026 |
| COL7A1 | 7971 |
| SEC24B | 7352 |
| SEC23A | 7129 |
| SAR1B | 6893 |
| SEC22B | 6272 |
| GOSR2 | 5986 |
| TMED2 | 5345 |
| GeneID | Gene Rank |
|---|---|
| F5 | 11434 |
| SERPINA1 | 11407 |
| TGFA | 10983 |
| SEC24D | 10803 |
| PREB | 10364 |
| CTSZ | 9943 |
| LMAN2 | 9480 |
| SEC24A | 9414 |
| CTSC | 9276 |
| SEC24C | 8993 |
| STX5 | 8547 |
| MIA2 | 8200 |
| F8 | 8026 |
| COL7A1 | 7971 |
| SEC24B | 7352 |
| SEC23A | 7129 |
| SAR1B | 6893 |
| SEC22B | 6272 |
| GOSR2 | 5986 |
| TMED2 | 5345 |
| MCFD2 | 5134 |
| CD59 | 4252 |
| CNIH2 | 4186 |
| AREG | 2386 |
| LMAN2L | 1586 |
| CNIH1 | -2698 |
| MIA3 | -3686 |
| TMED10 | -4413 |
| CNIH3 | -4435 |
| LMAN1 | -8522 |
Sema4D induced cell migration and growth-cone collapse
| 1061 | |
|---|---|
| set | Sema4D induced cell migration and growth-cone collapse |
| setSize | 19 |
| pANOVA | 0.000582 |
| s.dist | 0.456 |
| p.adjustANOVA | 0.00379 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ARHGEF11 | 11412 |
| MYL6 | 10185 |
| LIMK2 | 9689 |
| RHOA | 9401 |
| MYH9 | 9224 |
| ROCK1 | 8695 |
| MYH10 | 8632 |
| LIMK1 | 8062 |
| RHOB | 7921 |
| ROCK2 | 6611 |
| MYL12B | 5703 |
| PLXNB1 | 5405 |
| RHOC | 4639 |
| ARHGEF12 | 4165 |
| RND1 | 3716 |
| MYL9 | 1931 |
| SEMA4D | -1019 |
| MYH11 | -2243 |
| ERBB2 | -6142 |
| GeneID | Gene Rank |
|---|---|
| ARHGEF11 | 11412 |
| MYL6 | 10185 |
| LIMK2 | 9689 |
| RHOA | 9401 |
| MYH9 | 9224 |
| ROCK1 | 8695 |
| MYH10 | 8632 |
| LIMK1 | 8062 |
| RHOB | 7921 |
| ROCK2 | 6611 |
| MYL12B | 5703 |
| PLXNB1 | 5405 |
| RHOC | 4639 |
| ARHGEF12 | 4165 |
| RND1 | 3716 |
| MYL9 | 1931 |
| SEMA4D | -1019 |
| MYH11 | -2243 |
| ERBB2 | -6142 |
Leading Strand Synthesis
| 594 | |
|---|---|
| set | Leading Strand Synthesis |
| setSize | 14 |
| pANOVA | 0.00329 |
| s.dist | -0.454 |
| p.adjustANOVA | 0.0145 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| POLA1 | -9841 |
| RFC3 | -9405 |
| PRIM1 | -9166 |
| RFC4 | -8897 |
| POLA2 | -7950 |
| RFC5 | -7574 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| RFC1 | -5080 |
| POLD1 | -2573 |
| RFC2 | 5478 |
| POLD4 | 9079 |
| POLD3 | 10698 |
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| POLA1 | -9841 |
| RFC3 | -9405 |
| PRIM1 | -9166 |
| RFC4 | -8897 |
| POLA2 | -7950 |
| RFC5 | -7574 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| RFC1 | -5080 |
| POLD1 | -2573 |
| RFC2 | 5478 |
| POLD4 | 9079 |
| POLD3 | 10698 |
Polymerase switching
| 833 | |
|---|---|
| set | Polymerase switching |
| setSize | 14 |
| pANOVA | 0.00329 |
| s.dist | -0.454 |
| p.adjustANOVA | 0.0145 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| POLA1 | -9841 |
| RFC3 | -9405 |
| PRIM1 | -9166 |
| RFC4 | -8897 |
| POLA2 | -7950 |
| RFC5 | -7574 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| RFC1 | -5080 |
| POLD1 | -2573 |
| RFC2 | 5478 |
| POLD4 | 9079 |
| POLD3 | 10698 |
| GeneID | Gene Rank |
|---|---|
| POLD2 | -10054 |
| POLA1 | -9841 |
| RFC3 | -9405 |
| PRIM1 | -9166 |
| RFC4 | -8897 |
| POLA2 | -7950 |
| RFC5 | -7574 |
| PRIM2 | -7112 |
| PCNA | -7101 |
| RFC1 | -5080 |
| POLD1 | -2573 |
| RFC2 | 5478 |
| POLD4 | 9079 |
| POLD3 | 10698 |
Signaling by Erythropoietin
| 1083 | |
|---|---|
| set | Signaling by Erythropoietin |
| setSize | 24 |
| pANOVA | 0.000126 |
| s.dist | 0.452 |
| p.adjustANOVA | 0.00113 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| LYN | 10810 |
| GRB2 | 10733 |
| EPOR | 10409 |
| PLCG2 | 10244 |
| VAV1 | 10226 |
| SHC1 | 9541 |
| IRS2 | 9427 |
| PIK3CG | 9128 |
| PIK3CB | 9126 |
| PIK3CD | 8956 |
| STAT5B | 8742 |
| GAB1 | 8670 |
| STAT5A | 7833 |
| PIK3R5 | 7579 |
| KRAS | 6132 |
| CRKL | 5250 |
| RAPGEF1 | 5102 |
| NRAS | 4907 |
| JAK2 | 4428 |
| PIK3CA | 2133 |
| GeneID | Gene Rank |
|---|---|
| LYN | 10810 |
| GRB2 | 10733 |
| EPOR | 10409 |
| PLCG2 | 10244 |
| VAV1 | 10226 |
| SHC1 | 9541 |
| IRS2 | 9427 |
| PIK3CG | 9128 |
| PIK3CB | 9126 |
| PIK3CD | 8956 |
| STAT5B | 8742 |
| GAB1 | 8670 |
| STAT5A | 7833 |
| PIK3R5 | 7579 |
| KRAS | 6132 |
| CRKL | 5250 |
| RAPGEF1 | 5102 |
| NRAS | 4907 |
| JAK2 | 4428 |
| PIK3CA | 2133 |
| SOS1 | -2983 |
| HRAS | -5273 |
| PIK3R1 | -8831 |
| PLCG1 | -9412 |
GPVI-mediated activation cascade
| 429 | |
|---|---|
| set | GPVI-mediated activation cascade |
| setSize | 31 |
| pANOVA | 1.49e-05 |
| s.dist | 0.449 |
| p.adjustANOVA | 0.000179 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| FCER1G | 11216 |
| LYN | 10810 |
| RHOG | 10635 |
| RAC1 | 10624 |
| PTPN6 | 10446 |
| SYK | 10256 |
| PLCG2 | 10244 |
| VAV1 | 10226 |
| PIK3R6 | 10025 |
| RHOA | 9401 |
| PIK3CG | 9128 |
| PIK3CB | 9126 |
| PDPK1 | 8710 |
| VAV3 | 8413 |
| CLEC1B | 8373 |
| CDC42 | 8342 |
| RAC2 | 8237 |
| RHOB | 7921 |
| PIK3R5 | 7579 |
| PTPN11 | 6524 |
| GeneID | Gene Rank |
|---|---|
| FCER1G | 11216 |
| LYN | 10810 |
| RHOG | 10635 |
| RAC1 | 10624 |
| PTPN6 | 10446 |
| SYK | 10256 |
| PLCG2 | 10244 |
| VAV1 | 10226 |
| PIK3R6 | 10025 |
| RHOA | 9401 |
| PIK3CG | 9128 |
| PIK3CB | 9126 |
| PDPK1 | 8710 |
| VAV3 | 8413 |
| CLEC1B | 8373 |
| CDC42 | 8342 |
| RAC2 | 8237 |
| RHOB | 7921 |
| PIK3R5 | 7579 |
| PTPN11 | 6524 |
| PIK3R2 | 6511 |
| GP6 | 5660 |
| LCP2 | 3759 |
| VAV2 | 2755 |
| PIK3R3 | 2676 |
| PIK3CA | 2133 |
| FYN | -5211 |
| PRKCZ | -6016 |
| PIK3R1 | -8831 |
| LAT | -9470 |
| LCK | -9556 |
Neutrophil degranulation
| 734 | |
|---|---|
| set | Neutrophil degranulation |
| setSize | 458 |
| pANOVA | 3.16e-61 |
| s.dist | 0.449 |
| p.adjustANOVA | 4.3e-58 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC11A1 | 11464 |
| NCSTN | 11452 |
| DOK3 | 11443 |
| P2RX1 | 11442 |
| LILRB2 | 11437 |
| HK3 | 11430 |
| OSCAR | 11425 |
| IDH1 | 11418 |
| SIRPA | 11414 |
| GNS | 11410 |
| SERPINA1 | 11407 |
| CR1 | 11401 |
| DNASE1L1 | 11385 |
| SIGLEC9 | 11381 |
| QSOX1 | 11369 |
| CD63 | 11355 |
| MCEMP1 | 11349 |
| FGR | 11323 |
| HP | 11312 |
| NCKAP1L | 11304 |
| GeneID | Gene Rank |
|---|---|
| SLC11A1 | 11464 |
| NCSTN | 11452 |
| DOK3 | 11443 |
| P2RX1 | 11442 |
| LILRB2 | 11437 |
| HK3 | 11430 |
| OSCAR | 11425 |
| IDH1 | 11418 |
| SIRPA | 11414 |
| GNS | 11410 |
| SERPINA1 | 11407 |
| CR1 | 11401 |
| DNASE1L1 | 11385 |
| SIGLEC9 | 11381 |
| QSOX1 | 11369 |
| CD63 | 11355 |
| MCEMP1 | 11349 |
| FGR | 11323 |
| HP | 11312 |
| NCKAP1L | 11304 |
| IMPDH1 | 11303 |
| CTSD | 11297 |
| C3AR1 | 11294 |
| ATP6V0A1 | 11283 |
| LAIR1 | 11276 |
| ITGAM | 11269 |
| UNC13D | 11266 |
| CTSB | 11250 |
| ITGAX | 11231 |
| ANPEP | 11227 |
| FPR1 | 11221 |
| FCER1G | 11216 |
| TIMP2 | 11214 |
| S100A12 | 11206 |
| MAPK1 | 11193 |
| RNASE2 | 11192 |
| S100A8 | 11184 |
| ALOX5 | 11178 |
| GUSB | 11175 |
| PRKCD | 11168 |
| TCIRG1 | 11138 |
| TRPM2 | 11134 |
| PGAM1 | 11128 |
| PLAC8 | 11120 |
| MAPK14 | 11115 |
| PLD1 | 11091 |
| NEU1 | 11082 |
| SERPINB1 | 11081 |
| ACAA1 | 11076 |
| CD177 | 11068 |
| ALDH3B1 | 11063 |
| C5AR1 | 11061 |
| MMP25 | 11057 |
| AGPAT2 | 11054 |
| PLEKHO2 | 11053 |
| ADGRG3 | 11019 |
| VNN1 | 11000 |
| GCA | 10999 |
| ATP6V0C | 10995 |
| VAT1 | 10971 |
| BRI3 | 10962 |
| RAB10 | 10956 |
| PYGL | 10952 |
| MGAM | 10950 |
| CD36 | 10947 |
| CD93 | 10937 |
| MOSPD2 | 10933 |
| CEACAM3 | 10932 |
| MMP9 | 10920 |
| CD55 | 10914 |
| S100A11 | 10910 |
| NFAM1 | 10890 |
| FPR2 | 10883 |
| GYG1 | 10873 |
| ALDOA | 10868 |
| ITGB2 | 10861 |
| CDA | 10859 |
| GM2A | 10846 |
| CTSA | 10842 |
| GRN | 10837 |
| CKAP4 | 10819 |
| CRISPLD2 | 10814 |
| ASAH1 | 10796 |
| ATP11A | 10791 |
| LRG1 | 10785 |
| CYB5R3 | 10775 |
| TSPAN14 | 10759 |
| NBEAL2 | 10743 |
| RETN | 10732 |
| SLC2A3 | 10714 |
| ANXA2 | 10704 |
| QPCT | 10700 |
| SLC15A4 | 10684 |
| RAB3D | 10677 |
| RAB31 | 10661 |
| BST1 | 10647 |
| RHOG | 10635 |
| GPR84 | 10632 |
| RAC1 | 10624 |
| S100A9 | 10613 |
| CYSTM1 | 10605 |
| GLA | 10595 |
| TOM1 | 10594 |
| CAPN1 | 10570 |
| GSN | 10558 |
| TNFAIP6 | 10555 |
| CD68 | 10546 |
| LTA4H | 10541 |
| PYCARD | 10540 |
| TLR2 | 10535 |
| PKM | 10523 |
| IGF2R | 10494 |
| PLAUR | 10490 |
| FCGR2A | 10470 |
| ALAD | 10449 |
| PTPN6 | 10446 |
| LILRB3 | 10433 |
| PSEN1 | 10429 |
| CYFIP1 | 10420 |
| PECAM1 | 10414 |
| CLEC4D | 10398 |
| PGM2 | 10380 |
| DNAJC5 | 10371 |
| CD300A | 10362 |
| PTPRJ | 10340 |
| COTL1 | 10333 |
| CD53 | 10308 |
| ACLY | 10268 |
| PADI2 | 10252 |
| AP2A2 | 10223 |
| FCAR | 10219 |
| GLB1 | 10217 |
| TMBIM1 | 10197 |
| PTAFR | 10188 |
| AMPD3 | 10183 |
| CYBA | 10173 |
| DOCK2 | 10155 |
| NAPRT | 10133 |
| RAB7A | 10115 |
| CAT | 10103 |
| ARPC5 | 10102 |
| FTL | 10101 |
| TNFRSF1B | 10079 |
| ARG1 | 10061 |
| ARL8A | 10056 |
| ARSB | 10041 |
| IQGAP1 | 10037 |
| ADAM10 | 9992 |
| CPPED1 | 9991 |
| ATP6V1D | 9982 |
| SELL | 9974 |
| RAB6A | 9958 |
| SDCBP | 9947 |
| CTSZ | 9943 |
| CAP1 | 9934 |
| DNAJC13 | 9921 |
| S100P | 9918 |
| RAB5C | 9864 |
| MGST1 | 9847 |
| DNAJC3 | 9831 |
| DBNL | 9815 |
| BIN2 | 9720 |
| LAMP1 | 9712 |
| ARHGAP9 | 9702 |
| CD58 | 9688 |
| TOLLIP | 9682 |
| HSPA6 | 9675 |
| CYBB | 9660 |
| TYROBP | 9637 |
| VAPA | 9635 |
| RAB24 | 9634 |
| RAB27A | 9628 |
| AP1M1 | 9595 |
| CSTB | 9479 |
| CD14 | 9466 |
| GMFG | 9443 |
| RHOA | 9401 |
| CAB39 | 9379 |
| DERA | 9344 |
| HSPA1A | 9341 |
| CXCR1 | 9335 |
| VPS35L | 9320 |
| CTSC | 9276 |
| LAMTOR1 | 9265 |
| CANT1 | 9259 |
| CD44 | 9255 |
| SIGLEC5 | 9235 |
| LGALS3 | 9180 |
| SNAP29 | 9157 |
| CNN2 | 9140 |
| TRAPPC1 | 9087 |
| CEACAM1 | 9052 |
| GALNS | 9046 |
| LAMP2 | 9034 |
| PDAP1 | 9011 |
| IST1 | 8994 |
| STK10 | 8992 |
| CMTM6 | 8960 |
| ADAM8 | 8938 |
| ADGRE5 | 8937 |
| ACTR2 | 8895 |
| PSAP | 8894 |
| MNDA | 8892 |
| CFP | 8875 |
| STK11IP | 8872 |
| HPSE | 8832 |
| APAF1 | 8822 |
| HSPA1B | 8806 |
| MMP8 | 8706 |
| ROCK1 | 8695 |
| CREG1 | 8692 |
| GAA | 8625 |
| MVP | 8603 |
| HEBP2 | 8559 |
| ATP11B | 8523 |
| PRCP | 8518 |
| CLEC5A | 8487 |
| SLCO4C1 | 8486 |
| DDOST | 8464 |
| PSMB7 | 8460 |
| ARSA | 8456 |
| RAB4B | 8449 |
| TUBB4B | 8440 |
| IQGAP2 | 8437 |
| KCMF1 | 8403 |
| OSTF1 | 8338 |
| SURF4 | 8306 |
| DYNC1LI1 | 8276 |
| PDXK | 8267 |
| RAB5B | 8258 |
| PSMD1 | 8184 |
| PSMD2 | 8139 |
| PNP | 8043 |
| PTPRC | 8021 |
| LAMTOR2 | 8006 |
| COPB1 | 7997 |
| STOM | 7990 |
| RNASET2 | 7961 |
| FCN1 | 7954 |
| FABP5 | 7903 |
| ITGAV | 7847 |
| VCP | 7804 |
| PSMD11 | 7775 |
| B4GALT1 | 7763 |
| LPCAT1 | 7696 |
| HEXB | 7695 |
| MANBA | 7689 |
| OLFM4 | 7638 |
| RAP2C | 7598 |
| FAF2 | 7588 |
| SNAP23 | 7530 |
| RAP1A | 7335 |
| PSMD6 | 7307 |
| YPEL5 | 7288 |
| PGM1 | 7238 |
| GGH | 7233 |
| COMMD9 | 7156 |
| SIRPB1 | 7136 |
| DIAPH1 | 7128 |
| GPI | 7117 |
| CXCL1 | 7072 |
| RAB18 | 7038 |
| TMEM30A | 7030 |
| RAP1B | 6962 |
| GDI2 | 6949 |
| CD33 | 6932 |
| DYNLT1 | 6926 |
| FTH1 | 6883 |
| C6orf120 | 6840 |
| PSMD12 | 6820 |
| CXCR2 | 6720 |
| METTL7A | 6718 |
| HBB | 6697 |
| UBR4 | 6594 |
| CTSS | 6504 |
| FUCA1 | 6469 |
| KCNAB2 | 6369 |
| PIGR | 6337 |
| RAB3A | 6284 |
| VCL | 6193 |
| LRMP | 6184 |
| ATG7 | 6082 |
| FUCA2 | 6028 |
| PAFAH1B2 | 5996 |
| NDUFC2 | 5943 |
| ACTR10 | 5886 |
| CSNK2B | 5876 |
| MAN2B1 | 5768 |
| STBD1 | 5663 |
| SIGLEC14 | 5662 |
| SERPINB10 | 5629 |
| KPNB1 | 5604 |
| RAB14 | 5469 |
| LAMTOR3 | 5383 |
| SERPINB6 | 5280 |
| ATP8B4 | 5252 |
| SLC44A2 | 5180 |
| DGAT1 | 5173 |
| PRDX6 | 5085 |
| SRP14 | 5022 |
| NHLRC3 | 5010 |
| CTSH | 4985 |
| APEH | 4945 |
| ATP6AP2 | 4915 |
| PGLYRP1 | 4910 |
| NRAS | 4907 |
| PTPRN2 | 4854 |
| ERP44 | 4818 |
| GLIPR1 | 4675 |
| ARMC8 | 4598 |
| PSMC2 | 4543 |
| NFASC | 4356 |
| MAGT1 | 4339 |
| PSMD3 | 4297 |
| TICAM2 | 4262 |
| CD59 | 4252 |
| TARM1 | 3952 |
| RAP2B | 3915 |
| PLAU | 3907 |
| PSMD13 | 3766 |
| ITGAL | 3647 |
| ANO6 | 3404 |
| NPC2 | 3326 |
| DEGS1 | 3135 |
| CPNE3 | 2985 |
| HLA-C | 2969 |
| NFKB1 | 2860 |
| FOLR3 | 2736 |
| FRK | 2672 |
| AOC1 | 2506 |
| CLEC12A | 2330 |
| LCN2 | 2300 |
| CLEC4C | 2219 |
| CDK13 | 2118 |
| PSMD7 | 2084 |
| ORM1 | 2075 |
| GHDC | 1853 |
| XRCC5 | 1832 |
| CST3 | 1747 |
| DYNC1H1 | 1705 |
| DDX3X | 1692 |
| PTX3 | 1567 |
| DYNLL1 | 1530 |
| CRISP3 | 1416 |
| FCGR3B | 1391 |
| ADGRE3 | 1240 |
| HUWE1 | 1218 |
| CRACR2A | 1215 |
| PSMD14 | 941 |
| PSMC3 | 916 |
| SYNGR1 | 852 |
| MLEC | 796 |
| MME | 695 |
| ORM2 | 565 |
| CFD | 461 |
| GSDMD | 370 |
| AGL | 316 |
| STING1 | 94 |
| GOLGA7 | 14 |
| PGRMC1 | -59 |
| HLA-B | -98 |
| VAMP8 | -139 |
| HVCN1 | -250 |
| ENPP4 | -308 |
| LRRC7 | -340 |
| RNASE3 | -371 |
| PYGB | -418 |
| FRMPD3 | -550 |
| DSP | -573 |
| HGSNAT | -737 |
| GSTP1 | -759 |
| BST2 | -782 |
| NME2 | -791 |
| PRDX4 | -834 |
| RAB37 | -1057 |
| LYZ | -1067 |
| A1BG | -1468 |
| CPNE1 | -1632 |
| TMEM179B | -1671 |
| TUBB | -1675 |
| TCN1 | -1708 |
| CHIT1 | -1890 |
| PPBP | -1960 |
| TXNDC5 | -2141 |
| COMMD3 | -2657 |
| JUP | -2668 |
| HLA-H | -2741 |
| CCT8 | -2751 |
| PSMA2 | -2823 |
| SVIP | -3052 |
| SLPI | -3392 |
| C3 | -3394 |
| RAB44 | -3423 |
| PFKL | -3512 |
| PSMB1 | -3610 |
| HSP90AA1 | -4016 |
| RAB9B | -4177 |
| PTPRB | -4321 |
| ILF2 | -4378 |
| LTF | -4464 |
| EPX | -4781 |
| HRNR | -5086 |
| PA2G4 | -5255 |
| KRT1 | -5265 |
| DSN1 | -5307 |
| BPI | -5410 |
| PTGES2 | -5466 |
| ALDOC | -5613 |
| CHI3L1 | -5761 |
| ACTR1B | -5952 |
| HLA-A | -5985 |
| DPP7 | -6012 |
| FGL2 | -6015 |
| ORMDL3 | -6182 |
| SLC27A2 | -6278 |
| EEF2 | -6279 |
| PPIE | -6341 |
| SLC2A5 | -6479 |
| PPIA | -6498 |
| TMC6 | -6551 |
| HMGB1 | -6699 |
| ABCA13 | -6934 |
| B2M | -6943 |
| MS4A3 | -7001 |
| CAND1 | -7058 |
| MIF | -7102 |
| SCAMP1 | -7313 |
| PSMA5 | -7476 |
| CEACAM8 | -7546 |
| APRT | -7580 |
| TBC1D10C | -7608 |
| OLR1 | -7621 |
| AGA | -7674 |
| DEFA1 | -7680 |
| DEFA4 | -7723 |
| TMEM63A | -7978 |
| XRCC6 | -8146 |
| CEP290 | -8156 |
| MPO | -8263 |
| CEACAM6 | -8277 |
| ATAD3B | -8354 |
| ELANE | -8371 |
| CAMP | -8417 |
| RHOF | -8679 |
| HMOX2 | -8794 |
| HSPA8 | -9129 |
| NIT2 | -9152 |
| CD47 | -9164 |
| HSP90AB1 | -9172 |
| ATP8A1 | -9218 |
| PRTN3 | -9350 |
| AZU1 | -9380 |
| SPTAN1 | -9461 |
| CTSG | -9503 |
| DSC1 | -9630 |
| EEF1A1 | -9751 |
| CCT2 | -10024 |
| IMPDH2 | -10126 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism
| 981 | |
|---|---|
| set | Regulation of glycolysis by fructose 2,6-bisphosphate metabolism |
| setSize | 11 |
| pANOVA | 0.0102 |
| s.dist | 0.447 |
| p.adjustANOVA | 0.0363 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PFKFB4 | 11413 |
| PRKACA | 11363 |
| PFKFB3 | 11033 |
| PFKFB2 | 10694 |
| PPP2CB | 7451 |
| PPP2CA | 6806 |
| PPP2R5D | 6601 |
| PPP2R1A | 5189 |
| PPP2R1B | 89 |
| PFKFB1 | -427 |
| PRKACB | -9863 |
| GeneID | Gene Rank |
|---|---|
| PFKFB4 | 11413 |
| PRKACA | 11363 |
| PFKFB3 | 11033 |
| PFKFB2 | 10694 |
| PPP2CB | 7451 |
| PPP2CA | 6806 |
| PPP2R5D | 6601 |
| PPP2R1A | 5189 |
| PPP2R1B | 89 |
| PFKFB1 | -427 |
| PRKACB | -9863 |
RHO GTPases activate PAKs
| 891 | |
|---|---|
| set | RHO GTPases activate PAKs |
| setSize | 20 |
| pANOVA | 0.000538 |
| s.dist | 0.447 |
| p.adjustANOVA | 0.00359 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RAC1 | 10624 |
| MYL6 | 10185 |
| PAK1 | 10043 |
| MYH9 | 9224 |
| PAK2 | 9042 |
| MYH10 | 8632 |
| PPP1R12B | 8489 |
| CDC42 | 8342 |
| FLNA | 8318 |
| LIMK1 | 8062 |
| PPP1R12A | 7801 |
| PPP1CB | 6745 |
| MYL12B | 5703 |
| NF2 | 4139 |
| MYL9 | 1931 |
| MYLK | 1267 |
| CTTN | 514 |
| CALM1 | -1245 |
| MYH11 | -2243 |
| PAK3 | -5908 |
| GeneID | Gene Rank |
|---|---|
| RAC1 | 10624 |
| MYL6 | 10185 |
| PAK1 | 10043 |
| MYH9 | 9224 |
| PAK2 | 9042 |
| MYH10 | 8632 |
| PPP1R12B | 8489 |
| CDC42 | 8342 |
| FLNA | 8318 |
| LIMK1 | 8062 |
| PPP1R12A | 7801 |
| PPP1CB | 6745 |
| MYL12B | 5703 |
| NF2 | 4139 |
| MYL9 | 1931 |
| MYLK | 1267 |
| CTTN | 514 |
| CALM1 | -1245 |
| MYH11 | -2243 |
| PAK3 | -5908 |
Hyaluronan metabolism
| 502 | |
|---|---|
| set | Hyaluronan metabolism |
| setSize | 15 |
| pANOVA | 0.00274 |
| s.dist | 0.447 |
| p.adjustANOVA | 0.0124 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC9A1 | 11350 |
| HYAL2 | 11213 |
| GUSB | 11175 |
| LYVE1 | 10724 |
| CHP1 | 10038 |
| CD44 | 9255 |
| HYAL1 | 8371 |
| HEXB | 7695 |
| STAB2 | 3499 |
| HAS3 | 3339 |
| HMMR | 1858 |
| ABCC5 | 1588 |
| HYAL3 | -893 |
| HEXA | -1967 |
| CEMIP | -5033 |
| GeneID | Gene Rank |
|---|---|
| SLC9A1 | 11350 |
| HYAL2 | 11213 |
| GUSB | 11175 |
| LYVE1 | 10724 |
| CHP1 | 10038 |
| CD44 | 9255 |
| HYAL1 | 8371 |
| HEXB | 7695 |
| STAB2 | 3499 |
| HAS3 | 3339 |
| HMMR | 1858 |
| ABCC5 | 1588 |
| HYAL3 | -893 |
| HEXA | -1967 |
| CEMIP | -5033 |
Translation
| 1266 | |
|---|---|
| set | Translation |
| setSize | 295 |
| pANOVA | 9.42e-40 |
| s.dist | -0.446 |
| p.adjustANOVA | 2.14e-37 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| MRPS6 | -9838 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| EEF1A1 | -9751 |
| NARS2 | -9738 |
| EEF1B2 | -9732 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| LARS1 | -9637 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| FARS2 | -9569 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| GeneID | Gene Rank |
|---|---|
| RPL23A | -9979 |
| RPL3 | -9957 |
| RPL5 | -9881 |
| MRPS6 | -9838 |
| RPS3A | -9834 |
| RPL7 | -9765 |
| EEF1A1 | -9751 |
| NARS2 | -9738 |
| EEF1B2 | -9732 |
| RPS27A | -9723 |
| RPS6 | -9699 |
| RPL14 | -9698 |
| RPS25 | -9664 |
| RPL22 | -9659 |
| LARS1 | -9637 |
| EIF4A2 | -9593 |
| RPS2 | -9591 |
| FARS2 | -9569 |
| RPL4 | -9549 |
| EIF3B | -9526 |
| RPL21 | -9511 |
| RPL34 | -9492 |
| GFM1 | -9467 |
| MRPS33 | -9440 |
| RPS20 | -9413 |
| RPL13A | -9402 |
| RPS23 | -9387 |
| RPL32 | -9345 |
| RPL6 | -9309 |
| MRPL50 | -9302 |
| RPS3 | -9298 |
| EEF1G | -9293 |
| RPL35A | -9291 |
| N6AMT1 | -9282 |
| MRPS25 | -9279 |
| RPS12 | -9270 |
| RPLP0 | -9227 |
| RPL12 | -9177 |
| RPS27 | -9175 |
| RPS7 | -9165 |
| RPLP2 | -9163 |
| MRPS27 | -9147 |
| RPL11 | -9117 |
| RPL17 | -9116 |
| EIF3E | -9049 |
| RPL27A | -9048 |
| RPS5 | -9042 |
| RPL10 | -9031 |
| IARS1 | -8999 |
| RPL30 | -8930 |
| RPL10A | -8928 |
| MRPS9 | -8917 |
| RPL36A | -8909 |
| RPL24 | -8901 |
| RPL18A | -8896 |
| RPS15A | -8883 |
| RPL18 | -8863 |
| RPS8 | -8861 |
| MRPL48 | -8859 |
| RPL31 | -8769 |
| RPS13 | -8724 |
| RPL26 | -8706 |
| MRPL24 | -8692 |
| RPS4X | -8648 |
| RPS29 | -8637 |
| RPL39 | -8635 |
| RPL29 | -8621 |
| FARSB | -8580 |
| RPS16 | -8579 |
| EARS2 | -8562 |
| RPS14 | -8541 |
| RPS10 | -8494 |
| MRPL46 | -8479 |
| EIF1AX | -8383 |
| KARS1 | -8380 |
| RPL23 | -8373 |
| RPL19 | -8338 |
| RPS21 | -8330 |
| RPS18 | -8321 |
| RPL7A | -8286 |
| RPS17 | -8281 |
| MRPS30 | -8262 |
| EIF3L | -8255 |
| AARS2 | -8248 |
| RPL22L1 | -8202 |
| EIF4B | -8190 |
| RPL35 | -8183 |
| RPL15 | -8169 |
| MRPS18B | -8125 |
| RPS28 | -8083 |
| MRPL17 | -8047 |
| GSPT2 | -7995 |
| MRPL32 | -7992 |
| AIMP1 | -7990 |
| RPS11 | -7975 |
| RPL38 | -7968 |
| MARS2 | -7955 |
| MRPL39 | -7936 |
| SARS2 | -7925 |
| RPL37 | -7861 |
| RPL27 | -7810 |
| RPS19 | -7806 |
| RPL13 | -7671 |
| WARS2 | -7615 |
| MRPL1 | -7594 |
| RPL41 | -7561 |
| SRPRB | -7520 |
| MRPL38 | -7496 |
| RPL36 | -7493 |
| MRPS2 | -7237 |
| MRPL42 | -7224 |
| MRPL9 | -7188 |
| EIF3H | -7091 |
| DAP3 | -7087 |
| MRPL45 | -6990 |
| DARS1 | -6939 |
| MRPS17 | -6909 |
| EIF5B | -6867 |
| RPL37A | -6833 |
| HARS1 | -6831 |
| RPL9 | -6821 |
| RPS24 | -6818 |
| EIF3M | -6817 |
| AARS1 | -6785 |
| MRPL14 | -6728 |
| MRPS14 | -6718 |
| RPS15 | -6703 |
| MRPS7 | -6677 |
| EIF2B3 | -6649 |
| RPL36AL | -6646 |
| RPSA | -6629 |
| PTCD3 | -6500 |
| TRAM1 | -6480 |
| EIF3J | -6448 |
| EPRS1 | -6350 |
| MRPS21 | -6319 |
| EEF2 | -6279 |
| LARS2 | -6268 |
| MRPS28 | -6255 |
| RPL8 | -6101 |
| TSFM | -6082 |
| SEC11C | -6046 |
| SARS1 | -6044 |
| RPLP1 | -6018 |
| PPA1 | -5970 |
| MRPL35 | -5957 |
| MRPL3 | -5916 |
| EEF1A1P5 | -5877 |
| EEF1D | -5664 |
| MRPS12 | -5654 |
| MRPL49 | -5619 |
| MRPL54 | -5616 |
| EIF2B5 | -5580 |
| MRRF | -5487 |
| MRPL11 | -5474 |
| MRPS26 | -5430 |
| SEC61A2 | -5333 |
| EIF3F | -5200 |
| EIF3D | -5158 |
| MT-RNR1 | -5094 |
| MRPL57 | -5039 |
| YARS2 | -5018 |
| MRPL34 | -4765 |
| EIF3C | -4716 |
| MRPL43 | -4449 |
| MRPL27 | -4262 |
| MRPS23 | -4230 |
| MRPL19 | -4123 |
| VARS1 | -4083 |
| MRPL58 | -3985 |
| RARS1 | -3944 |
| RPL28 | -3873 |
| MRPS31 | -3868 |
| MRPL12 | -3819 |
| RARS2 | -3810 |
| QARS1 | -3758 |
| WARS1 | -3717 |
| VARS2 | -3646 |
| FAU | -3618 |
| SRP72 | -3562 |
| MRPL55 | -3524 |
| UBA52 | -3490 |
| MRPL41 | -3438 |
| SRP9 | -3414 |
| AIMP2 | -3343 |
| MRPS35 | -3315 |
| MRPL18 | -3314 |
| EEF1A2 | -3246 |
| SEC61G | -3152 |
| MTIF2 | -3020 |
| PABPC1 | -2991 |
| MRPL40 | -2981 |
| MRPL15 | -2975 |
| SSR2 | -2917 |
| GADD45GIP1 | -2813 |
| EIF3G | -2746 |
| MRPS10 | -2725 |
| EEF1E1 | -2716 |
| EIF3I | -2580 |
| MRPL21 | -2473 |
| PPA2 | -2453 |
| MRPL2 | -2449 |
| MRPL30 | -2421 |
| MRPS22 | -2388 |
| EIF3K | -2369 |
| TRMT112 | -2296 |
| EIF2B1 | -2228 |
| MRPS34 | -2208 |
| MRPS18C | -2145 |
| MRPL47 | -2119 |
| GSPT1 | -2025 |
| MRPL4 | -1924 |
| MRPL16 | -1832 |
| SPCS1 | -1700 |
| RPL39L | -1661 |
| EIF2S1 | -1649 |
| MRPL20 | -1647 |
| IARS2 | -1595 |
| ERAL1 | -1389 |
| EIF3A | -1276 |
| NARS1 | -1189 |
| RPS26 | -1154 |
| SPCS2 | -977 |
| MRPS15 | -924 |
| SRP19 | -625 |
| FARSA | -514 |
| RPS27L | -496 |
| MRPS36 | -492 |
| MRPL22 | -462 |
| MT-RNR2 | -408 |
| MRPL13 | -237 |
| MRPL37 | 177 |
| MTIF3 | 221 |
| RPS4Y1 | 331 |
| MRPS16 | 350 |
| EIF2S2 | 554 |
| SRP68 | 787 |
| TARS2 | 801 |
| PARS2 | 910 |
| MRPS24 | 1048 |
| SSR1 | 1143 |
| SSR4 | 1294 |
| MRPS18A | 1407 |
| GFM2 | 1540 |
| MRPL36 | 1646 |
| EIF4E | 1661 |
| YARS1 | 1707 |
| TARS1 | 1786 |
| OXA1L | 1825 |
| RPS9 | 1841 |
| MRPL44 | 1847 |
| SPCS3 | 1967 |
| MRPS11 | 2087 |
| MRPS5 | 2484 |
| EIF2S3 | 2500 |
| SSR3 | 2510 |
| MRPL51 | 2595 |
| MRPL33 | 2637 |
| HARS2 | 2776 |
| EIF4EBP1 | 2825 |
| EIF5 | 2937 |
| DARS2 | 2971 |
| MT-TV | 3363 |
| TUFM | 3457 |
| CHCHD1 | 3643 |
| MRPL52 | 4004 |
| MRPL10 | 4156 |
| EIF2B4 | 4294 |
| SEC61B | 4322 |
| MTFMT | 4587 |
| MRPL23 | 4865 |
| APEH | 4945 |
| SRP14 | 5022 |
| RPL3L | 5150 |
| MTRF1L | 5386 |
| EIF4A1 | 5541 |
| AURKAIP1 | 5758 |
| RPL26L1 | 6001 |
| MRPL53 | 6626 |
| SEC11A | 6634 |
| GARS1 | 6727 |
| ETF1 | 6835 |
| RPN1 | 7151 |
| MARS1 | 7358 |
| SEC61A1 | 7486 |
| EIF2B2 | 7498 |
| EIF4H | 7768 |
| SRP54 | 7912 |
| SRPRA | 8301 |
| DDOST | 8464 |
| CARS2 | 8664 |
| RPN2 | 8874 |
| MRPL28 | 9785 |
| EIF4G1 | 10506 |
| CARS1 | 10656 |
Frs2-mediated activation
| 399 | |
|---|---|
| set | Frs2-mediated activation |
| setSize | 11 |
| pANOVA | 0.0105 |
| s.dist | 0.445 |
| p.adjustANOVA | 0.0369 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 11193 |
| MAP2K1 | 10148 |
| MAPK3 | 9750 |
| RAP1A | 7335 |
| MAP2K2 | 7222 |
| CRKL | 5250 |
| RAPGEF1 | 5102 |
| YWHAB | 4721 |
| BRAF | 4367 |
| FRS2 | -1144 |
| NTRK1 | -3793 |
| GeneID | Gene Rank |
|---|---|
| MAPK1 | 11193 |
| MAP2K1 | 10148 |
| MAPK3 | 9750 |
| RAP1A | 7335 |
| MAP2K2 | 7222 |
| CRKL | 5250 |
| RAPGEF1 | 5102 |
| YWHAB | 4721 |
| BRAF | 4367 |
| FRS2 | -1144 |
| NTRK1 | -3793 |
Regulated proteolysis of p75NTR
| 944 | |
|---|---|
| set | Regulated proteolysis of p75NTR |
| setSize | 11 |
| pANOVA | 0.0109 |
| s.dist | 0.443 |
| p.adjustANOVA | 0.0378 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NCSTN | 11452 |
| ADAM17 | 10964 |
| PSEN1 | 10429 |
| APH1B | 9474 |
| PSENEN | 7091 |
| NGFR | 7009 |
| TRAF6 | 4673 |
| NFKB1 | 2860 |
| APH1A | 2563 |
| RELA | -204 |
| PSEN2 | -6393 |
| GeneID | Gene Rank |
|---|---|
| NCSTN | 11452 |
| ADAM17 | 10964 |
| PSEN1 | 10429 |
| APH1B | 9474 |
| PSENEN | 7091 |
| NGFR | 7009 |
| TRAF6 | 4673 |
| NFKB1 | 2860 |
| APH1A | 2563 |
| RELA | -204 |
| PSEN2 | -6393 |
Translesion synthesis by REV1
| 1273 | |
|---|---|
| set | Translesion synthesis by REV1 |
| setSize | 16 |
| pANOVA | 0.00221 |
| s.dist | -0.442 |
| p.adjustANOVA | 0.0107 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPA1 | -9799 |
| RPS27A | -9723 |
| RFC3 | -9405 |
| RPA3 | -9220 |
| RFC4 | -8897 |
| RFC5 | -7574 |
| REV1 | -7478 |
| PCNA | -7101 |
| REV3L | -5347 |
| RFC1 | -5080 |
| RPA2 | -4811 |
| UBA52 | -3490 |
| UBB | 1026 |
| RFC2 | 5478 |
| UBC | 6135 |
| MAD2L2 | 9324 |
| GeneID | Gene Rank |
|---|---|
| RPA1 | -9799 |
| RPS27A | -9723 |
| RFC3 | -9405 |
| RPA3 | -9220 |
| RFC4 | -8897 |
| RFC5 | -7574 |
| REV1 | -7478 |
| PCNA | -7101 |
| REV3L | -5347 |
| RFC1 | -5080 |
| RPA2 | -4811 |
| UBA52 | -3490 |
| UBB | 1026 |
| RFC2 | 5478 |
| UBC | 6135 |
| MAD2L2 | 9324 |
Trafficking of GluR2-containing AMPA receptors
| 1246 | |
|---|---|
| set | Trafficking of GluR2-containing AMPA receptors |
| setSize | 12 |
| pANOVA | 0.00828 |
| s.dist | 0.44 |
| p.adjustANOVA | 0.0301 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| AP2A1 | 11340 |
| AP2A2 | 10223 |
| NSF | 9870 |
| AP2M1 | 8799 |
| PRKCB | 8577 |
| AP2S1 | 8045 |
| PICK1 | 6735 |
| GRIA4 | 5498 |
| TSPAN7 | 5060 |
| AP2B1 | 2910 |
| PRKCA | -2408 |
| GRIP1 | -9719 |
| GeneID | Gene Rank |
|---|---|
| AP2A1 | 11340 |
| AP2A2 | 10223 |
| NSF | 9870 |
| AP2M1 | 8799 |
| PRKCB | 8577 |
| AP2S1 | 8045 |
| PICK1 | 6735 |
| GRIA4 | 5498 |
| TSPAN7 | 5060 |
| AP2B1 | 2910 |
| PRKCA | -2408 |
| GRIP1 | -9719 |
AKT phosphorylates targets in the cytosol
| 8 | |
|---|---|
| set | AKT phosphorylates targets in the cytosol |
| setSize | 14 |
| pANOVA | 0.00465 |
| s.dist | 0.437 |
| p.adjustANOVA | 0.0189 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CASP9 | 11186 |
| GSK3A | 9979 |
| CHUK | 8723 |
| AKT1S1 | 8410 |
| BAD | 7263 |
| GSK3B | 7147 |
| MKRN1 | 6583 |
| AKT1 | 6498 |
| MDM2 | 6043 |
| CDKN1A | 5537 |
| AKT2 | 5502 |
| TSC2 | 4311 |
| CDKN1B | -3127 |
| AKT3 | -8810 |
| GeneID | Gene Rank |
|---|---|
| CASP9 | 11186 |
| GSK3A | 9979 |
| CHUK | 8723 |
| AKT1S1 | 8410 |
| BAD | 7263 |
| GSK3B | 7147 |
| MKRN1 | 6583 |
| AKT1 | 6498 |
| MDM2 | 6043 |
| CDKN1A | 5537 |
| AKT2 | 5502 |
| TSC2 | 4311 |
| CDKN1B | -3127 |
| AKT3 | -8810 |
Mucopolysaccharidoses
| 681 | |
|---|---|
| set | Mucopolysaccharidoses |
| setSize | 11 |
| pANOVA | 0.0122 |
| s.dist | 0.437 |
| p.adjustANOVA | 0.0412 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GNS | 11410 |
| GUSB | 11175 |
| GLB1 | 10217 |
| ARSB | 10041 |
| GALNS | 9046 |
| HYAL1 | 8371 |
| SGSH | 2887 |
| NAGLU | 1714 |
| IDS | 1338 |
| HGSNAT | -737 |
| IDUA | -6370 |
| GeneID | Gene Rank |
|---|---|
| GNS | 11410 |
| GUSB | 11175 |
| GLB1 | 10217 |
| ARSB | 10041 |
| GALNS | 9046 |
| HYAL1 | 8371 |
| SGSH | 2887 |
| NAGLU | 1714 |
| IDS | 1338 |
| HGSNAT | -737 |
| IDUA | -6370 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.0.2 (2020-06-22)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 18.04.5 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.7.1
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.7.1
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.1.0 GGally_2.0.0
## [3] beeswarm_0.2.3 gtools_3.8.2
## [5] echarts4r_0.3.2 mitch_1.0.6
## [7] MASS_7.3-52 fgsea_1.14.0
## [9] gplots_3.0.3 DESeq2_1.28.1
## [11] SummarizedExperiment_1.18.1 DelayedArray_0.14.0
## [13] matrixStats_0.56.0 Biobase_2.48.0
## [15] GenomicRanges_1.40.0 GenomeInfoDb_1.24.2
## [17] IRanges_2.22.2 S4Vectors_0.26.1
## [19] BiocGenerics_0.34.0 reshape2_1.4.4
## [21] forcats_0.5.0 stringr_1.4.0
## [23] dplyr_1.0.0 purrr_0.3.4
## [25] readr_1.3.1 tidyr_1.1.0
## [27] tibble_3.0.1 ggplot2_3.3.2
## [29] tidyverse_1.3.0
##
## loaded via a namespace (and not attached):
## [1] colorspace_1.4-1 ellipsis_0.3.1 rprojroot_1.3-2
## [4] XVector_0.28.0 fs_1.4.2 rstudioapi_0.11
## [7] bit64_0.9-7 AnnotationDbi_1.50.1 fansi_0.4.1
## [10] lubridate_1.7.9 xml2_1.3.2 splines_4.0.2
## [13] geneplotter_1.66.0 knitr_1.29 jsonlite_1.7.0
## [16] broom_0.5.6 annotate_1.66.0 dbplyr_1.4.4
## [19] shiny_1.5.0 compiler_4.0.2 httr_1.4.1
## [22] backports_1.1.8 assertthat_0.2.1 Matrix_1.2-18
## [25] fastmap_1.0.1 cli_2.0.2 later_1.1.0.1
## [28] htmltools_0.5.0 tools_4.0.2 gtable_0.3.0
## [31] glue_1.4.1 GenomeInfoDbData_1.2.3 fastmatch_1.1-0
## [34] Rcpp_1.0.4.6 cellranger_1.1.0 vctrs_0.3.1
## [37] gdata_2.18.0 nlme_3.1-148 xfun_0.15
## [40] testthat_2.3.2 rvest_0.3.5 mime_0.9
## [43] lifecycle_0.2.0 XML_3.99-0.3 zlibbioc_1.34.0
## [46] scales_1.1.1 hms_0.5.3 promises_1.1.1
## [49] RColorBrewer_1.1-2 yaml_2.2.1 memoise_1.1.0
## [52] gridExtra_2.3 reshape_0.8.8 stringi_1.4.6
## [55] RSQLite_2.2.0 highr_0.8 genefilter_1.70.0
## [58] desc_1.2.0 caTools_1.18.0 BiocParallel_1.22.0
## [61] rlang_0.4.6 pkgconfig_2.0.3 bitops_1.0-6
## [64] evaluate_0.14 lattice_0.20-41 htmlwidgets_1.5.1
## [67] bit_1.1-15.2 tidyselect_1.1.0 plyr_1.8.6
## [70] magrittr_1.5 R6_2.4.1 generics_0.0.2
## [73] DBI_1.1.0 pillar_1.4.4 haven_2.3.1
## [76] withr_2.2.0 survival_3.2-3 RCurl_1.98-1.2
## [79] modelr_0.1.8 crayon_1.3.4 KernSmooth_2.23-17
## [82] rmarkdown_2.3 locfit_1.5-9.4 grid_4.0.2
## [85] readxl_1.3.1 data.table_1.12.8 blob_1.2.1
## [88] reprex_0.3.0 digest_0.6.25 pbmcapply_1.5.0
## [91] xtable_1.8-4 httpuv_1.5.4 munsell_0.5.0
END of report